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Background
It has been estimated in meta-analyses that about 70% of individuals in the general 
population have been exposed to at least one trauma during their life (Benjet 
et al., 2016). The life time prevalence of posttraumatic stress disorders (PTSD) is 
estimated about 7.8% in the Netherlands (de Vries & Olff, 2009) and for instance 
10% in the USA (Kessler, Petukhova, Sampson, Zaslavsky, & Wittchen, 2012). The 
year prevalence of PTSD in the Netherlands is 3,3 % (de Vries & Olff, 2009). This 
percentage contrasts with the 12.4% (95% CI 4.0–20.8%) estimated year prevalence 
of PTSD among individuals with psychotic disorders (Achim et al., 2011). Compared 
to single diagnosis individuals, individuals with both a psychotic disorder and PTSD are 
at risk for even worse symptomatology and  functioning (Lysaker & LaRocco, 2008; 
Mueser, Lu, Rosenberg, & Wolfe, 2010; Sautter et al., 1999) and for more future re-
exposure to traumatic events (Kuijpers, van der Knaap, & Winkel, 2012; Maniglio, 
2009). We don’t know from studies what the impact is on economic costs of this 
particular combination of psychosis and PTSD. But is seems reasonable to assume that 
compared to the single diagnosis groups costs will be higher in terms of both health 
care costs and productivity loss.
In the light of the knowledge that the comorbidity of PTSD creates even more 
disadvantages to patients with psychotic disorders a relevant question is: do we then 
effectively detect and treat trauma and PTSD in this patient group? One explorative 
hallmark study addressed the issue of assessing trauma exposure and PTSD (Lommen 
& Restifo, 2009). The authors found that about two third of the worst traumas of 
psychotic patients’ were recorded in medical charts but that not one patient (0%) with 
a current full blown co morbid PTSD (9.1%) had that diagnosis reported in the medical 
chart. On top of the relative underdetection of trauma and the striking underdiagnosis 
of PTSD it has been shown that the chance of being treated for a once recorded PTSD is 
extremely slim for a person with a psychotic disorder (Meyer, Farrell, Kemp, Blakey, & 
Deacon, 2014). It is widely accepted and considered self-evident by clinicians (Becker, 
Zayfert, & Anderson, 2004; Foa, Zoellner, Feeny, Hembree, & Alvarez-Conrad, 2002; 
Gairns, Alvarez-Jimenez, Hulbert, McGorry, & Bendall, 2013; van Minnen, Hendriks, & 
Olff, 2010) and researchers (Olatunji, Cisler, & Tolin, 2010; Ronconi, Shiner, & Watts, 
2014; Spinazzola, Blaustein, & van der Kolk, 2005; van Minnen, Harned, Zoellner, & 
Mills, 2012)  that psychosis is a contraindication for PTSD treatment. Aspects of the 
history and motives for considering psychosis a contraindication for PTSD treatment 
will be briefly described in following paragraphs; anyhow the consequence is that in 
this patient population research into the clinical effects of trauma-focused treatments 
on PTSD-symptoms and co morbid symptoms (such as the psychotic symptoms) is 
scarce and cost effect studies on the economic impact  are lacking altogether.
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This dissertation addresses two main issues: PTSD detection and PTSD 
treatment effects in psychotic individuals in care as usual. The first goal  is to validate 
a trauma and PTSD screening instrument for use in the psychosis population and to 
determine the prevalence of trauma exposure and PTSD in psychotic patients in mental 
health care. The second pivotal purpose is to examine various effects of psychological 
PTSD treatments as compared to no treatment; that is, effects on PTSD-symptoms 
(primary effects), on comorbid symptoms such as psychosis (secondary effects) and 
on relative financial costs concomitant with relative effects on health gain or clinical 
diagnosis (cost-effectivity). 
In this general introduction most of the terms, concepts and backgrounds 
that are of importance in this dissertation will be clarified. An outline of this thesis is 
provided at the end.
Psychotic disorders 1
People who suffer from symptoms of ‘schizophrenia or other forms of psychotic 
disorders’ (APA, 2000) may present so called positive and negative symptoms. Positive 
symptoms are defined as excesses or distortions of normal functioning or as aberrant 
responses and these include delusions, hallucinations and disorganized speech and/
or behavior. Negative symptoms are defined as functionally impairing deficits such as 
affective flattening, alogia, avolition or anhedonia. It is the specific mix of the above 
mentioned symptoms, as well as their duration, course  and concurrence with mood 
disorders, that determine the DSM-IV-TR diagnosis of a particular psychotic disorder 
(e.g. ‘schizophrenic disorder’, ‘schizoaffective disorder’) or a mood disorder with 
psychotic features.
The life time prevalence of psychotic disorders is 0.4% (Saha, Chant, Welham, 
& McGrath, 2005). Psychotic conditions, in particular schizophrenic disorders, belong 
to the world’s most functionally impairing psychiatric conditions (Murray et al., 2012; 
Neil, Carr, Mihalopoulos, Mackinnon, & Morgan, 2014b). The health-related economic 
costs of psychotic disorders are very high (Neil et al., 2014a), in particular due to 
hospitalization and loss of jobs (Carr, Neil, Halpin, Holmes, & Lewin, 2003). 
Posttraumatic stress disorder (PTSD) 2
PTSD as described in the DSM-IV-TR (APA, 2000) may develop as a consequence of 
experiencing or witnessing actual or threatened death or serious injury, or a threat to 
the physical integrity of self or others. During exposure to the traumatic event the 
1 In this thesis the DSM-IV-TR classification (APA, 2000) was used by design for inclusion and assessment of  
 effects. The DSM5 (APA, 2013) will be cited only if relevant. See Discussion for implications of differences  
 between the two DSM manuals.
2 In this thesis the DSM-IV-TR classification (APA, 2000) was used by design for inclusion and assessment of  
 effects. The DSM5 (APA, 2013) will be cited only if relevant. See Discussion for implications of differences  
 between the two DSM manuals.
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person’s response involves intense fear, helplessness, or horror. In PTSD the traumatic 
event is recurrently and intrusively re-experienced, the person is persistently avoidant 
of stimuli associated with the trauma and finally symptoms of increased arousal (not 
present before the trauma) impede the patient’s functioning. 
Of particular interest in the present thesis are issues of secondary 
symptomatology and costs of PTSD. Most patients with PTSD have at least one 
comorbid disorder (80-90%) (van Minnen, Zoellner, Harned, & Mills, 2015), most 
commonly major depressive disorder (50%) (Rytwinski, Scur, Feeny, & Youngstrom, 
2013). In addition, among all psychiatric disorders, PTSD constitutes one of the 
highest ranking disorders in terms of personal burden and societal cost (Greenberg 
et al., 1999; Issakidis, Sanderson, Corry, Andrews, & Lapsley, 2004; Kessler, Sonnega, 
Bromet, Hughes, & Nelson, 1995; Kessler, 2000).
Trauma, psychosis and PTSD 
Trauma, psychosis and PTSD are interlinked in multiple ways (Fowler et al., 2006). 
Obviously PTSD is linked to trauma by definition (APA, 2000) but the the relationship 
between trauma and psychosis is more complicated. Researchers have begun to 
unravel some of the pathways linking trauma to psychotic disorders. Firstly, psychotic 
individuals are likely to have been exposed to traumatic experiences in childhood 
about three times more than individuals in the general population (Matheson, 
Shepherd, Pinchbeck, Laurens, & Carr, 2013; Varese et al., 2012). Childhood trauma 
contributes to the risk for and maintenance of psychotic experiences (Björkenstam, 
Burström, Vinnerljung, & Kosidou, 2016; Trotta, Murray, & Fisher, 2015). Reviews and 
meta-analyses have consistently concluded that (childhood) trauma increases the risk 
of developing psychotic symptoms (Bendall, Alvarez-Jimenez, Hulbert, McGorry, & 
Jackson, 2012; Bentall, Wickham, Shevlin, & Varese, 2012; Varese et al., 2012) and 
this association is not explained by genetic confounding (Alemany et al., 2013). 
Causal dose-response-associations were consistently found (Varese et al., 2012), e.g. 
a five-times more likely diagnosis of a psychotic disorder in association with two types 
of adversity (e.g., sexual abuse and bullying), and a 30-times greater likelihood of 
psychosis after three adversities (Shevlin, Houston, Dorahy, & Adamson, 2007). The 
onset of first psychotic symptoms related to child abuse is not necessarily delayed until 
adulthood, but may occur already in childhood (Arseneault et al., 2011). Secondly, 
besides childhood traumas, traumas in adulthood are also strongly associated with 
psychosis, in particular with a subsequent onset of psychotic experiences and disorders 
(Linscott & Van Os, 2013). In short, research shows that trauma is a potent risk 
factor for psychosis. Therefore, it has been suggested that trauma should be included 
in the list of known risk factors for psychotic experiences, such as age, minority or 
migrant status, low income and education, unemployment, single status, alcohol and 
cannabis use, stress, urbanization and a family history of mental illness (Linscott & 
Van Os, 2013). 
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The connection between trauma and psychosis may also work the other way 
around, i.e. that psychosis may evoke traumatic experiences and eventually PTSD 
(Mueser et al., 2010; Rodrigues & Anderson, 2017). One example is that terrifying 
psychotic experiences (e.g., the delusion of being poisoned by loved ones) may cause 
the onset of PTSD; a second type of psychosis-related PTSD might occur due to the 
experience of threatening situations such as seclusion, police encounters or fights.
With regard to the relationship between PTSD and psychosis, there is an 
increased likelihood, relative to individuals in the general population, that a person with 
PTSD will experience psychotic symptoms (OR=3.55, 95% CI=2.74-4.55) (Sareen, 
Cox, Goodwin, & Asmundson, 2005). Vice versa, PTSD co-occurs in about 12.4% of 
psychotic individuals (95% CI, 4.0%-20.8%) (Achim et al., 2011). A systematic review 
including 34 studies on the co morbidity of PTSD and schizophrenic disorders  indicates 
that this combination is associated with increases in positive symptomology, general 
psychopathology and neurocognitive impairment as well as poorer functioning and 
quality of life (Seow et al., 2016). Moreover, treatment adherence and treatment 
response to antipsychotic medication are worse for psychotic individuals with a history 
of (childhood) trauma (Hassan & De Luca, 2015; Lecomte, Corbiere, & Laisne, 2006). 
The combination of psychosis and PTSD has been found to worsen the course and 
prognosis of the psychotic disorders (Lysaker & LaRocco, 2008; Sautter et al., 1999). 
What complicates the interrelationships between trauma, PTSD and psychosis 
even further is that compared to the general population both psychotic patients 
(Maniglio, 2009) and PTSD patients (Kuijpers et al., 2012) are more likely to 
experience new traumas (i.e. revictimization). As a result, revictimization presumably 
increases psychopathology and costs. 
The joint impact of all negative interactions mentioned makes for a more severe 
symptomatology and impairment, poorer prognosis and elevated economic costs.
The clinicians’ dilemma
Based on the negative consequences of interactions between trauma, PTSD and 
psychosis it would seem natural to assume that clinicians in the past paid attention 
to the screening and treatment of PTSD in psychotic individuals. However, as it turns 
out  (Bradley, Greene, Russ, Dutra, & Westen, 2005; Powers, Halpern, Ferenschak, 
Gillihan, & Foa, 2010; Ronconi et al., 2014) little empirical studies on this particular 
topics are available, which has not helped clinicians to address the issue with solid 
knowledge and confidence. And indeed PTSD, though fairly common in psychotic 
patients (Achim et al., 2011), is rarely or not addressed in clinical practice (Foa, 
McLean, Capaldi, & Rosenfield, 2013; Lommen & Restifo, 2009; Meyer et al., 2014; 
Shiner et al., 2013). Possibly, once clinicians have established the presence of a 
psychosis, they stop paying attention to other mental problems and conditions such 
as the patient’s trauma history and possible PTSD (Cusack, Wells, Grubaugh, Hiers, 
& Frueh, 2007). In addition there is evidence (Meyer et al, 204; Becker et al., 2004; 
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van Minnen et al., 2012; Read, Hammersley, & Rudegeair, 2007) that clinicians are 
scared that addressing trauma may cause harm to psychotic patients. They believe 
that talking about trauma may evoke adverse events (e.g. suicide) and/or exacerbate 
symptoms of for instance psychosis, depression or the PTSD. The likelihood of asking 
about traumas is minimized in the face of these concerns. 
Besides the fear of doing harm to patients, there is another and truly tragic reason 
for not talking with patients about their trauma history and that is disbelief about the 
truthfulness or plausibility of psychotic patients’ trauma reports. In psychiatry there is a 
long history of clinicians reframing psychotic patients’ reports of trauma to fantasies, i.e. 
to psychotic fantasies (delusions) or to wish-fulfilling childhood fantasies. This tradition 
inadvertently started with Sigmund Freud (Freud, 1963). Freud made a notorious shift 
from the so called ‘seduction theory’ of psychiatric problems that stated that real trauma 
caused later symptomatology, to the ‘infantile sexuality theory’ that postulated impulses 
and fantasies in the individual’s own mind as the cause of psychopathology (Masson, 
1984). This shift set a powerful scene for generations of clinicians asserting that 
psychiatric problems do not stem from real childhood trauma. Freud’s ‘infantile sexuality 
theory’ has given rise to much criticism for many decades (Masson, 1984; Rush, 1996), 
but even so the theory has held position for a long time (Karon & Widener, 1999):
Many schizophrenics have talked about incest, sexual abuse, and 
physical abuse as problems; but such talk has almost always been 
dismissed as the ravings of lunatics (Rieger, 1896). When Freud 
reported that the incest memories related in psychoanalysis were 
revealed more often to be fantasies than real events, psychology, 
psychiatry, and psychoanalysis falsely generalized this conclusion 
to all patients. It was believed incest was a rare event (Strachey 
& Jones, cited in Masson, 1984, p. 213). Interestingly, Freud 
continued to say that many memories of incest were undoubtedly 
of real events (Freud, 1917/1963, p. 370). (p.199)
The assumption was that actual childhood traumas such as incest were rare. 
Consequently, the many reports of trauma were considered not ‘real’, yet wish-fulfilling 
fantasies or signs of psychosis, thus trivializing the impact of childhood trauma. From 
a historic perspective it is interesting that this view was still prevailing only decades 
ago -. an example is found in the chapter on incest (Henderson, 1975) in the leading 
1975 Comprehensive Textbook of Psychiatry (Sadock, Kaplan, & Freedman, 1975). 
Here it was assumed without empirical reference that the prevalence of incest was 
about 1 in 1 million girls/women. Girls in incestuous relation with their father were 
described to “collude in the incestuous liaison and play an active and even initiating 
role in establishing the pattern”. Protest by the daughter against the incest, if 
Chapter 1
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present at all, was supposed to be motivated out of revenge or anger “evoked by 
the perception of withdrawal of the father’s attention”. The author stated that there 
was little agreement about the role of father-daughter incest as a source of serious 
subsequent psychopathology. Instead he wrote that incest often was pleasurable, 
mutually accepted, and moreover, possibly protective of becoming psychotic later in life 
(sic, italics PdB) (Henderson, 1975):
The father-daughter liaison satisfies instinctual drives in a setting 
where mutual alliance with an omnipotent adult condones the 
transgression. Moreover, the act offers an opportunity to test in 
reality an infantile fantasy whose consequences are found to be 
gratifying and pleasurable. It has even be suggested that the Ego’s 
capacity for sublimation is favored by the pleasure afforded by incest 
and that such incestuous activity diminishes the subject’s chance 
of psychosis and allows a better adjustment to the external world.  
There is often found little deleterious influence on the subsequent 
personality of the incestuous daughter. One study found that the 
vast majority of them to be none the worse for the experience.  
(p. 1537).
Hence, historically a tangle of empirically unsubstantiated statements, theories and 
assumptions has led to the widespread reluctance or hesitation to ask and talk about 
traumas in patients with psychosis. As an unavoidable consequence, PTSD is highly 
under-adressed. 
It was not until 1999 (Goodman et al., 1999)  that a first empirical study 
demonstrated that assessments of trauma history and PTSD among men and women 
with severe mental illness yielded reliable information.
Exclusion from empirical research 
The clinical paradigm of excluding psychotic patients from trauma-focused treatment 
was shared with researchers’attitudes and demeanor: psychosis has been identified 
as the number one exclusion criterion in PTSD treatment efficacy research (Ronconi 
et al., 2014; Bradley et al. 2005; Powers et al., 2010). The authors of a meta-analysis 
of randomized clinical PTSD outcome studies (Bradley et al., 2005) concluded 
that “none of the studies addressed the issue of treatment of PTSD with comorbid 
psychotic symptoms [...], typically without the reliability of that determination 
reported”. Strikingly ironically this perceptive comment is followed by the authors’ 
recommendation that “[…] future studies should impose only those exclusion criteria 
that are medically necessary or that a reasonable clinician in practice would impose 
(e.g., schizophrenia)” (italics PdB). A decade later, in 2014 (Powers et al., 2010) 
General introduction
Ch
ap
te
r 1
15
a psychosis exclusion rate of 93% was still found in PTSD studies. Apparently, the 
exclusion of patients with psychotic disorders from trauma-focused PTSD treatment 
is widely accepted, tenacious and persistent, though not empirically validated. It’s a 
pre-scientific paradigm in academic PTSD treatment studies. 
Consequentially, scientists and clinicians together maintained the status quo 
of not providing trauma-focused treatment, deterring the development of evidence-
based  guidelines regarding trauma-focused treatments in patients with psychotic 
disorders. In practice, clinicians had to rely or fall back on non-validated assumptions, 
clinical impressions and practice-based ‘evidence’, which in this case led to under-
diagnosis and under-treatment. The exclusion paradigm in clinical practice is not to be 
dismissed as a part of history. For example, in the Netherlands 67% of psychologists 
trained in trauma-focused PTSD treatment (EMDR therapy and exposure therapy) 
considered a comorbid diagnosis of psychotic disorders a contraindication for PTSD 
treatment (van den Berg & van Minnen, 2014). Only in the last decade publications 
(Read et al., 2007; Frueh, Cusack, Grubaugh, Sauvageot, & Wells, 2006) describe 
clinicians and clinical staffs trying to develop trauma-focused treatment programs 
for people with psychotic disorders, and to go beyond their own or their colleagues’ 
fearful reluctance. This is good news for patients who have expressed pain and 
suffering inflicted by clinicians who in the eys of patients displayed abstinent behavior, 
disbelief or aloof skepticism when the patient revealed his or her traumas (Lothian 
& Read, 2002). But except for  clinicians, the efforts of researchers are very much 
needed too in contributing to the development of valid treatment strategies.
Trauma-focused treatments for PTSD
Trauma-focused cognitive behavioral therapy (TF-CBT) is an effective treatment 
for PTSD (Bisson, Roberts, Andrew, Cooper, & Lewis, 2013; Watts et al., 2013). TF-
CBT for PTSD has a relatively short duration of 8 to 12 sessions with an optimum 
of 90 minutes per sessions Bisson et al., 2013; Bradley et al., 2005; Foa, Keane, & 
Friedman, 2000; Seidler & Wagner, 2006). One of the key ingredients of TF-CBT 
next to cognitive restructuring is prolonged exposure (PE). PE takes the form of 
repeated imaginal exposure to memories of traumatic events and exposure in-vivo to 
trauma-related stimuli that are avoided (Bisson et al., 2013;  Foa, Keane, & Friedman, 
2000; Seidler & Wagner, 2006; Paunovic, 1997; Craske, Treanor, Conway, Zbozinek, 
& Vervliet, 2014) as described in a treatment manual (Foa, Hembree, & Rothbaum, 
2007). At present, the body of evidence for the efficacy of TF-CBT/PE for PTSD is 
the most comprehensive among the psychological therapies for PTSD (Committee 
on Treatment of Posttraumatic Stress Disorder, 2008; Van Balkom et al., 2013; 
WHO, 2013).
Eye movement desensitization and reprocessing therapy (EMDR) (Shapiro, 
2001) is also a well-established therapy for PTSD (Bradley et al., 2005; Foa et al., 2000; 
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Seidler & Wagner, 2006; Taylor, 1998). The therapeutic effects are similar to those in 
TF-CBT and the evidence is strong enough to recommend EMDR for the treatment of 
PTSD (Bradley et al., 2005; Bisson et al., 2013; Watts et al., 2013; WHO, 2013).
In summary, TF-CBT/PE and EMDR are recognized trauma focused treatments 
and both are recommended as psychotherapies of choice to treat PTSD. Thus, why 
not apply these therapies to PTSD in psychosis? Indeed, the crucial starting point for 
this dissertation is that, in spite of what is widely assumed and adhered to in research 
and clinical practice, to date there is no empirical evidence whatsoever supporting 
the notion that the guideline psychotherapies for PTSD are not helpful or even 
harmful in the treatment of PTSD in psychotic patients (see for a critical discussion of 
international PTSD treatment guidelines (De Jongh et al., 2016).
Cost effects of PTSD treatment in patients with psychotic disorders
In a veteran PTSD population it has been found that outpatient PTSD treatment is more 
cost-effective than inpatient treatment (Fontana & Rosenheck, 1997). Review studies 
on pharmacological and non pharmacological interventions for anxiety disorders indicate 
that evidence based treatments, particularly CBT, is cost-effective compared to care as 
usual (Issakidis, 2004; Mihalopoulos, Baxter, Whiteford, & Vos, 2014) - notwithstanding 
the fact that the reviewed studies widely differ in design, methodological quality and 
context, which makes comparisons difficult (Mihalopoulos et al., 2014). 
With regard to PTSD it has been proven that implementing the PTSD guideline 
treatments for adults is cost-effective for TF-CBT and to a lesser extent for selective 
serotonin reuptake inhibitors (SSRIs) (Mihalopoulos et al., 2015); similar economic 
benefits were ascertained in youth care community provider agencies (Dopp, Hanson, 
Saunders, Dismuke, & Moreland, 2017; Gospodarevskaya & Segal, 2012). 
 In view of our study design we specifically examined the literature for cost-
effectiveness studies on prolonged exposure (PE), on EMDR and on PTSD in patients 
with psychosis. We found two studies examining cost-effectiveness of PE. In one 
study (Le, Doctor, Zoellner, & Feeny, 2014) PE was compared to a pharmacological 
treatment (Sertraline) in a group of PTSD patients and the results showed PE to be the 
most cost effective of the two interventions.. In the second study (Tuerk et al., 2013) 
PE was found to be cost-effective in the PTSD treatment of veterans, mainly due to 
reductions in mental health service utilization. Surprisingly, no studies examining cost-
effectiveness of EMDR were found, which would make our study the first to explore 
cost-effectiveness of EMDR. We also didn’t find research on the cost effectiveness of 
PTSD treatment in patients with psychotic disorders; the practice of treating PTSD 
in psychotic patients is so new that studies in this field have firstly targeted clinical 
effects and not yet the cost effects. Yet given the fact that the clinical results are 
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hopeful, economic studies are welcome. Especially since both PTSD (Greenberg et 
al., 1999; Issakidis et al., 2004; Kessler et al., 1995; Beard, Weisberg, & Keller, 2010)
and psychotic disorders (Murray et al., 2012; Carr et al., 2003; Neil et al., 2014b) are 
associated with considerable economic costs due to health care (e.g. medication, family 
doctor, admission to hospital) and due to productivity loss (in jobs and household). 
And as described, the combined diagnosis of psychosis and PTSD guarantees a raise 
in complexity and intensity of symptoms and dysfunctioning and thereby probably 
a raise in costs too. Therefore it seems reasonable to assume that successful PTSD 
treatment might reduce costs by reducing the primary outcome symptomatology 
(PTSD) and possibly also secondary outcomes such as psychosis or social functioning. 
At this moment, we have no way of knowing how financial costs  hypothetically will 
change as a consequence of treatment. The aim of the cost-effectiveness study is to 
provide some insight in the economics of psychological PTSD treatment in patients 
with psychosis. This is of use for policy makers and clinicians in mental health care 
who must decide on implementations of new treatment applications.
Outline of this dissertation
First we started with conducting a pilot study examining the feasibility and effectivity 
of PTSD treatment in psychotic patients. The feasibility study was followed up by 
a large single-blind multi-centered randomized controlled trial, named ‘Treating 
Trauma In Psychosis’ (TTIP). This dissertation is one of three dissertations that 
present the findings derived from the TTIP project. This dissertation focusses on 
TTIPs research questions regarding screening and treatment effects. The screening 
question comprises of developing a valid PTSD screening instrument for the psychosis 
population and of determining PTSD prevalence. The treatment questions relate to 
the primary (PTSD), secondary (e.g. psychosis) and cost effects of trauma-focused 
treatments in patients with psychotic disorders.
Chapter 2 describes a pilot study assessing the feasibility and efficacy of 
trauma-focused treatment, being either prolonged exposure or EMDR therapy in a 
randomized time-controlled study including 10 patients with psychosis and PTSD.
In chapter 3 the design of the TTIP study is presented. Here we provide a detailed 
description as to how we examined various issues involving the under-diagnosis of 
PTSD, the PTSD treatment effects on PTSD and other types of symptomatology, on 
safety and various adverse events, the beliefs concerning the supposed harm that 
PTSD treatment might inflict, the economic costs, and possible working mechanisms. 
Chapter 4 firstly describes how we validated the short PTSD screening 
instrument Trauma Screening Questionnaire (TSQ; Brewin, 2002) in the population 
of patients with psychotic disorders. Bare in mind the empirical finding that in 
clinical practice little attention is given to prior exposure to traumatic events and its 
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consequences in terms of PTSD in patients with psychosis. So a practical and validated 
tool might help to improve PTSD assessment. Secondly, this chapter describes how 
we used the validated TSQ to estimate the prevalence of PTSD in the population of 
patients with psychosis in mental health care in the Netherlands.
Chapter 5 describes the primary effects of the experimental trauma-focused 
treatments prolonged exposure and EMDR for PTSD in a sample of patients with 
psychotic disorders. Our purpose was to answer the question whether PTSD-
diagnosis, PTSD symptom severity and posttraumatic cognitions would change as a 
consequence of PTSD treatment. In an RCT design the results of the experimental 
conditions of PE and EMDR are compared to the results of a waiting list condition at 
posttreatment and at 6 months follow up. 
Chapter 6 addresses the concerns of clinicians that trauma-focused treatment 
in patients with psychotic disorders might have detrimental side effects on other 
clusters of symptomatology, in particular psychotic symptoms. Using an RCT design, 
the research question was what the secondary effects were of prolonged exposure 
and EMDR in terms of symptoms of psychosis and depression, and social functioning. 
Effects of EMDR and PE were compared to a waitlist condition at posttreatment and 
at 6 months follow up.
Chapter 7 presents the economic evaluation of the trauma-focused 
interventions of our TTIP clinical trial. The cost-utility of gains in quality adjusted 
life years (QALYs) and the cost-effectiveness of loss of PTSD diagnosis (LoD) were 
examined. The aim was to examine our assumption that costs associated with the 
EMDR and PE treatments are at least acceptable and maybe even favorable compared 
to the effects of a waitlist on QALYs and LoD. Conditions were compared at 6 month 
follow-up and checked for consolidation at 12 month follow-up.
Chapter 8 presents the General Discussion. It provides a critical review of the 
studies and its results, and also addresses the needs for future research.
Chapter 9 contains summaries, curriculum vitae and publications
• 9.1 English summary.
• 9.2 Dutch summary / Nederlandse samenvatting.
• 9.3 Curriculum vitae 
• 9.4 List of publications.
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The present study uses a within-group controlled design to examine the efficacy and 
safety of two psychological approaches to posttraumatic stress disorder (PTSD) in 10 
patients with a concurrent psychotic disorder. Patients were randomly assigned either 
to prolonged exposure (PE; N = 5) or eye movement desensitization and reprocessing 
(EMDR; N = 5). Before, during, and after treatment, a total of 20 weekly assessments 
of PTSD symptoms, hallucinations, and delusions were carried out. Twelve weekly 
assessments of adverse events took place during the treatment phase. PTSD diagnosis, 
level of social functioning, psychosis-prone thinking, and general psychopathology were 
assessed pretreatment, posttreatment, and at three-month follow-up. Throughout the 
treatment, adverse events were monitored at each session.
An intention-to-treat analysis of the 10 patients starting treatment showed that the PTSD 
treatment protocols of PE and EMDR significantly reduced PTSD symptom severity; PE 
and EMDR were equally effective and safe. Eight of the 10 patients completed the full 
intervention period. Seven of the 10 patients (70%) no longer met the diagnostic criteria 
for PTSD at follow-up. No serious adverse events occurred, nor did patients show any 
worsening of hallucinations, delusions, psychosis proneness, general psychopathology, 
or social functioning. The results of this feasibility trial suggest that PTSD patients with 
comorbid psychotic disorders benefit from trauma-focused treatment approaches such 
as PE and EMDR.
Treating PTSD in patients with psychosis: 
A within-group controlled feasibility study examining the efficacy and safety of evidence-based PE and EMDR protocols.
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Between 50 and 98% of patients who have experienced psychotic episodes 
report having been exposed to one or more traumatic life events (see Read, Van Os, 
Morrison, & Ross, 2005, for a review). Accordingly, the prevalence of PTSD in people 
with psychotic disorders is relatively high, ranging from 12 to 29% (Achim et al., 2011; 
Buckley, Miller, Lehrer, & Castle, 2009). It is also important to mention that recent meta-
analytical research (Varese et al., 2012) shows that being traumatized as a child almost 
triples the chance of developing psychosis. This strong association between childhood 
adversities and the increased risk for psychosis was found both in population-based 
cross-sectional studies (OR = 2.99), and in prospective studies (OR = 2.75), even after 
controlling for potentially confounding variables such as genetic liability. These meta-
analytical findings suggest that without the causal factor of childhood trauma, there 
would be 33% less people suffering from psychosis. Significant associations have been 
shown between type of trauma on the one hand, and hallucinations and delusions on the 
other (Bentall, Wickham, Shevlin, & Varese, 2012; Varese et al., 2012).
Meta-analyses (Bisson & Andrew, 2009; National Institute for Clinical Excellence, 
2005) indicate that PTSD can best be treated using each of the following three 
treatments: (a) trauma-focused cognitivebehavioral therapy (TF-CBT; see Powers, 
Halpern, Ferenschak, Gillihan, & Foa, 2010). TF-CBT can be subdivided in several effective 
types of treatment: prolonged exposure (PE; e.g., Foa, Hembree, & Rothbaum, 2007; 
Schnurr et al., 2007) and cognitive processing therapy (e.g., Resick, Nishith, Weaver, 
Astin, & Feuer, 2002); (b) eye movement desensitization and reprocessing therapy 
(EMDR; Nijdam, Gersons, Reitsma, De Jongh, & Olff, 2012; Shapiro, 2001); and (c) 
stress management training (e.g., Taylor et al., 2003). However, significant reductions 
in PTSD and associated symptom severity may also be achieved by other interventions, 
such as psychodynamic therapy, hypnotherapy, and supportive counseling (Bisson 
& Andrew, 2009; Ford, Chang, Levine, & Zhang, 2012; National Institute for Clinical 
Excellence, 2005).
The presence of a past or present comorbid psychotic disorder is the highest-
ranking exclusion criterion found in meta-analyses of randomized clinical PTSD outcome 
studies (Bradley, Greene, Russ, Dutra, & Westen, 2005; Powers et al., 2010; Spinazzola, 
Blaustein, & Van der Kolk, 2005). Most randomized controlled trials do not report the 
rationale for excluding patients with psychosis (Bradley et al., 2005). Out of their concern 
about the potentially adverse effects of trauma treatment, 87% of clinicians also see 
comorbid psychosis as a contraindication for PE (Becker, Zayfert, & Anderson, 2004). In 
this vulnerable group—and especially in patients suffering from schizophrenia (Lothian 
& Read, 2002; Young, Read, Barker-Collo, & Harrison, 2001)—they fear symptom 
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exacerbation or dropout (Becker et al., 2004; van Minnen, Hendriks, & Olff, 2010), 
or the induction of false memories (Read, Hammersley, & Rudegeair, 2007). On the 
other hand, some authors specifically encourage mental health professionals to address 
psychological trauma, especially when clients are suffering from the consequences of 
child abuse or neglect (e.g., Larkin & Morrison, 2006; Read et al., 2007).
Few explorative TF-CBT outcome studies have been conducted in patients with 
serious mental illness, including those with psychosis and with comorbid PTSD (Lu et al., 
2009; Mueser et al., 2008; Rosenberg, Mueser, Jankowski, Salyers, & Acker, 2004). One 
study specifically examined the effects of PE in 20 PTSD patients with psychotic disorders 
(Frueh et al., 2009). They were treated in 14 preparatory sessions comprising anxiety-
management training and social-skills training, followed by eight PE sessions. While 
PTSD symptoms did not decrease in the preparation phase, they decreased significantly 
during and after PE, without any adverse events being noted. Although these results 
were promising, the study lacked a control condition, and psychotic symptoms were 
not monitored. It is not known how PE affected the severity of patients’ symptoms of 
psychosis.
With regard toEMDR, an important EMDR study addressed PTSD in 27 outpatients 
with a lifetime diagnosis of psychosis including schizophrenic disorder (Van den Berg 
& van der Gaag, 2012). Results showed that, after six 90-minute EMDR sessions, 
patients improved significantly with regard to PTSD symptoms, depression, anxiety, 
hallucinations, and self-esteem, and that no adverse events had occurred. There was no 
control condition.
In sum, it is suggested by the few exploratory studies that have evaluated 
treatment outcomes in patients with PTSD and comorbid psychosis that PE and EMDR 
are both safe approaches to treating PTSD in  this population. The results challenge the 
consensus among many clinicians and researchers that PTSD treatment and research 
in this particular group is potentially dangerous and should therefore be avoided (van 
Minnen, Harned, Zoellner, & Mills, 2012). 
The main aim of the present study was to replicate previous findings (Frueh et al., 
2009; Van den Berg & van der Gaag, 2012) indicating efficacy of evidence based PTSD 
protocols (i.e., PE and EMDR) in treating patientswith comorbid PTSD and psychosis, 
and to extend the previous studies through the inclusion of a control condition. The 
second aim of the present study was to evaluate the safety of both trauma treatments. 
The safety effects of treatment were indexed using weekly monitoring, and pertained to 
several variables that are often perceived as barriers for trauma-focused treatments in 
patients with psychosis: hallucinations, delusions, psychotic thinking, social functioning, 
general psychopathology, and distress, and the occurrence of serious adverse events 
(e.g., self-harm and suicidal behavior). The third goal was to tentatively compare the PE 
and EMDR protocols in terms of their differential effects on PTSD symptoms, treatment 
acceptance, and safety.
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Method 
Participants
Potential candidates for our trial were recruited from a local Dutch mental health 
outpatient center, and referred by their therapists. Those eligible were adult patients 
who had suffered a severe psychotic episode up to 3 years prior to the study, with current 
positive or negative psychotic symptoms remaining, and who received treatment for 
their symptoms of psychosis. In total, 32 patients were referred, 10 of whom declined 
further participation; 22 consented to an inclusion interview (see also the flowchart 
in Figure 1). Eligibility was established by assessing psychotic symptoms as part of a 
psychotic or mood disorder; PTSD symptoms were established through the Structured 
Clinical Interview for DSM-IV diagnoses (SCID-I; First, Spitzer, Gibbon, & Williams, 2002). 
PTSD diagnoses were verified using the Clinician-Administered PTSD Scale (CAPS; Blake 
et al., 1990, 1995; Dutch version by Hovens, Luinge, & van Minnen, 2005). There were 
three exclusion criteria: acute suicidality, an IQ below 70 according to chart diagnosis or 
intelligence test, and poor Dutch language skills. See Fig. 1 for the patient flow, and Table 
1 for the patient characteristics of the 10 patients included. During the study period, all 
candidates continued to receive treatment as usual (TAU) for their psychosis, aimed at 
stabilizing their psychiatric condition; TAU included case management and medication 
in all cases.
Treatment
Each psychological PTSD treatment (PE or EMDR) comprised a maximum of twelve 
90-minute sessions. Provided a patient achieved Posttraumatic Stress Symptom Scale, 
Self-Report (PSS-SR) scores below 10 in three consecutive sessions, early completion 
was allowed.
Both treatments were given by the first author (PdB), a licensed clinical 
psychologist and psychotherapist with extensive experience in the two treatment 
modalities. For supervision purposes, all sessions were videotaped; treatment integrity 
was monitored by the coauthors, both experts in their respective fields (AvM exposure; 
AdJ EMDR).
In the first session, the treatment rationale was presented to the patient. The 
target trauma was identified (or, in the case of multiple traumatic events, the trauma 
that would be the focus of treatment). PE and EMDR treatment were delivered according 
to the standardized treatment protocols outlined below.
Prolonged Exposure
In accordance with the treatment manual (Foa et al., 2007), the first PE session was 
dedicated to the treatment rationale, psychoeducation, and trauma identification. Next, 
the therapist and patient agreed on the hierarchical ordering of memories according to 
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their relevance to the PTSD. Each subsequent session comprised 60 minutes of prolonged 
imaginal exposure in which the patient was helped to process the traumatic memory 
and emotions associated with it by describing the event to the therapist. He or she was 
encouraged to revisit the memories of the trauma, and to recount, in the present tense, 
the most frightening parts of the traumatic memory in all sensory details.
Each imaginal exposure session was recorded on audiotape, and the patient was 
asked to listen to that week’s tape 5 days a week at home. From Session 2 in vivo exposure 
to feared but safe trauma-related stimuli was added. The homework assignments were 
Figure 1. Flow diagram. Note. AHRS = PSYRATS Auditory Hallucination Rating Scale, CAPS = Clinician-
Administered PTSD Scale, DRS = PSYRATS Delusion Rating Scale, EMDR = eye movement desensitization 
and reprocessing, ITT = intention to treat, LOCF =, O-LIFE = Oxford–Liverpool Inventory of Feelings and 
Experiences, OQ-45.2 = Outcome Questionnaire, PE = prolonged exposure, PSS-SR = Posttraumatic Stress 
Symptom Scale Self-Report, SCID-I = Structured Clinical Interview for DSM-IV, SFS = Social Functioning Scale.
Referrals (n=32) 
Post-treatment measurements (n=8       4 PE, 4 EMDR) 
PSS-SR, AHRS, DRS  
T2: CAPS, O-LIFE, OQ-45.2, SFS-s/-o) 
Baseline measurements (n=10) 
PSS-SR, AHRS, DRS  
T1: CAPS, O-LIFE, OQ-45.2, SFS-s/-o 
Mixed Models ITT (n=10) & completers (n=8):  
PSS-SR, AHRS and DRS 
Wilcoxon ITT+LOCF (n=10):  
CAPS,O-LIFE,OQ-45.2 and SFS-s/-o
Baseline phase
Analysis 
Post-Treatment 
phase 
Interviews (n=22) 
CAPS 
SCID-1
Enrollment Exclusion (n=12) 
 no PTSD (n=4) 
 no psychosis (n=1) 
 poor language skills (n=1) 
 paranoid of video (n=2) 
 reasons unknown (n=2) 
Treatment phase
Follow-Up 
Drop out (n=2) 
 PE (n=1) 
 EMDR (n=1) 
Treatment phase measurements  
(n=10       5 PE, 5 EMDR) 
PSS-SR, AHRS, DRS 
clinically adverse events 
Follow-up measurements after 3 months (n=8      4 PE, 4 EMDR) 
PSS-SR, AHRS, DRS  
T3: CAPS, O-LIFE, OQ-45.2, SFS-s/-o
Inclusions (n=10) 
Random assignment to PE (n=5) or EMDR (n=5)
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discussed and assessed at the start of each session. Patients were also asked to monitor 
distress levels at home using the Subjective Units of Distress scale before, during, 
and after each exposure task, and also to record any changes in their cognitive and/
or emotional responses to the stimuli they feared. The rationale behind this was that 
the main mechanism in PE is thought to be fear extinction: exposure enables patients 
to engage emotionally in the traumatic memories, and to process them by emotionally 
experiencing that confronting trauma stimuli in imagination and in vivo is safe (see Foa 
et al., 2007, for more details).
Eye Movement Desensitization and Reprocessing 
EMDR is a protocolized psychotherapeutic approach intended to resolve the symptoms 
that can result from disturbing and unprocessed life experiences (Shapiro, 2001). 
Following the Dutch translation of the EMDR protocol (De Jongh & Ten Broeke, 2003) 
the treatment rationale, psychoeducation, and treatment planning were addressed in the 
first EMDR session. The subsequent sessions focused on a patient’s traumatic memories. 
First the patient was asked to recall the memory of a particular traumatic event. He or 
she was then asked to concentrate on specific aspects of it, particularly (a) its most 
distressing “image”; (b) the cognition associated with it, that is, the patient’s negative or 
dysfunctional belief of him- or herself; and (c) the accompanying emotions and physical 
responses.
Table 1: Patient Characteristics
Patient 
Number a
Sex Age Yrs of
Treatment
Diagnosis Ethnic
Group
Trauma
1 b
Trauma
2
Trauma 
3
1
2
3
4
5
6
7
8
9
10
F
F
F
F
M
F
F
M
F
F
49
28
48
49
26
44
33
48
56
55
12
2
>20
>20
13
3
2
10
20
16
Schizophrenia
Schizophrenia
Psychosis NOS
Psychosis NOS
Schizophrenia
Schizoaffective
Psychosis NOS
Psychotic bipolar
Schizophrenia
Psychosis NOS
Dutch
Dutch
Dutch
Dutch
Bosnian
Dutch
Dutch
Dutch
Dutch
Dutch
V
V
ASA
CSA
W
CPA
CPA
CSA
ASA
CSA
CEA
n.a.
CEA
00
n.a.
CEA
CEA
CEA
APA
CEA
n.a.
n.a.
n.a.
CEA
n.a.
n.a.
n.a.
n.a.
CEA
CB
Note. APA = adult physical abuse, ASA = adult sexual abuse, CB = childhood bullying, CEA = child emotional abuse, 
CPA = child physical abuse, CSA = child sexual abuse, n.a. = not applicable, V = violence, W = war.
a Patients 1–5 received prolonged exposure and patients 6–10 received EMDR.
b DSM-IV-TR PTSD A-criterion: traumatic incidents (maximum of three) reported on the Clinician-Administered PTSD Scale 
(CAPS); there was no second or third A-criterion trauma.
At the core of the EMDR technique is the principle of taxing the working memory. In 
this study, this was operationalized by distracting the patients with loud audio tones 
(clicks) bilaterally through a headphone while they were mentally confronting the most 
disturbing part of the traumatic event. The patient was asked to focus on the clicks 
and to concurrently report emotional, cognitive, and/or somatic experiences. This 
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procedure has been found to resolve patients’ fearful and negative responses to the 
traumatic memories, enabling them to develop strong, positive beliefs about themselves 
(Jeffries & Davis, 2012).
To help foster closure, each session ends on a positive note. Homework between 
sessions is not a standard part of EMDR. Its underlying adaptive information processing 
theory (Shapiro, 2001) has been supported by experimental studies that showed that 
the vividness and emotionality of aversive memories was reduced by eye movements 
during their recall (Engelhard, van den Hout, & Smeets, 2011; Gunter & Bodner, 2008). 
While it has been questioned whether the effects of EMDR can be attributed to the 
eye movements or to exposure and cognitive restructuring (Davidson, 2001), a recent 
review and a meta-analysis provided evidence that eye movements and other exposure-
based components have differential effects on traumaticmemories (Jeffries & Davis, 
2012; Lee & Cuijpers, 2013).
Measures And Design
Primary Outcome: PTSD Measures.
To monitor weekly changes in PTSD symptoms throughout the study, the PSS-SR (Foa, 
Riggs, Dancu, & Rothbaum, 1993) was used. The 17 items of the PSS-SR correspond 
to the 17 diagnostic DSM-IV-TR criteria for PTSD. The PSS-SR total score ranges from 
0 to 51. The self-report scale has been shown to have good reliability and validity (Foa 
et al., 1993; Dutch version: alpha = .85; Engelhard, Arntz, & van den Hout, 2007). The 
CAPS (Blake et al., 1995; Dutch version: Hovens et al., 2005)was used to check the 
diagnostic criteria for PTSD and to assess the severity of PTSD symptoms. The CAPS 
rates the frequency and intensity of the DSM-IV-TR criteria; its total score ranges from 
0 to 136. The reliability, validity, and sensitivity of the CAPS are good (Weathers, Keane, 
& Davidson, 2001; Dutch version: reliability alpha = .93 to .98; Hovens et al., 1994). 
The CAPS was administered at the baseline, posttreatment, and 3-month follow-up 
assessments.
Secondary Outcome: Safety Measures
In this study we considered treatment to be unsafe if psychotic symptoms and symptoms 
of general psychopathology were exacerbated, if the level of social functioning 
decreased, and if clinically adverse events occurred as a consequence of the intervention. 
We therefore checked for these signs weekly during the treatment.
Psychotic symptom severity
Psychotic symptom severity was monitored weekly by means of the Psychotic Symptom 
Rating Scale interview (PSYRATS; Haddock, McCannon, Tarrier, & Faragher, 1999). 
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The interview uses the Auditory Hallucination Rating Scale (AHRS; 11 questions, total 
score range 0–55) to help establish the occurrence and severity of hallucinations, and 
the Delusion Rating Scale (DRS; 6 questions, total score range 0–30) to establish the 
occurrence of delusions. With regard to the hearing of voices, the AHRS assesses the 
frequency, duration, location, loudness, causal attribution, negative content, severity of 
negative content, the extent and severity of discomfort and suffering, any disruption of 
daily life caused by hearing voices, and any experience of control over voices. The DRS 
assesses the extent and duration of preoccupation with the delusion, the credibility of 
the delusion, the extent and severity of discomfort and suffering, and the disruption 
of daily life caused by the delusions. All PSYRATS items are scored from 0 (not) to 5 
(continuously). Interrater reliability (AHRS alphas .78–.1.00; DRS alphas .88–.99) and 
validity were found to be good to excellent (Haddock et al., 1999).
Psychosis proneness 
Proneness to psychosis was assessed by the Oxford-Liverpool Inventory of Feelings 
and Experiences (O-LIFE; Mason, Claridge, & Jackson, 1995). The O-LIFE considers 
unusual experiences, cognitive disorganization, introvertive anhedonia, and impulsive 
nonconformity. Its total score ranges from 0 to 104, its test–retest reliability was found 
to be high (alpha N > .70; Burch, Steel, & Hemsley, 1998), and its validity was shown 
to be good (Mason & Claridge, 2006). The O-LIFE was administered at the baseline, 
posttreatment, and 3-month follow-up assessments.
General psychopathology and distress 
We used the Dutch version of the Outcome Questionnaire (OQ-45.2; Lambert et al., 
1996) to assess psychiatric symptom distress (25 items), interpersonal relations (11 
items), and social role functioning (9 items). The QQ-45.2 provides a total score that 
ranges from 0 to 180. The original and the Dutch versions have both been found to have 
high reliability and good validity (De Jong et al., 2007; Lambert et al., 1996; alpha = .68 
and .95). The OQ-45.2 was administered at the baseline, posttreatment, and 3-month 
follow-up assessments.
Social functioning 
This was checked using the Social Functioning Scale (SFS; Birchwood, Smith, Cochrane, 
Wetton, & Copestake, 1990), a 79-item scale designed to index social functioning in 
schizophrenia. It is completed independently twice: once by the patient (“self-report”), 
and once by someone close to the patient, for example, a family member (“other 
report”). The SFS total score ranges from 9 to 197; subscale raw scores may be converted 
to scale-score equivalents (X = 100, SD = 15). The SFS scales have been shown to be 
reliable (alphas .69–.78), valid, and sensitive measures of social functioning (Birchwood 
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et al., 1990). The SFS was administered at the baseline, posttreatment and three-month 
follow-up assessments. 
Clinically adverse events
Undesirable effects that were potentially related to the PTSD treatment were screened 
for every session. At the beginning of each session, the patient was asked about (a) 
hospital admissions, (b) suicidal behavior and nonsuicidal self-injury, (c) changes in 
medication (nonprescribed medication, or the need for more medication), or (d) crisis 
interventions provided by caregivers in the past week.
Design
The enrollment phase (Fig. 1) was completed with the random assignment of the 
10 patients to either PE or EMDR treatment. Next, the N = 10 study was designed 
to allow the treatment phase, posttreatment, and follow-up scores to be compared 
with baseline scores. The design has two arms of measurements, with within-group 
controlled observations in each of the two arms: one controlled arm of 20 weeks 
repeated measurement, and one controlled arm with three time points of measurements 
(see Table 2). 
In the first arm the severity of PTSD symptoms, hallucinations, and delusions were 
assessed repeatedly per patient in a multiple baseline design (Table 2): 20 times within a 
20-week study period, and once again at 3-month follow-up. Each baseline phase length 
was randomly assigned to one participant in the PE treatment, and to one participant in 
the EMDR treatment.During treatment per patient a maximum of 12 assessments took 
place. On a group level this repeatedmeasurements design plans for the comparison of 
40 observations in the baseline, 120 observations in the treatment, 40 observations in 
the posttreatment, and 10 observations at follow-up. The grouped baseline observations 
served as the control condition in the comparison.
In the second arm the PTSD diagnosis (CAPS), level of social functioning (SFS), 
psychosis-prone thinking (O-LIFE), and general psychopathology (OQ-45.2) were 
Table 2: Measurement Planning in the Two Controlled Arms: (1) Repeated Measurements in a Multiple Baseline Design and 
(2) Measurements at Three Time Points
Arm Planning of Measurements
1. aBaseline a
 Baseline b
 Baseline c
 Baseline d
 Baseline e
BB | TTTTTTTTTTTT | PPPPPP | 3 months | FU
BBB | TTTTTTTTTTTT | PPPPP | 3 months | FU
BBBB | TTTTTTTTTTTT | PPPP | 3 months | FU
BBBBB | TTTTTTTTTTTT | PPP | 3 months | FU
BBBBBB | TTTTTTTTTTTT | PP | 3 months | FU
2. bThree time points T1 | (treatment) | T2 | 3 months | T3
Note. B = baseline; 2–6 weeks, FU = follow-up; 3 months, P = posttreatment; 2–6 weeks, T = treatment; 12 weeks.
a Each baseline phase length was randomly assigned to one participant in the PE treatment, and to one participant in the 
EMDR treatment.
b For all N = 10 patients: T1 = baseline, T2 = posttreatment, T3 = 3 months follow-up.
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assessed at three single time points: at baseline, after treatment, and at 3-month follow-
up (Table 2). Adverse events were monitored in each session throughout the treatment 
phase.
Data Analysis
Primary outcome measures
First, changes in PTSD symptom severity as assessed with the PSS-SR were analyzed 
using the mixed-model procedure in SPSS, which allows all the individually varying 
number of observations within each phase to be entered into the analysis, producing 
an estimated marginal mean (EMM) for each phase. Scores obtained within the four 
phases (baseline, treatment, posttreatment, and follow-up) were defined as the main 
fixed effects. Patients were defined as the random factors within the phases, that is, 
each score (observation) obtained from the patients in each phase was considered as a 
random sample of possible scores. The random-effect covariance matrix was specified 
as ar1 (first-order autoregressive). To assess treatment effect on the PSS-SR, the EMMs 
computed for the treatment, posttreatment, and follow-up phases were each compared 
with the baseline EMM. All analyses were conducted using PASWS Statistics Version 
18.0.3 (SPSS Inc., Chicago, Il). Effect sizes were calculated with the formula r = (EMM 
baseline – EMM x)/Sd, an estimator used in parametric statistics. The individual graphs 
of PSS-SR symptom changes during and after the active treatment phase were inspected 
visually for changes relative to the baseline phase.
Second, using Wilcoxon pairwise tests, the CAPS PTSD total scores of the intention-
to-treat (ITT) group at posttreatment (T2) and follow-up (T3) were compared with 
those at baseline (T1), and the follow-up (T3) scores were compared with posttreatment 
(T2) scores. The reason we used the nonparametric Wilcoxon pairwise testing, was first 
because the distribution of scores did not meet the criteria for parametric testing, and 
second because of the small number of observations per phase (10 in T1, 8 in T2, and 8 
in T3). Effect sizes were calculated with the formula r = Z/√N, which is an estimator used 
in nonparametric statistics (Wilcoxon tests). Third, we compared posttreatment (T2) 
and follow-up (T3) CAPS PTSD diagnoses with baseline values (T1).
Secondary outcome measures
To analyze the adverse effects of the treatment in terms of psychotic symptom severity 
as assessed with the PSYRATS (AHRS and DRS), we used the mixed-model procedure 
described above. We also inspected the graphs for changes in psychotic symptoms. 
Adverse treatment effects on the O-LIFE, OQ-45.2, and SFS were tested using Wilcoxon 
pairwise tests to compare baseline (T1) to posttreatment (T2) and follow-up (T3), and 
the follow-up (T3) scores to posttreatment (T2) scores.
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Comparison of PE and EMDR
We compared PE and EMDR in terms of PTSD end-state diagnosis, treatment dropout, 
early completion, and serious adverse events.
Results
Treatment completion
Two of the 10 patientswho started treatment dropped out prematurely (one in PE, one 
in EMDR). Two PE participants completed their treatment early (one in Session 5 and 
one in Session 7), as did one EMDR participant (in Session 10). The mean number of 
sessions was 9 in PE, and 11.5 in EMDR.
Primary Outcomes: PTSD PSS-SR symptom severity
See Table 3 for descriptive statistics. All patients scored above the clinical cutoff score of 
14 for the PSS-SR at baseline (Wohlfarth, van den Brink, Winkel, & ter Smitten, 2003); 
the high mean baseline PSS-SR scores indicated a severity of PTSD symptoms that is 
comparable with other severely mentally ill populations (e.g., Cloitre et al., 2010).
The mixed-model analysis showed that, given the TAU baseline phase as the 
statistical control condition, PTSD symptom severity in the ITT group had decreased 
significantly in the treatment phase (p < .001, r = .64), and that this effect was maintained 
in the posttreatment phase (p < .001, r = .73) and follow-up phase (p < .001). The 
significant F value reflects the effect of the phases, F(3, 56.998) = 13.2, p < .001. 
For the completers (N = 8; see Table 3), the decrease in PTSD symptom severity 
in the treatment phase was significant, showing large treatment effects (p < .001, 
r = 1.21) that were sustained posttreatment (p < .001, r = 1.39) and during follow-up 
(p < .001). The significant F value reflects the effect of the phases, F(3, 49) = 12.53, 
p < .001. Fig. 2 shows the individual PSS-SR graphs. After the start of treatment, PTSD 
symptoms decreased in Patients 1, 2, 5, 7, 8, and 9. Patients 3 and 6 dropped out. The 
effects in Patients 4 and 10 were ambiguous.
CAPS symptom severity
See Table 3 for descriptive statistics. At follow-up, CAPS total scores were significantly 
lower than the pretreatment values (Z = –2.52, p = .012, effect size r = .63). The 
posttreatment total scores had also decreased, but only reached borderline significance 
(Z = –1.96, p = .05, r = .49).
CAPS end-state functioning
At the posttreatment (T2) assessment, six of the eight completers no longer met the 
criteria for a PTSD diagnosis; at follow-up (T3) this was the case with seven of the eight 
completers.
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Secondary outcomes: safety
Psychotic symptom severity
See Table 3 for descriptive statistics. The mixed-model analysis of the PSYRATS 
values showed no significant phase effects of PTSD treatment on the EMMs of 
auditory hallucinations (AHRS), ITT: F(3, 60) = .86, p = .466, completers, F(3, 50) = .73, 
p = .54); or on delusions (DRS), ITT: F(3, 49) = 1.77, p = .165, completers, F(3, 48) = 1.57, 
p = .21.
See Figs. 3 and 4 for the individual AHRS and DRS graphs. During the treatment 
phase, nine patients had no increase in psychotic symptoms. Note that Patients 3 and 
6 dropped out of treatment. Patient 4 had a sudden increase in auditory hallucinations, 
which she attributed to a stressful life event in her family. Before this incident, PE had not 
provoked any hallucinations.
Psychosis proneness
See Table 4 for the descriptive statistics. Pre-to-post analyses (T1–T2) yielded a 
significant decline in psychosis-prone thinking (Z = –2.05, p = .041, r = .65). Changes 
from baseline (T1) to follow-up were not significant (T3; Z = –1,75, p = .080, r = .55).
General psychopathology and distress 
See Table 4 for the descriptive statistics. Relative to the scores at baseline (T1), OQ-45.2 
posttreatment (T2) total scores were significantly lower (Z = –2.19, p = .028, r = .69). 
So, too,were the follow-up (T3) scores (Z = –2,37, p = .018, r = .75).
Table 3: Estimated Marginal Means (EMM) and Standard Errors (SE) for the Mixed-Models Analysis for the Session-to-Session Analyses 
of PTSD (PSS-SR Self-Report) and for Verbal Hallucinations and Delusions (AHRS and DRS Interviews) During the Four Study Phases 
(Intention to Treat N = 10, Treatment Completers N = 8, PE and EMDR Together)
Phases of the Study
Baseline Treatment Posttreatment Follow-up
PSS-SR EMM SE EMM SE EMM SE EMM SE
N = 10
N = 8
31.92
30.22
5.30
5.75
21.97 **
19.49 **
4.67
5.11
15.67 **
14.13 **
4.68
4.97
14.06 **
12.75 **
4.68
4.94
AHRS EMM SE EMM SE EMM SE EMM SE
N = 10
N = 8
18.71
14.54
8.19
9.49
18.06
14.37
7.27
8.50
13.89
10.67
7.17
8.14
16.65
13.62
7.09
8.02
DRS EMM SE EMM SE EMM SE EMM SE
N = 10
N = 8
6.28
5.68
2.61
2.76
5.09
3.91
2.23
2.37
1.94
1.49
2.46
2.49
1.97
1.75
2.53
2.55
Note. PSS-SR = Posttraumatic Stress Symptom Scale Self-Report, AHRS = PSYRATS Auditory Hallucination Rating Scale, 
DRS = PSYRATS Delusion Rating Scale.
** = p ≤ .01 relative to the baseline phase.
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Social functioning
See Table 4 for the descriptive statistics. Posttreatment and follow-up values were not 
significantly different from those at baseline (T1, T2, T3 all p > .05).
Clinically adverse events
During the treatment phases, no negative effects occurred (i.e., no hospital admissions, 
suicidal behavior/nonsuicidal self-injury, changes in medication, or crisis interventions 
by caregivers).
Comparison of PE and EMDR
Of the eight completers, three patients in the PE treatment and three in the EMDR 
treatment no longer met the criteria for a PTSD diagnosis as assessed with the CAPS 
at T2 (posttreatment). At T3 (follow-up), this was four in the PE treatment and three 
in the EMDR treatment.
The graphs in Figs. 2, 3, and 4 show that patient response to PE and EMDR was 
comparable: PTSD symptoms decreased clearly after the start of treatment in three 
patients in both PE and EMDR(Patients 1, 2, and 5 in PE, and Patients 7, 8, and 9 in 
EMDR), and these effectswere sustained. At first, Patient 4 (PE) improved, but this was 
not sustained after Session 6— possibly because, as stated above, to the occurrence of a 
stressful life event in the patient’s family. Patient 10 (EMDR) also improved, but this was 
less pronounced. Symptoms of psychosis increased in one patient in PE, and in none of 
the patients in the EMDR.
Discussion
As in previous studies (Frueh et al., 2009; Van den Berg & van der Gaag, 2012), our results 
suggest that PE and EMDR—both evidence-based trauma-focused treatments—are 
effective in reducing PTSD symptoms in patients with a psychotic disorder. Seven of the 8 
patients (87.5%) who completed the treatment, and 7 of the 10 patients starting treatment 
(70%) no longer fulfilled the CAPS diagnostic criteria for PTSD, showing that both PE 
and EMDR were highly effective. As the controlled design of the trial allowed statistical 
hypothesis testing of treatment efficacy, it is plausible that the significant decrease in 
PTSD symptoms was a result of the interventions, with effects being maintained for 3 
months after the end of treatment. Comparison of the two treatments (PE and EMDR) 
revealed no significant or marked qualitative differences, either in terms of effect, or in 
terms of safety.
As stated in the introduction, many therapists tend to refrain from trauma-
focused interventions for fear that such approaches are too burdensome to the psychotic 
patient, or are even harmful (Becker et al., 2004; van Minnen et al., 2010). As none of our 
patients showed a treatment-related increase in psychotic or other psychopathological 
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Figure 2. Primary outcome variable of PTSD: PSS-SR symptom severity. Session scores across baseline, 
treatment, posttreatment, and follow-up (phases divided by vertical lines; x-axis = number of days; 
y-axis = outcome scores).
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symptoms, and as we found no signs of a deterioration in social functioning or of 
clinically adverse events, our findings demonstrate that PE and EMDR can be used safely 
for patients with psychosis.
Nonetheless, one patient who started treatment without psychotic symptoms 
reported sudden hallucinations during the second half of treatment, and a very mild 
delusion at one assessment. Although this patient claimed that the incidents were not 
related to the intervention, future studies will need to compare the proportion of patients 
in whom such psychotic symptoms increase during trauma-focused treatment with the 
incidence of similar symptoms in patients not receiving treatment.
Overall, the significant improvements posttreatment with regard to psychosis-
prone thinking and general psychopathology are interesting: they indicate that, rather 
than increasing, these comorbid symptoms tended to decrease together with the PTSD 
symptoms. Our finding that treatment had no positive effects on hallucinations and 
delusions (as assessed with the AHRS and DRS), may have been due to a floor effect, as 
the overall scores on these measures were already relatively low at the start of treatment.
Both intervention modalities were well accepted, and most patients were able to 
comply with the treatment sessions. For trauma-focused treatments, the 20% dropout 
rate is acceptable (Bisson & Andrew, 2009; Hembree et al., 2003).
While one patient ended treatment prematurely due to very hostile verbal and 
visual hallucinations, these hallucinations had not been provoked or intensified by 
the treatment: the patient had been having such hallucinations for many years, and 
their presence had already been established in the baseline phase. Nonetheless, her 
delusions did seem to have been mildly provoked by the treatment: her hallucinations 
had “forbidden” her to talk about the traumatic events for many years, and were 
now exacerbating her fear. Even though she was highly motivated, she was afraid to 
subject herself to treatment—a dilemma that may be specific to this particular patient 
population, and may be the only argument, if a crucial one—in favor of modifying the PE 
or EMDR protocols accordingly. 
Not all patients suffered from auditory hallucinations. Hallucinations in other 
modalities have not been monitored. Monitoring hallucinations in all modalities, 
especially visual hallucinations (Bentall et al., 2012) certainly is recommendable for 
future research.
The protocols we used in this study were not modified for the study group. With 
the exception of some basic anxiety management strategies that are integral to the 
treatments, neither did they include any of the elements that are routinely incorporated 
in many PTSD approaches, such as pretreatment stabilization modules, skill-coping 
training, or relaxation exercises.
Our trial has a relatively low dropout. This may be explained by the absence of 
a preparatory phase before the actual trauma-focused interventions: a previous study 
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Figure 3. Secondary outcome safety variable of hallucinations: PSYRATS-AHRS symptom severity. Session 
scores across baseline, treatment, posttreatment, and follow-up (phases divided by vertical lines; x-axis = 
number of days; y-axis = outcome scores).
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(Frueh et al., 2009) showed that most patients dropped out in the skills-training phase 
that preceded the PE sessions.
The present study focused specifically on PE and EMDR. But we acknowledge 
that cognitive processing and stress management, and combinations of typical CBT 
interventions, may have potential for the successful treatment of PTSD in this comorbid 
population (see Jackson et al., 2009; Mueser et al., 2008).
Two important limitations of this study should be mentioned. The first is the small 
sample size, which clearly restricts the generalizability of the results. The second is the 
limited time frame—three months including follow-up only—this cannot show clearly 
whether the positive effects are sustained for a longer period.
In summary, this is the first controlled case study in which prolonged exposure 
and EMDR—two recommended evidence-based psychological treatments for PTSD—
were successfully used in patients suffering from psychosis. It is our hope that the 
findings foster the inclusion of patients with psychosis in evidence-based trauma-focused 
treatments, both in empirical research and in clinical practice.
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Table 4: Means, Medians, and SDs for Wilcoxon Pairwise Tests for the Primary and Secondary Outcome Measures (Intention to Treat  
N =10, PE and EMDR Together)
T1(Baseline) T2 (Posttreatment) T3 (Follow-up 3 months)
Mean Median SD Mean Median SD Mean Median SD
CAPS
O-LIFE
OQ-45.2
SFS-self
SFS-other
71.20
51.90
89.60
104.70
102.60
72.50
58.00
93.50
112.50
100.00
22.49
19.95
33.56
27.80
26.86
48.20 *
45.90 *
77.40 *
107.80
107.80
35.50
52.00
79.00
112.00
108.50
38.29
20.78
36.86
29.74
27.53
37.60 *
48.10
75.30 *
105.80
104.60
25.50
55.00
74.00
108.00
108.00
34.68
21.51
33.08
28.26
28.24
Note. CAPS = Clinician-Administered PTSD Scale, O-LIFE = Oxford-Liverpool Inventory of Feelings and Experiences, OQ-
45.2 = Outcome Questionnaire, SFS = Social Functioning Scale.
* p ≤ .05 relative to T1.
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Figure 4. Secondary outcome safety variable of delusions: PSYRATS-DRS symptom severity. Session scores 
across baseline, treatment, posttreatment, and follow-up (phases divided by vertical lines; x-axis = number of 
days; y-axis = outcome scores).
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Abstract
Background Trauma contributes to psychosis and in psychotic disorders post-traumatic stress 
disorder (PTSD) is often a comorbid disorder. A problem is that PTSD is underdiagnosed and 
undertreated in people with psychotic disorders. This study’s primary goal is to examine the 
efficacy and safety of prolonged exposure and eye movement desensitization and reprocessing 
(EMDR) for PTSD in patients with both psychotic disorders and PTSD, as compared to a waiting 
list. Secondly, the effects of both treatments are determined on (a) symptoms of psychosis, in 
particular verbal hallucinations, (b) depression and social performance, and (c) economic costs. 
Thirdly, goals concern links between trauma exposure and psychotic symptomatology and the 
prevalence of exposure to traumatic events, and of PTSD. Fourthly predictors, moderators, and 
mediators for treatment success will be explored. These include cognitions and experiences 
concerning treatment harm, credibility and burden in both participants and therapists.
Methods/Design A short PTSD-screener assesses the possible presence of PTSD in adult 
patients (21- to 65- years old) with psychotic disorders, while the Clinician Administered 
PTSD Scale interview will be used for the diagnosis of current PTSD. The M.I.N.I. Plus interview 
will be used for diagnosing lifetime psychotic disorders and mood disorders with psychotic 
features. The purpose is to include consenting participants (N = 240) in a multi-site single 
blind randomized clinical trial. Patients will be allocated to one of three treatment conditions 
(N = 80 each): prolonged exposure or EMDR (both consisting of eight weekly sessions of 90 
minutes each) or a six-month waiting list. All participants are subjected to blind assessments 
at pre-treatment, two months post treatment, and six months post treatment. In addition, 
participants in the experimental conditions will have assessments at mid treatment and at 12 
months follow-up.
Discussion The results from the post treatment measurement can be considered strong 
empirical indicators of the safety and effectiveness of prolonged exposure and EMDR. 
The six-month and twelve-month follow-up data have the potential of reliably providing 
documentation of the long-term effects of both treatments on the various outcome 
variables. Data from pre-treatment and midtreatment can be used to reveal possible 
pathways of change.
Trial registration Current Controlled Trials: ISRCTN79584912
Keywords Psychosis, PTSD, Trauma, Schizophrenia, Hallucinations, Working memory, 
Prolonged exposure, EMDR, Economic evaluation, Moderators, Mediators
A multi-site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization 
and reprocessing and waiting list on patients with a current diagnosis of psychosis and comorbid posttraumatic stress disorder: 
study protocol for the randomized controlled trial Treating Trauma in Psychosis
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Background
 
Links between trauma, PTSD and psychosis
Of patients who have ever experienced psychotic episodes, 50% to 98% report having 
been exposed to one or more traumatic events in their lives (Achim et al., 2011). As a 
result, the prevalence of post traumatic stress disorder (PTSD) in people with psychotic 
disorders ranges from 12% to 29% (Achim et al., 2011; Buckley, Miller, Lehrer, & Castle, 
2009). This can be considered high compared to estimated prevalence rates in the 
general population, which range from 0.4% to 3.5% (Alonso et al., 2004; Creamer, 
Burgess, & McFarlane, 2001; Darves-Bornoz et al., 2008).
In a meta-analytical study evidence was found that major adversities in childhood 
(before the 18th year of life) increase the risk of psychosis by 2.8 times on average 
(Varese et al., 2012). A dose–response relationship was found in almost all studies: the 
more severe the trauma, the greater the risk of developing psychosis. Childhood trauma 
as a major risk factor probably adds 33% to the onset of psychosis in society (Varese et 
al., 2012). Significant associations between all types of childhood adversities (except 
the loss of a parent) and symptoms of paranoia and auditory hallucinations have been 
reported (Bentall, Wickham, Shevlin, & Varese, 2012; Varese et al., 2012). Childhood 
sexual abuse is associated with hallucinations (odds ratio (OR) 8.9, confidence interval 
(CI) = 1.86 to 42.44), and being brought up in institutional care is specifically associated 
with paranoia (OR = 11.08, CI = 3.26 to 37.62 (Bentall et al., 2012).
Traumatic events, PTSD and psychosis appear to have several interactions. 
The presence of a comorbid PTSD has been found to have a negative impact on the 
course and prognosis of the psychotic disorder (Lysaker, Buck, & LaRocco, 2007), and 
the combination of psychosis and PTSD appears to be associated with poorer social 
functioning and greater risk of relapsing in psychosis (Lysaker et al., 2007; Morrison, 
Frame, & Larkin, 2003; Mueser, Lu, Rosenberg, & Wolfe, 2010). There are also indications 
that the content of hallucinations may fully match that of experienced traumas (12.5%) 
or the themes of hallucinations can be very similar to that of experienced traumas (45%) 
(Hardy et al., 2005). The occurrence of re-experiencing symptoms of PTSD is strongly 
associated with a predisposition to hallucinations. Negative beliefs about self and 
others have been found to be associated with a predisposition to paranoia (McGorry 
et al., 1991).
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There is also evidence to suggest that experiencing a psychotic episode, and 
experiencing problems with the health care system, may potentially be experienced as 
traumatic events and may result in PTSD (McGorry et al., 1991; Shaw, McFarlane, & 
Bookless, 1997; Shaw, McFarlane, Bookless, & Air, 2002).
Considering these findings and being aware that PTSD in general is associated 
with forms of non-effective coping, more abuse of alcohol and drugs, negative 
selfesteem, negative expectations of other people, and a greater risk of exposure to 
future potentially traumatic events (Mueser, Rosenberg, Goodman, & Trumbetta, 2002), 
it becomes clear that trauma exposure is associated with impairment and major health 
problems in patients with psychosis, creating a burden for both patients and society 
(Hong, Windmeijer, Novick, Haro, & Brown, 2009;  Mueser et al., 2002).
Clinical attitudes and practice
In clinical practice, trauma exposure, PTSD and their links to psychosis do not seem 
to get that much attention. Traumatic experiences and the diagnosis of PTSD appear 
to be underreported in the charts of patients with a severe mental illness or psychotic 
disorder (Lommen & Restifo, 2009; Mueser et al., 1998). In addition, clinicians are 
reluctant to address trauma histories in patients with psychosis (Read, Hammersley, & 
Rudegeair, 2007; Young, Read, Barker-Collo, & Harrison, 2001). They will not easily offer 
therapy, especially not exposure therapy, to overcome PTSD symptoms; instead, they 
suggest establishing trust and rapport with patients first, and giving patients a sense of 
mastery, before starting to explore traumatic experiences the patients might have had 
(Christopher Frueh, Cusack, Grubaugh, Sauvageot, & Wells, 2006). Many clinicians seem 
to fear that trauma treatment with this patient group will lead to symptom exacerbation, 
crisis, hospitalization, self-harm and suicidal behavior, or rapid changes in medication. 
They presume that before a PTSD treatment can be safely conducted, stabilizing 
interventions are necessary (Becker, Zayfert, & Anderson, 2004; Christopher Frueh et 
al., 2006). 
Studies examining PTSD treatment efficacy 
Meta-analytic studies of clinical trials show that, generally speaking, trauma focused 
cognitive behavioral therapy (TF-CBT), such as prolonged exposure (PE), and eye 
movement desensitization and reprocessing (EMDR) are safe and effective. These 
treatments should be the firstline psychological treatment for PTSD (Bisson & Andrew, 
2009; Bisson et al., 2007; NICE, 2005). Unfortunately, people with a psychotic disorder 
are often excluded from PTSD treatment efficacy research (Spinazzola, Blaustein, & 
van der Kolk, 2005; van Minnen, Harned, Zoellner, & Mills, 2012). Therefore, not much 
is known about the generalizability of PE or EMDR efficacy to people with psychotic 
disorders (Bradley, Greene, Russ, Dutra, & Westen, 2005). This question of applicability 
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of PE and EMDR in patients with psychosis is the starting point of the present 
study protocol.
A number of studies have already addressed this issue. In a randomized controlled 
trial (RCT), the effects of Cognitive Behavior Therapy (CBT) were investigated in 
108 participants with severe mental illness, of which 14% (N =17) had a diagnosis of 
schizophrenic or schizoaffective disorder (Mueser et al., 2008). The protocol consisted 
of 12 to 16 sessions of combined CBT interventions (a crisis plan, psycho-education, 
breathing exercise, cognitive restructuring). CBT proved to be effective in reducing PTSD 
symptoms and was safe. In an open study, the effect of PE in people with psychosis was 
studied (B.C. Frueh et al., 2009). Participants (N = 20) were given fourteen preparatory 
sessions and eight PE sessions. The drop out was high during preparatory sessions and 
this phase did not result in a decline of symptoms. A high compliance, no adverse events 
and a significant reduction of PTSD symptoms, during and after PE, were, however, 
noted. These results suggest that PE is effective and safe and preparation for PE may be 
unnecessary.
Recently, our research group conducted two small feasibility trials. The first, an 
open study (N = 27), used EMDR for PTSD in people with a life time history of psychosis 
(van den Berg & van der Gaag, 2012). The second study used EMDR (N = 5) and PE 
(N = 5) in a multiple baseline controlled design (De Bont, Van Minnen, & De Jongh, 
2013). Results showed that both treatments were effective in reducing PTSD symptoms. 
Van den Berg and Van der Gaag (van den Berg & van der Gaag, 2012) found significant 
reductions in end-state PTSD, symptom severity of PTSD, delusions, hallucinations, 
depression and anxiety and an increase in self-esteem. De Bont and colleagues (De 
Bont et al., 2013) found significant reductions of PTSD and of general psychopathology 
and distress. In both studies no serious adverse events or symptom exacerbations were 
found. Both treatments were well accepted by participants and attrition was low. Taken 
together, results from pilot studies suggest that trauma-focused treatments, such as PE 
and EMDR, can be effectively and safely applied to patients with psychotic disorders, 
but well-controlled studies are lacking. To fill this gap, we set up the present study, the 
Treating Trauma in Psychosis (T.TIP) study.
Objectives
 
Primary objective –effects of treatment on PTSD symptoms and safety
In a sample of patients who receive treatment as usual (TAU) for a current diagnosis 
of psychosis this study examines: a) the efficacy of PE versus waiting list, and of EMDR 
versus waiting list, on the symptomatology of a comorbid PTSD; and b) the safety of PE 
versus waiting list and EMDR versus waiting list in the treatment of PTSD. 
Chapter 3
58
Secondary objectives - effects of treatment on psychopathology and cost 
effectiveness
Other objectives were to determine the efficacy of PE versus waiting list and of EMDR 
versus waiting list on the symptomatology of psychosis. In this context the experience 
sampling method (ESM) (Myin-Germeys et al., 2009) will be applied to examine the 
effects of treatment on temporal associations between intrusions, daily events and 
activities, and verbal hallucinations, depression,social functioning and post traumatic 
cognitions.An economic evaluation will determine the cost effectiveness of the PTSD 
treatments.
Tertiary objectives - links between trauma exposure, PTSD and psychosis
An important objective is to assess, in the psychosis sample, exposure to traumatic events, 
to assess and calculate the risk of having a comorbid PTSD, and to diagnose comorbid 
PTSD. In this context, the diagnostic accuracy of the Trauma Screening Questionnaire 
(Brewin et al., 2002), in the population of patients with psychotic disorder, will be 
examined.
The present T.TIP study will address the question as to whether certain types and 
severities of trauma exposure are associated with specific phenomenological aspects of 
psychotic symptoms (Alemany et al., 2010; Bentall et al., 2012; Daly, 2011; Varese et al., 
2012). Specifically, the study aims to explore the links between traumatic events, PTSD 
and verbal hallucinations (Hardy et al., 2005; van den Berg & van der Gaag, 2012).
Quaternary objectives – mediators, moderators and predictors of treatment outcome
In the intervention study we will conduct additional research to explore mechanisms 
of changes in the treatment outcome variables. Variables that are potential predictors, 
mediators and moderators will be examined, such as: a) bullying (Bentall et al., 2012; 
Varese et al., 2012); b) tonic immobility (Abrams, Carleton, & Asmundson, 2012; Bovin, 
Jager-Hyman, Gold, Marx, & Sloan, 2008; Humphreys, Sauder, Martin, & Marx, 2010); c) 
the capacity of participants’ working memory (Metzak et al., 2011; Smeets, Dijs, Pervan, 
Engelhard, & van den Hout, 2012); d) credibility of treatment and burden of treatment 
(Taylor, Abramowitz, & McKay, 2012; Zoellner, Feeny, Cochran, & Pruitt, 2003). 
Both participants and therapists will have cognitions about treatment that may affect 
treatment outcome. Therefore assessments will be made of harm expectancy and harm 
experience, expected burden and experienced burden and credibility of treatment; e) 
demographic and trauma characteristics; f ) self esteem (Ben-Zeev, Morris, Swendsen, 
& Granholm, 2011; Garety, Kuipers, Fowler, Freeman, & Bebbington, 2001); g) personal 
beliefs about illness (Csipke & Kinderman, 2006; Kinderman, Setzu, Lobban, & Salmon, 
2006); h) post traumatic cognitions (Birchwood, Jackson, Brunet, Holden, & Barton, 
2012); i) cognitive biases (Bentall et al., 2009; Menon, Mizrahi, & Kapur, 2008; So et al., 
2012); j) cognitions about voices; k) memory characteristics (Halligan, Clark, & Ehlers, 
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2002; Layton & Krikorian, 2002; Schweizer & Dalgleish, 2011); and l) social support 
during treatment (Tarrier & Humphreys, 2003; Tarrier, Sommerfield, & Pilgrim, 1999).
Methods/Design
 
Design
The T.TIP study is a single blind randomized controlled trial with three arms: PE, EMDR and 
a waiting list. The three groups are compared at pre-treatment (T0), at post treatment 
at two months (T2) and at six months (T6), on a set of variables that are linked to 
the various research questions. Mediator and moderator variables are assessed again at 
midtreatment (T1). A 12-month treatment intervention follow-up measurement (T12) 
will give indications whether treatment effects endure. The waiting list condition will 
receive the treatment of choice after sixmonths (T6).
The assessing research assistants are blind to the participants’ research condition.
The design of this study was approved by the Medical Ethics Committee of the 
medical centre of the VU University and is registered as N:36649.029.12.
Participants
Patients, 18- to 65-years old, with a chart diagnosis of psychotic disorder or a mood 
disorder with psychotic features according to the Diagnostic and Statistical Manual of 
Mental Disorders, fourth edition text revsion (DSM-IV-TR) are recruited from outpatient 
services of thirteen mental health organizations in the Netherlands. The trial process 
starts with a short self-report screening. During the screening, participants report 
on traumatic events that fulfill DSM-IV-TR PTSD criterion A1 and associated PTSD 
symptoms using the 10 item Trauma Screening Questionnaire (TSQ) (Brewin et al., 
2002). If participants report traumatic events and score above the TSQ’s cut-off criterion 
(x = ≥6), and give informed consent for further interviewing, an appointment will be 
made for the inclusion interview.
Inclusion and exclusion
The criteria for inclusion in the intervention study are: a) age between 18 and 65 
years; b) a lifetime history of a psychotic disorder or a mood disorder with psychotic 
features (M.I.N.I. plus); c) meeting DSM-IV-TR diagnostic criteria for PTSD (Clinician 
Administered PTSD Scale (CAPS)). 
The criteria for exclusion are: a) high suicidality, operationalized as the combination 
of having a high suicidality score on the M.I.N.I. with the last suicide attempt within the 
past six months and a depression score on the Beck Depression Inventory-II (BDI-II) of 
35 or higher; b) changes in medication (mood regulators, antipsychotics) within two 
months prior to the study; c) insufficient competence in the Dutch language; d) severe 
intellectual impairment, defined as an estimated IQ below 70 (mental retardation); 
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e) not being able to travel to and from the place of assessment and therapy; and 
f) participant is in seclusion or admitted to a closed ward.
See Figure 1, the T.TIP flowchart. All mental health teams that signed up for 
cooperation in the T.TIP study carry out the standard procedure for screening of all 
patients suffering from psychosis. After that, the flow of consenting and screened 
participants into the study has three pathways: (1) ‘regular’ inclusion, meaning that each 
patient demonstrating a high risk for PTSD (TSQ ≥6) will be invited for an inclusion 
interview; (2) ‘low TSQ’ inclusion, meaning that a random sample of patients across the 
teams (N = 200) demonstrating a low risk of having a PTSD (TSQ ≤5) will be invited for 
a ‘low TSQ’-inclusion interview; and (3) ‘incidental referrals’-inclusion.
The inclusion interview conducted by the research assistant (RA) will be the same 
for all three categories ‘regular’, ‘low TSQ’ and ‘incidental referrals’: (a) three sections 
of the M.I.N.I.-Plus interview for assessing psychotic disorders, mood disorders with 
psychotic features and a risk analysis regarding acute suicidality; (b) the CAPS (Blake et 
al., 1995) for assessing a PTSD diagnosis; and (c) the BDI-II (Beck, Steer, Ball, & Ranieri, 
1996a) for assessing the severity of depressive symptoms.
‘Regular’ participants who meet the inclusion criteria and give consent go to 
the randomization phase. ‘Low TSQ’-participants who appear to meet all criteria for 
inclusion (including a PTSD despite their low TSQ screening score) may also enter the 
randomization phase. The third group is that of incidental ‘referrals’. Referred participants 
will not be recruited using the standard screening procedures in cooperating teams. 
Instead, psychiatrists, psychotherapists, caseworkers or patients from other teams will 
be offered the opportunity to refer for screening and possible entry in the intervention 
study. They may do so, if thereare indications the patient may have psychosis and PTSD 
and may benefit from participation. The diagnostic data of referred participants will 
be excluded from some of the study’s analyses, but these will be part of all treatment 
outcome analyses.
Randomization
All patients meeting the inclusion criteria are asked for written informed consent to 
participate in the intervention study. Consenting participants receive the pre-treatment 
(T0) measurements. (Note that for patients with auditory hallucinations six days of T0 
measurements on auditory verbal hallucinations are added, using ESM; see Instruments). 
After T0, participants are randomized to PE, EMDR or the waiting list. A group of fifteen 
random assignments for each participating therapist will be made. These groups are 
made using the scientific randomization program on the Internet (www.randomizer.
org) by the independent randomization bureau of the Parnassia Psychiatric Institute. 
Each block has five assignments for each condition: PE or EMDR or waiting list. Thus, 
each therapist treats five people with PE and five people with EMDR. After six months, 
the therapist will offer the five people from the waiting list the therapy of their choice.
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Figure 1. Flow Diagram T.TIP
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Power and sample size calculation
An F-test over three groups with a medium effect-size of treatment compared to waiting 
list, alpha .05 and power .80 needs 159 participants. Attrition is estimated conservatively 
to be high at 33%. The needed number of participants is 240. We will use 3 x 80 
participants.
To minimize missing values: (a) research assistants will use letters, text messages, 
telephone calls, and contacts with participants’ case workers for inviting participants and 
for reminding them about their assessment appointments; (b) therapists are reminded 
by mail and in supervision to conduct their assessments, be it assessments within sessions 
or at T1, T2 and T6; and (c) therapists are encouraged by mail to remind and support 
the participant to go to the assessment appointments with the RA at T2, T6 and T12.
All the participants will receive financial compensation of twenty-five euros for 
every single measurement at T0, T2, T6 and T12, regardless of whether or not the 
participant drops out of treatment. The compensation will be paid at the planned end 
of participation (T6 for waiting list participants, T12 for participants in the treatment 
condition).
Interventions
 
Treatment as usual (TAU)
Participants in all three conditions PE, EMDR and waiting list receive TAU, consisting of 
antipsychotic medication, and treatment and/or supportive counseling by therapists, 
caseworkers or coaches (for example, Individual Placement and Support). TAU is 
considered to be equal in the three conditions as a result of the randomization procedure 
used (see Randomization).
Prolonged exposure (PE)
PE therapy is a psychotherapeutic approach that reduces PTSD symptom-severity by 
systematically exposing the subject,in both imaginary and in vivo ways, to previously 
avoided traumatic internal and external stimuli (Foa, Hembree, & Rothbaum, 2007). 
The trauma-related fear memory network is activated by PE and psychopathological 
cognitions may be changed during PE (Foa & Rauch, 2004). PE consists of eight sessions 
of 90 minutes.
In the first treatment session, a case conceptualization is made in order to plan the 
treatment sessions. The therapist receives information from the Interview for Traumatic 
Events in Childhood (ITEC) (Lobbestael, Arntz, Harkema-Schouten, & Bernstein, 
2009), an interview that is part of T0. The ITEC captures categories (for example, 
sexual abuse, physical abuse) of experienced traumatic events. In addition, the intensity 
of re-experiencing symptoms of each traumatic event is assessed. Based on the ITEC, 
the therapist draws up a preliminary, formatted PE case conceptualization. In the first 
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treatment session, the therapist will discuss and complete the case conceptualization 
together with the patient. This results in a hierarchy of the most relevant traumatic 
memories in order of significance with regard to the symptoms of PTSD. A highly 
qualified supervisor (AvM) reviews each case conceptualization.
In the first session, the therapist will explain the treatment rationale to the 
participant. Imaginary PE is carried out from the second treatment session: the 
confrontation with avoided anxiety provoking memories, during 45 to 60 minutes per 
session. The participant imaginarily relives the traumatic events. The therapist prompts 
the participant to tell details about the memory and to relive the memories very vividly, 
as if it was happening here and now. The participant is instructed to reveal sensory details 
of the traumatic events, and to talk in the present tense and from a personal first person 
perspective. The therapist helps the participant to expose himself or herself to the most 
fearful parts of the memory, the socalled hot spots. Subjective Units of Distress (SUDs, 
range 0 to 100) reflecting the levels of distress are monitored during the PE sessions. 
Each session is recorded and stored with a voice recorder. At home the participant listens 
to the complete recording five days a week, scoring the SUDs prior to, during and after 
listening. At session three exposure in vivo is added. A list is made of avoided trauma 
related stimuli. As homework, the participant sets out to confront these situations in 
vivo (including: on the internet). Again distress levels (SUDs) prior to, during, and after 
in vivo exposure are monitored.
Eye movement desensitization and reprocessing (EMDR)
EMDR is a psychotherapeutic approach, in which memory representations of traumatic 
life experiences are processed in order to change dysfunctional beliefs about self or 
others that originated from damaging traumatic experiences (Shapiro, 2001, 2002). 
EMDR consist of eight sessions of 90 minutes. 
As in PE, in the first treatment session a case conceptualization is made in order to 
plan the treatment sessions. The therapist receives information from the ITEC. The ITEC 
captures categories (for example, sexual abuse, physical abuse) of experienced traumatic 
events. In addition, the intensity of re-experiencing symptoms of each traumatic event is 
assessed. Based on the ITEC, the therapist draws up a preliminary, formatted EMDR case 
conceptualization. In the first treatment session, the therapist will discuss and complete 
the case conceptualization together with the patient. This results in a hierarchy of the 
most relevant traumatic memories in order of significance with regard to the symptoms 
of PTSD. A highly qualified supervisor (CdR) reviews each case conceptualization.
After acceptance, memories are subsequently processed following the Dutch 
translation (Broeke, de Jongh, & Oppenheim, 2009; de Jongh & Broeke, 2003) of the 
basic EMDR protocol (Shapiro, 2001). The participant is asked to focus on the currently 
most distressing image of a memory in a multimodal manner, including image, thought 
(an experienced negative cognition (NC) and a more healthy positive cognition (PC)), 
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emotion, physical sensation and level of tension (SUD). Processing of the memory starts 
when the therapist asks the patient to hold the target image in mind while concentrating 
on a distracting stimulus (the finger of the therapist eliciting eye movements) for about 
30 seconds. The patient reports briefly what comes to mind and is guided by the clinician 
to refocus on that element while focusing on the distracting stimulus. This continues 
until no more associations come up and the disturbance level associated with the target 
memory (SUD) drops to zero. Then the therapist guides the participant in installing 
the PC to a maximum validity, that is a Validity of Cognition (VOC) score seven. The 
participant identifies any residual disturbing sensations and, if present, the memory will 
be processed again in the same manner as described above, until the SUD is zero and 
the VOC PC is seven. The therapist facilitates a positive closure to the session. In the 
next session a re-evaluation takes place in which the participant comments on previously 
processed targets as a basis for further intervention.
Early completions
A participant will be considered an early completer of treatment when (a) his or her 
score on the PTSD Symptoms Scale – Self Report (PSS-SR) is lower than 10 on two 
consecutive occasions, and if (b) the SUDs from all situations that are part of the case 
conceptualization are reduced to zero.
Measurements
Subjects participate in the study for 12 months. At T0, the RA assesses baseline 
measurements of all primary, secondary, tertiary and quaternary variables. At T1, at 
midtreatment, participants in treatment conditions are assessed for their scores on 
the moderator and mediator variables by self-report questionnaires handed out by the 
therapist. At T2, the end of treatment, the RA assesses treatment outcome variables. 
T6 is the first follow-up measurement, and this is the starting point for treatment for 
the waiting list group. T12 is the 12-month follow up measurement for the PE and 
EMDR group.
For participants in the treatment conditions PE and EMDR some assessments are 
planned within sessions: PTSD symptom severity, therapy burden, harm expectancy 
(pre-session) and experienced harm (post-session), adverse events (pre- and post-
session), credibility of treatment and memory characteristics. Note that therapists 
are also assessed independently from the participants for perceived and experienced 
treatment burden credibility and harm, before, during and after treatment.
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Instruments
Measurements – inclusion
The M.I.N.I.-International Neuropsychiatric Interview-Plus (M.I.N.I.-Plus) (Lecrubier et 
al., 1997; Sheehan et al., 1997; Sheehan et al., 1998) is used as an inclusion tool. The 
M.I.N.I.-Plus sections for psychotic and mood disorders will be used to assess lifetime 
psychotic disorder or mood disorder with psychotic features at recruitment. The 
M.I.N.I.-Plus is a short diagnostic interview schedule that can be easily incorporated into 
routine clinical interviews and is well accepted by patients (Pinninti, Madison, Musser, 
& Rissmiller, 2003). The M. I.N.I.-Plus may be used in research (Van Vliet & De Beurs, 
2007); it is fit to classify psychotic and mood disorders (Mordal, Gundersen, & Bramness, 
2010; Van Vliet & De Beurs, 2007). According to the C.I.D.I. (Lecrubier et al., 1997) the 
Kappa coefficient, sensitivity and specificity of the M.I.N.I. were good (>0.70) or very 
good (>0.80) for most diagnoses including psychotic and mood disorders. Inter-rater 
and test-retest reliability were good (>0.70). Validation against the Structured Clinical 
Interview for DSM-IV (SCID-P) supported the validity and reliability of the M.I.N.I. 
(Sheehan et al., 1997).
As pointed out in the section Inclusion, the original M.I.N.I. module of suicidality 
was used as part of the algorithm used to exclude patients.
Measurements –effects of treatment on PTSD symptoms and safety
See Table 1, Primary outcome measurements.
The CAPS (Blake et al., 1995) is the primary outcome measure. The CAPS 
assesses the presence or absence of PTSD diagnosis and the frequency and intensity 
of the clinician’s rated PTSD symptoms. The CAPS provides ratings of the frequency 
and intensity of each of the 17 DSM-IV–TR based PTSD symptoms on 0 to 4 Likert-
type scales, thereby allowing for a maximal score of 8 for each symptom and a total-
score range from 0 to 136. The CAPS is considered the gold standard to diagnose 
posttraumatic stress disorder as defined in the DSM-IV -TR and to establish its severity. 
A review of the empirical literature on psychometric properties of the CAPS (Weathers, 
Keane, & Davidson, 2001) indicates that the CAPS has excellent reliability (>0.90), 
yielding consistent scores across items, raters and testing occasions. There is also strong 
Table 1: Measurements primary objectives: PTSD and safety of treatment
Primary
outcome
MeasurementInterview(i),
self-report(s)
T0
baseline
T1
midtreatment
Within-session
(1–8)
T2
posttreatment
T6 FU 6
months
T12 FU 12
months
PTSD CAPS (i) x x x x
PSS-SR (s) x 1, 2, 3, 4, 5, 6, 7, 8 x x x
Adverse 
events
TAEQ (s) x x x x x
AE session ratings (s) 2, 3
AE. adverse events, CAPS Clinician Administered Post traumatic stress disorder Scale, FU follow up, PSS-SR Posttraumatic 
Stress Disorder Symptom Scale - Self Report, TAEQ T.TIP Adverse Events Questionnaire.
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evidence of validity: the CAPS has excellent (>0.90) convergent and discriminant validity, 
diagnostic utility, and sensitivity to clinical change.
The Posttraumatic Stress Symptom Scale, Self-Report (PSS-SR) (Foa, Riggs, 
Dancu, & Rothbaum, 1993) is administered to assess self-reported severity of PTSD 
symptoms (Wohlfarth, van den Brink, Winkel, & ter Smitten, 2003). The PSS-SR consists 
of 17 items corresponding to the 17 diagnostic DSM-IV-TR criteria of PTSD which are 
rated on a 3-point Likert scale, where 0 = not at all, 1 = a little bit, 2 = somewhat and 
3 = very much. It yields a total score measuring symptom severity (range 0 to 51), as 
well as separate severity scores for re-experiencing (range 0 to 15), avoidance (range 
0 to 21), and arousal (range 0 to 15). The PSS-SR is assessed before each treatment 
session, to assess changes in the PTSD symptoms during treatment.
There is a satisfactory internal consistency (Cronbach’s alpha = 0.91), high test–
retest reliability (r = 0.74) and good concurrent validity (sensitivity = 62%, positive 
predictive power = 100%, negative predictive power = 82% (Foa et al., 1993; Kilcommons 
& Morrison, 2005). In a sample of patients with a first-episode psychosis the screening 
performance of the PSS-SR was tested against CAPS interview results (Sin, Abdin, & Lee, 
2012). The data suggest that the PSS-SR can be a useful screening instrument for PTSD 
in this group of patients. Sensitivity was 0.83 and specificity was 0.83.
The T.TIP Adverse Events Questionnaire (T-AEQ) is a checklist that establishes 
treatment safety. In seven questions the patient is asked to report any self-inflicted pain 
or injury, suicide attempt, deliberately hurting or physically wounding another person, 
excessive use of alcohol, excessive use of drugs, having needed help because of a crisis 
and being admitted to a psychiatric hospital. The time frame is two months.
The Adverse Events session ratings assesses adverse events in the participant 
before and after treatment sessions (sessions two and three), for example, being suicidal, 
Table 2: Measurements secondary objectives: psychopathology and cost effectiveness
Secondary outcome MeasurementInterview(i),
self-report(s)
T0 
baseline
T1
midtreatment
T2 
posttreatment
T6 FU 6
months
T12 FU 12
months
Paranoid thinking
Verbal hallucinations
Delusions
Basic assumptions
Verbal hallucinations
Depression
Social functioning
Posttrauma cognitions
Remission
Care consumption
Health outcome
GPTS (s)
AHRS (i)
DRS (i)
AVH-BAS (s)
ESM (s, psymate)
BDI-II (s)
PSP (i)
PTCI (s)
SCI-SR (i)
TiC-P (s)
EQ-5D (s)
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
AHRS. Auditory Hallucination Rating Scale, AVH-BAS Auditory Verbal Hallucinations – Basic Assumptions Scale, BDI-II Beck 
Depression Inventory - II, DRS Delusion Rating Scale, ESM Experience Sampling Method, EQ-5D™ EuroQol - 5 dimensions 
GPTS Green ParanoiaThought Scale, PSP Social Performance Scale PTCI Posttraumatic Cognitions Inventory, SCI-SR 
Structured Clinical Interview for Symptoms of Remission for the PANSS, TiC-P Trimbos/iMTA questionnaire for Costs 
associated with Psychiatric Illness - short version.
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hearing voices. Participants respond on a 10-point visual analog scale (VAS;‘no, not at all’ 
to ‘yes, very much’) to the questions.
Measurements – effects of treatment on psychopathology and cost effectiveness
See Table 2, Secondary outcome measurements.
The Green Paranoid Thought Scales (GPTS) (Green et al., 2008) is a self-report 
measure that assesses changes in paranoid experiences and in ideas of reference. It 
consists of 32 statements about experiences in the last month, sixteen items about ideas 
of persecution and sixteen items about ideas of reference. Items are scored on a Likert 
scale ranging from 1 (not at all) to 5 (totally). The range of the total score is 32 to 
160, with higher scores indicating higher levels of paranoia. The GPTS has good internal 
consistency, is valid, reliable and sensitive to clinical change (Green et al., 2008).
The Auditory Hallucination Rating Scale (AHRS), which is part of the Psychotic 
Symptom Rating Scale(PSYRATS) (Haddock, McCarron, Tarrier, & Faragher, 1999), 
is an eleven questions interview that assesses the severity of auditory hallucinations: 
their frequency, duration, location, loudness, causal attribution, negative content, the 
severity of negative content, the extent and the severity of discomfort and suffering, the 
disruption of daily life because of voice hearing and the experience of control over voices. 
Scores are on a range from 0 (for example,‘not’) to 5 (for example,‘continuously’). The 
range of the total score is 11 to 55. The inter-rater reliability is excellent (.79 to 1.00).
The Delusion Rating Scale (DRS) is part the Psychotic Symptom Rating Scale 
(PSYRATS) (Haddock et al., 1999). It assesses the severity of delusions. Six questions 
go into the extent and the duration of preoccupation with the delusion, the credibility, 
the extent and severity of discomfort and suffering, and the disruption of daily life 
because of the delusions. Items are scored from 0 (for example, ‘not’) to 5 (for example, 
‘continuously’). Total score ranges from 0 to 30. Inter-rater reliability is excellent 
(.79 to 1.00).
The ESM is an assessment technique designed to obtain repeated self-reports, 
using an electronic beeper that signals subjects to fill in a questionnaire at preselected 
but randomized time points for several days (Joore et al., 2010). In T.TIP the effect of 
treatment on auditory (verbal) hallucinations is studied. Therefore, only participants 
that experience verbal hallucinations every day may participate. Participants who will 
be part of this ESM study carry a palmtop-like device called a Psymate (Barton et al., 
2009), programmed to beep 10 times a day for six consecutive days at T0 and T6. The 
questionnaire consists of 50 self-exploratory questions used in previous studies, beginning 
with the most transient experiences (mood, thoughts and symptoms), followed by more 
stable items (context) and retrospective items in last position. All items are scored on 
Likert scales (range 1 to 7) or category boxes.
ESM has been proven to be a valid, reliable and feasible method of investigating 
psychotic experiences (Myin-Germeys et al., 2009; Oorschot, Lataster, Thewissen, 
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Wichers, & Myin-Germeys, 2012) by the use of face validity, comparison of aggregated 
data between groups, correlations between similar and dissimilar items and determining 
associations with available behavioral/external referents. ESM is useful for refining 
the phenomenology of psychotic symptoms, for investigating etiological mechanisms 
underlying psychosis and in clinical practice (Kimhy et al., 2006; Oorschot, Kwapil, 
Delespaul, & Myin-Germeys, 2009).
The Beck Depression Inventory second edition (BDI-II) (Beck, Steer, & Brown, 
1996b) is a self-report that consists of twenty-one items. Each item is rated on a 4-point 
Likert-type scale ranging from 0 to 3, with higher scores indicating higher levels of 
depression. The measure asks respondents to rate statements characterizing how they 
have been feeling throughout the past two weeks. The maximum total score for all 21 
items is 63. Score categories range from 0 to 13 (minimal depression), 14 to 19 (mild 
depression), 20 to 28 (moderate depression) and 29 to 63 (severe depression). Good 
psychometric properties have been shown for the original BDI (Beck, Steer, & Garbin, 
1988) and for the 1996 revision BDI-II (Beck et al., 1996) that is adapted to depression 
criteria in the DSM-IV. The BDI-II shows good validity compared to the Hamilton 
Depression Rating Scale (Pearson r of 0.71). The test has high internal consistency 
(α=.91) (Beck et al., 1996a).
The Personal and Social Performance Scale (PSP) (Morosini, Magliano, Brambilla, 
Ugolini, & Pioli, 2000) assesses social functioning as a secondary treatment outcome 
measure. The PSP scale is a clinician-rated scale that measures personal and social 
functioning in the domains of socially useful activities (for example, work and study), 
personal and social relationships, self-care, and disturbing and aggressive behaviors. 
Difficulty in each area is rated according to set criteria, using a six-point scale: absent, 
mild, manifest but not marked, marked, severe, and very severe. On the basis of the 
subscale ratings, a global score is rated by the interviewer, ranging from 1 to 100 in ten 
point intervals, where lower scores indicate lower functioning.
The PSP was shown to be able to detect changes in patients with both stable and 
acute psychotic disorders (Patrick et al., 2009). The PSP has been developed through 
focus groups and reliability studies on the basis of the social functioning component of 
the DSM-IV-TR Social and Occupational Functioning Assessment Scale (SOFAS). The 
PSP showed good (>0.80) interrater reliability and test–retest reliability (Morosini et al., 
2000; Nasrallah, Morosini, & Gagnon, 2008; Patrick et al., 2009).
The Posttraumatic Cognitions Inventory (PTCI) (Foa, Ehlers, Clark, Tolin, & Orsillo, 
1999) assesses cognitions after having experienced a trauma. Note that the PTCI will 
be mentioned again in the section on ‘Tertiary measurements: predictors, moderators 
and mediators of treatment outcome’. The PTCI serves two goals: (a) post traumatic 
cognitions may be altered as a consequence of treatment; and (b) post traumatic 
cognitions may function as a predictor variable of treatment outcome. The PTCI consists 
of 33 items and three subscales. Negative Cognitions  About Self (general negative view of 
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self, permanent change, alienation, hopelessness, self-trust and negative interpretation 
of symptoms) contains 21 items). Seven items represent the second factor of Negative 
Cognitions About the World (unsafe world and mistrust of other people). Five items 
represent the third factor of Self-Blame. Participants rate each item on a 7-point Likert-
type scale, from 1 (totally disagree) to 7 (totally agree). Thus, high scale scores indicate 
stronger maladaptive cognitions. The scores of the three factors are calculated by dividing 
the sum score by the number of items (factor scores range from 0 to 7). The total score 
is the sum of the three factor scores (maximum of 21). Internal consistencies of the 
three subscales were found to be excellent (0.86 to 0.97). The test-retest reliability was 
good (0.74 to 0.86). The PTCI was shown to discriminate better between individuals 
with and without PTSD (86% classified correctly) than other tools for assessing trauma-
related cognitions (Foa et al., 1999). Sensitivity and specificity were proven good (van 
Emmerik, Schoorl, Emmelkamp, & Kamphuis, 2006). The Structured Clinical Interview 
for Symptoms of Remission for the PANSS (SCI-SR, eight items) (Opler, Yang, Caleo, 
& Alberti, 2007) is a brief eight-item interview that is used in research and treatment 
settings to assess remission of psychotic symptoms, based on eight items of the Positive 
And Negative Syndrome Scale (PANSS) (Kay, Fiszbein, & Opler, 1987). In the present 
study it is part of the research of economic costs. The participant has to confirm functional 
status on four items: delusions, unusual content of thought, hallucinations and apathy. 
Scores on the other four items are based on observation and participants’ responses: 
conceptual disorganization, lack of spontaneity, blunted affect and posturing. Each item 
is rated using criteria described in the PANSS Manual. The PANSS determines severity of 
symptoms on 7-point Likert scales. Remission on the PANSS-SCI-SR is defined as a score 
of three (mild) or less for each item, maintained over a sixmonth period (Andreasen et 
al., 2005). Compared to the total PANSS score the specificity of the remission criteria 
was 85%. The sensitivity was 75%. The remission criteria are both sensitive and specific 
indicators of clinical status. Additional analyses are required to determine if remission 
status predicts other outcomes, such as employment, independent living, and prognosis 
(Hakkaart-van Roijen, van Straten, Rutten, & Donker, 2006).
The Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness 
(TiC-P, short version) (Roijen, Straten, Tiemens, & Donker, 2002) will be used to 
assess the costs. Trimbos and the Institute for Medical Technology Assessment (MTA) 
developed this care consumption list. The TiC-P is commonly applied in the economic 
evaluation of treatment in mental health care, including trials on the cost utility of brief 
psychological treatment for anxiety (for example, see Hakkaart-van Roijen et al., 2006; 
IJff et al., 2007). To be able to calculate the total direct medical costs, the first part of 
the Tic-P assesses the total number of medical contacts (outpatient visits, length of 
stay in hospital, use of medication, and so on). Afterwards, the data will be multiplied 
by unit costs of the corresponding health care services. Reference unit prices of health 
care services will be applied and adjusted to the year of this study according to the 
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consumer price index. In the second part of the TiC-P a short form of the Health and 
Labor questionnaire (HLQ) (Van Roijen, Essink-Bot, Koopmanschap, Bonsel, & Rutten, 
1996) will be used to collect data on productivity losses. The Short-Form HLQ (SF-HLQ) 
consists of three modules that measure productivity losses: absence from work, reduced 
efficiency at work and difficulties with job performance.
The EuroQol (EQ-5D™) (Brazier, 2010; König, Roick, & Angermeyer, 2007) is a 
standardized instrument for measuring health outcome. This patientreported outcome 
measure has five dimensions: mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression, and each dimension has three levels (no problem, some problem, 
severe problem). Together, these five dimensions make a simple descriptive profile that 
can be compared to a total of 243 health states scored using values obtained from a 
survey of the general population. Participants also point out a single index value for 
current health status on a scale from 0 (‘worst possible health’) to 100 (‘best possible 
health’). The EQ-5D measures and expresses quality of life in utilities. Utilities can be 
combined with cost-effectiveness data into Quality Adjusted Life Years (QALYs). The 
EQ-5D has good reliability and validity (König et al., 2007).
Measurements – links between trauma exposure, PTSD and psychosis
See Table 3, Tertiary outcome measurements. Note that the measurements of psychosis 
mentioned in Table 2 are  necessary, too, for examination of the tertiary objectives.
T.TIP screener, including the TSQ. The T.TIP screener is designed for the purpose 
of briefly asking: a) about having experienced overwhelming or life threatening 
experiences (‘yes’ or ‘no’); and b) If ‘yes’, then participants are asked what kind of PTSD 
DSM-IV-TR criterion A traumatic events they have experienced: physical abuse, sexual 
abuse, emotional abuse, extreme neglect and/or accidents/disasters/war. Because 
patients in this specific patient population may also have experienced traumatic events 
during psychotic episodes, this category was added. For each category of traumatic 
events the participant chooses between ‘yes, one traumatic experience’, ‘yes, more than 
one traumatic experience’ or ‘no traumatic experience’. c) To gain more information 
about the phenomenological similarities between trauma content and content of the 
symptoms of their psychosis, participants are asked about similarities (‘no similarity at 
all’, ‘some similarity’ or ‘strong similarity’). d) Participants then answer questions about 
PTSD symptoms they may suffer, using the TSQ (Brewin et al., 2002). The TSQ is a 10-
item scale with the five re-experiencing items and five hyperarousal items of the PSS-
SR. All items are answered with binary ‘yes’ (symptom is present two times a week or 
more) or ‘no’ (symptom is not present or present once a week) responses; the minimum 
score is zero and the maximum score is ten. The TSQ has a good sensitivity in assessing 
potential PTSD in crime victims (0.76) and rail crash victims (0.86), as well as a high 
specificity in both of these groups (0.93 and 0.97, respectively) (Brewin et al., 2002). 
The TSQ has also shown to be a good measure to predict future PTSD in assault victims, 
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with a sensitivity of 0.85, a specificity of 0.89, and an efficiency of 0.90 (Walters, Bisson, 
& Shepherd, 2007). Both studies mentioned above (Brewin et al., 2002; Walters et al., 
2007) calculated that the optimum cut-off score is 6; any combination of six or more 
re-experiencing or hyper arousal symptoms predicts PTSD best. The TSQ is not yet 
calibrated for people with psychotic disorders.
The Inventory of Traumatic Events in Childhood (ITEC) (Lobbestael et al., 2009) 
is used to interview the participant for traumatic events in his or her life. The ITEC 
consists of five subcategories: sexual abuse, physical abuse, emotional or psychological 
abuse, emotional and physical neglect, and ‘other traumas’ that include items such 
as disaster, war, accidents, illness and death of loved ones. Within each category (for 
example, physical abuse) a number of specific events are presented (for example,‘You 
were beaten or got punched’). The participant has to respond to several questions: 
‘Did this ever happen to you? ‘, ‘Who did this to you?’, ‘How old were you when this 
happened?’, ‘Did this occur once, or more?’
For the purpose of the study (a) a category of traumatic events during psychotic 
episodes was added. This category includes specific events such as ‘A psychosis in which 
you hurt yourself or tried to kill yourself’; ‘a psychosis in which you were locked up or 
tied up against your will?’; and b) an assessment was added of both intensity (SUD) 
and frequency of intrusions for each reported traumatic event. The psychometric 
properties are good (Lobbestael et al., 2009). The scales had good internal consistency 
(>0.70), except for the physical neglect subscale and an excellent (>0.90) inter-rater 
reliability. The scales were highly associated with equivalent scales of the Childhood 
Trauma Questionnaire (CTQ) (that is, good convergent validity) and showed good 
correspondence with patient file information (that is, good criterion validity). Internal 
reliability of the ITEC subscales range from .58 to .89 with a mean of .79. The reliability for 
the physical neglect scale is inadequate, while the other scales display moderate to good 
reliability. Results showed excellent agreement between the raters for most subscales 
(intraclass correlation coefficient (ICC) sexual and physical abuse = 1.00; ICC emotional 
abuse and neglect = .99; ICC witnessing physical abuse = .88; ICC witnessing emotional 
abuse = .96) and good agreement for the physical neglect scale (ICC = .72). Additionally, 
high correlations with the corresponding subscales of the CTQ (Bernstein, Ahluvalia, 
Pogge, & Handelsman, 1997; Bernstein et al., 1994; Fink, Bernstein, Handelsman, Foote, 
Table 3: Measurements secondary objectives: psychopathology and cost effectiveness
Secondary outcome MeasurementInterview(i),
self-report(s)
T0 baseline T1
midtreatment
Trauma categories; PTSD risk T.TIP screener /TSQ (s) x
Traumatic events ITEC (i) x
ITEC. Interview for Traumatic Events in Childhood, T.TIP screening/TSQ TTIP screening including the Trauma Screening 
Questionnaire.
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& Lovejoy, 1995) were obtained, indicating good convergent validity. Finally, criterion 
validity was assessed by comparing the presence of maltreatment as mapped by the ITEC 
with patient file information. Data indicated that the ITEC’s sensitivity was excellent, and 
their scores on their parallel ITEC subscales uniquely predicted sexual and physical abuse 
and neglect. This was not the case for emotional abuse.
Measurement – moderators, mediators and predictors of treatment outcome
See Table 4, Quaternary measurements. Note that only measurements on participant 
variables are included. Look at the therapist ratings section for explanation of 
measurements of therapist variables.
The Bullying Questionnaire (BQ) (Arseneault et al., 2006; Olweus, 1996) is 
used to collect information about being severely bullied in childhood (age <17) as a 
predictor variable of treatment outcome. The BQ is derived from the original Olweus 
Bully/Victim list, which has 40 items. The BQ has five items. The BQ questions have 
been used in the European network of national schizophrenia networks studying Gene-
Environment Interactions (EU-GEI). The BQ questions are taken from the Environmental 
Risk (E-Risk) longitudinal twin study which they adapted from Olweus and have used in 
several publications, showing good test-retest reliability (Arseneault et al., 2006) and 
reasonable inter-raterreliability (Kyriakides, Kaloyirou, & Lindsay, 2006).
Participants answer if they have been bullied by other children, if they have 
been physically hurt or injured by other children, if they have been hurt emotionally or 
psychologically, how severe the bullying was, and if they ever have bullied other children 
themselves. Scores are on a range from zero (‘never’ or ‘not’) to four (‘often’ or ‘severe’) 
and total scores of the BQ thus range from 0 to 20.
The Tonic Immobility Scale–Adult Form, Part 1- Short Version (TIS-A-1-SF)
(Forsyth, 2000) is used to study tonic immobility as a predictor of treatment outcome. 
TI as a reaction to a traumatic event is originally found mostly in sexually abused women 
(Heidt, Marx, Forsyth, 2005) but is also known to occur during other traumatic events. 
The original TIS-A-Part 1 addresses symptoms of tonic immobility and peritraumatic 
fear and perceived inescapability (Fuse, Forsyth, Marx, Gallup, & Weaver, 2007). Thus, 
this TIS-A -Part 1 score represents the individual’s experience of various aspects of the TI 
response during the traumatic event. The TIS-A-Part 1-Short Form specifically addresses 
TI. It consists of four items, assessing four possible responses during the traumatic event: 
(1) freezing, (2) immobility, (3) not being able to shout or scream and (4) possibility of 
escaping the situation. Answers are on a 7-point Likerttype scale (0 to 6). Psychometric 
properties of the original TIS-A scale (Fuse et al., 2007) were good, but no data are 
available with regard to the short version used in the T.TIP study.
The auditory Random Interval Repetition (RIR) task is a computerized reaction 
time task, that is studied as a possible predictor and moderator of treatment outcome. 
During this task participants wear headphones that present repetitive beeps of 200 Hz, 
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each lasting for 50 ms. The inter-stimulus-interval (ISI) on this computerized RIR task 
is either 850 or 1450 ms. Participants are instructed to respond as fast as possible by 
pressing a bar, every time they hear a beep, and the reaction time (RT) is the dependent 
variable. The RIR task is carried out under two conditions of three minutes each: 1) 
while making a distracting task, in this case eye movements, elicited by the index-finger 
of the research assistant, moving horizontally at 30 cm from the eyes at a pace of two 
seconds per cycle, and 2) without a distracting task. The order of the conditions is 
counterbalanced to control for carry over effects. The degree to which eye movements 
tax the central executive component of the working memory is operationalized as the 
slowing down of RTs and reduced accuracy (more errors and non-responses) during the 
distracting task compared with the no-distracting task condition. The task is constructed 
and performances measured with E-Prime 1.2 software.
Table 4: Measurements quaternary objectives: predictors, moderators, mediators (participant variables.
Quaternary outcome Measurement 
Interview(i)
self-report(s)
T0 
baseline
T1 
midtreatment
Within-session
(1 to 8)
T2 
posttreatment
T6 FU 6
month
T12 FU 12
months
Bullying
Tonic immobility
Working memory
Credibility participant
Burden participant
Harm expectancy pre
Harm experience post
Demographics
Self esteem
Illness beliefs
Post trauma cognitions
Cognitive bias
Memory
Social support
BQ (s)
TIS-A-1-SF (s)
RIR
CS-PF (s)
BS-PF (s)
session rating (s)
session rating (s)
TDQ
SERS-SF (s)
PBIQ (s)
PTCI (s)
DACOBS (s)
MCQ-RF (s)
MOS-SSS (s)
x
x
x
x
x
x
x
x
x
x
x
x
1, 8
1, 8
2, 3
2, 3
2, 3, 8
x
x
x
x
x
x x
AVH-BAS. Auditory Verbal Hallucinations Basic Assumptions Scale, BQ Bullying Questionnaire, BS-PF Burden Scale – 
Participant Form, DACOBS Davos Assessment of Cognitive Biases Scale, FU follow up, MCQ-RF Memory Characteristics 
Questionnaire – Revised Form (adapted for T.TIP), MOS-SSS Medical Outcome Studies - Social Support Survey, PBIQ 
Personal Beliefs about Illness Questionnaire – Revised version, PTCL Posttraumatic Cognitions Inventory, RIR Random 
Interval Repetition, SERS-SF Self Esteem Rating Scale - Short Form, TDQ T.TIP demographic questionnaire, TIS-A-1-SF Tonic 
Immobility Scale- Adult Form-Part 1-Short Form.
To have a RT task carried out while the subject is being distracted simultaneously, 
is a valid way to assess the presence and severity of cognitive taxing (Golicki, Zawodnik, 
Janssen, Kiljan, & Hermanowski, 2010). RTs to auditory cues presented at an RIR 
task, provide a valid and highly sensitive measure of taxation of the central executive 
component of the working memory (Ravens-Sieberer et al., 2010). Laboratory 
experiments with undergraduates have shown that 1) making eye movements during a 
stimulus discrimination task slows down RTs and raises the number of errors made (van 
den Hout et al., 2011) and 2) more taxing of the working memory results in higher RTs, 
more errors and more non-responses (van den Hout et al., 2010). In a pilot study with 
12 patients with a psychotic disorder we found the same patterns in the performance on 
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the RIR task with three conditions: no eye movements, eye movements at one second 
per cycle and eye movements at two seconds per cycle (publication in preparation). In 
T.TIP two seconds per cycle will be used.
Several measures of treatment credibility, burden, harm expectancy and harm 
experience are administered to both therapists and participants.
First, the T.TIP Therapist attitude questionnaire (TTAQ) aims to measure therapist 
attitude towards the treatments (PE and EMDR). This has two goals: (i) to study 
therapist treatment attitude as a predictor variable on treatment outcome, and (ii) to 
study the impact of training and experience on therapist treatment attitude. The T-TAQ 
is repeatedly administered in the context of training and supervision sessions. The T-TAQ 
consists of 15 items, divided into three parts a, b (with within session extension) and c 
(with within session extension). (a) The Impact of Training and Therapeutic Experience 
Questionnaire – therapist form (ITTEQ-TF) assesses the therapist factor of ‘Training 
and therapeutic experience’ in PE and EMDR. In this three item therapist self-report list, 
therapists disclose on a 1 (‘totally disagree’) to 10 (‘totally agree’) VAS their level of (1) 
training in EMDR/PE, (2) experience in carrying out EMDR/PE and (3) the number of 
patients treated successfully using EMDR/PE. (b-1)The Credibility Scale- therapist form 
(CS-TF) therapists respond to five treatment credibility statements regarding PE and 
EMDR on a 1 to 10 VAS: (1) This treatment seems logical to me. (2) This treatment 
seems scientific to me. (3) If I have a PTSD, I would choose this treatment. (4) This 
treatment would be effective for most people. (5) If a close friend or relative has PTSD, 
I would recommend this therapy to them. The CS-TF is an adaptation of the original 
Credibility/Expectancy Questionnaire (Devilly & Borkovec, 2000) which demonstrated 
high internal consistency within each factor (credibility and expectancy) and good 
test–retest reliability. (b-2) The Credibility Scale- therapist session form (CS-TSF) is 
an adaptation of the CS-TF. It is an extra 10-item credibility rating that will be applied 
within actual treatment sessions (1 and 8); the therapist rates not only his or her own 
opinions on credibility, but in addition makes an estimation of how he or she expects 
the participant to rate the credibility of the treatment on the same five questions of 
the CS-TF (‘logical’ and so on). (c-1)The Burden Scale-therapist form (BS-TF). Seven 
questions regarding PE and EMDR assess ‘Perceived barriers’ on a 1 to 10 VAS: (1) PTSD 
will get worse, (2) psychosis will get worse, (3) other comorbid symptoms will get 
worse, (4) the treatment is a burden to the patient, (5) the treatment is a burden to the 
therapist, (6) the treatment will facilitate drop out, (7) the treatment will facilitate crisis 
or admissions to hospital. The BS-TF is inspired by studies that compare the burden and 
endorsement of CBT and EMDR (for example, studies using the Distress/Endorsement 
Validation Scale (DEVS)) (Devilly, 2004; Devilly & Huther, 2008). The BS-TF is not an 
adaptation of the DEVS, however. It is adapted to suit the research questions of the 
study regarding (perceived) barriers for treatment in the population of patients with 
psychosis. There are no psychometric evaluations available. (c-2) The Burden Scale- 
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therapist session form (BS-TSF) is an adaptation of the BS-TF. It is an extra three-item 
burden rating that will be applied within actual treatment sessions (1 and 8); the content 
is limited to estimations by the therapist of how he or she expects the participant to rate 
the burden of the treatment on a 1 to 10 VAS (‘no, not at all’ to ‘yes, very much’): (1) 
Does the participant fear treatment?, (2) Is he or she hesitant to have this treatment?, 
and (3; only for PE) Does the participant expect that listening to the recordings at home 
will be a burden?
The Treatment Preference and Experience-Therapist Scale (TPE-TS) allows 
therapists, before treatment starts, to score their treatment experience with both PE 
and EMDR and their personal preference to start with PE and EMDR with this particular 
patient, on a VAS-scale from 0 to 100. Post treatment the therapist again scores his/
her personal preference to use PE and EMDR with this particular patient using the same 
scale. Psychometric evaluations are not available.
The Burden Scale – Participant Form (BS-PF) assesses burden in participants 
before (expected) and after (experienced) treatment in both conditions, PE and EMDR. 
Before treatment the participants responds on a 10-point Likerttype Scale (‘no, not at 
all’ to ‘yes, very much’) to the following questions: (1) Do you fear treatment?, (2) Are 
you hesitant to have this treatment?, and (3, only for PE) Do you expect that listening 
to the recordings at home will be a burden? After treatment the participant responds 
on a 10-point VAS (‘no, not at all’ to ‘yes, very much’) to the questions: (1) Do you feel 
that afterwards the treatment was less burdensome than you had expected?, (2) Was 
the treatment much of a burden to you?, (3) How much of a burden was it to listen to 
recordings at home? No psychometric evaluations are available.
The Credibility Scale - Participant Form (CS–PF) assesses credibility before and 
after treatment in both conditions PE and EMDR. Participants respond on a 10-point 
VAS (‘no, not at all’ to ‘yes, very much’) to the statements: (1) This treatment seems 
logical to me, (2) This treatment seems scientific to me, (3) If I have a PTSD, I think this 
treatment will help me, and (4) If a close friend or relative has PTSD, I would recommend 
this therapy to them. There are no psychometric evaluations available.
The Harm Expectancy session ratings assess the treatment harm expectancies 
(before the session) and experienced harm (after the session) in two sessions (sessions 
2 and 3). Participants respond on a 10-point VAS (‘no, not at all’ to ‘yes, very much’) 
to the questions, describing expected or actually experienced fear of going crazy, 
panicking and losing control, panicking and drop out of the session, or yet another harm 
expectancy or harm experience.
The T.TIP Demographic questionnaire (TDQ) assesses basic personal, social and 
medical data as predictors of treatment outcome variables: 1) age; 2) date of birth; 
3) country of birth (participant, father, mother); 4) highest level of achievement in 
education; 5) daily housing/living situation; 6) DSM-IV-TR diagnoses; 7) substance 
abuse or dependence; 8) current medication; 9) years of illness of psychosis and PTSD.
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The Self-Esteem Rating Scale - Short form (SERS-SF) (Lecomte, Corbiere, & 
Laisne, 2006) assesses the mediator/moderator variable of self esteem on treatment 
outcome. The 20-item SERS-SF, with its positive and negative self-esteem subscales, 
appears to be a valid and reliable self-esteem measure for individuals with severe mental 
health problems. The original 40-item SERS was reduced to a psychometrically good 
20 item version of the SERS, the SERS-SF. The SERS-SF (Lecomte et al., 2006) has 10 
positive and 10 negative items on self-esteem. The two scales have excellent internal 
consistency (α = .91 positive scale; α = .87 negative scale). The test–retest reliability of 
both scales is high (r =0.90; r =0.91). The SERS total score correlated highly with both 
scales (r = 0.72 and r = 0.79), indicating good convergent validity.
The Personal Beliefs about Illness Questionnaire – Revised version (PBIQ-R) 
(Birchwood et al., 2012) assesses the mediator/moderator variable of cognitions 
about, and coping with, being ill on treatment outcome. The original PBIQ was a 16-
item scale developed to assess people’s appraisals of a psychotic illness in five domains, 
namely (1) control over illness; (2) self as illness; (3) illness as an impediment to the 
attainment of goals; (4) humiliation and guilt, and (5) need for social containment. A 
revised 29-item scale (PBIQ-R) measures five different modes of experience following 
a psychotic illness: shame (six items); loss (seven items); entrapment in psychosis (six 
items); control over illness (five items); and social marginalization/group fit (five items). 
Participants respond to statements (for example, ‘I will always need medical care’) by 
choosing between: ‘strongly disagree’, ‘diagree’, ‘agree’ or ‘strongly agree’. The PBIQ has 
no total score. The PBIQ-R has good predictive validity for relapse as a result of negative 
appraisals of illness and coping skills (Gumley et al., 2006).
The Posttraumatic Cognitions Inventory (PTCI) (Foa et al., 1999) is assessed as a 
mediator/moderator variable on treatment outcome. For a description, see the section 
on Measurements – effects of treatment on psychopathology and cost effectiveness.
The Davos Assessment of Cognitive Biases Scales (DACOBS) (van der Gaag et 
al., 2013) assesses the mediator/moderator variable of cognitive biases in psychoses on 
treatment outcome. Cognitive problems and biases play an important role in the development 
and continuation of psychosis. The DACOBS has been developed as a self-report measure 
of these deficits and processes. It assesses seven statistically independent deficient 
thought  processes. Each  factor is represented with six items: jumping to  conclusions, 
confirmation bias/dogmatism, selective  attention for threat, self as target, theory of mind 
problems, subjective cognitive failure and avoidance behavior. Each item is a statement 
that is scored on a 7-point Likert scale within a two-week time frame. Reliability was good 
(α = 0.90; split-half reliability = 0.92; test-retest reliability = 0.86). The DACOBS 
distinguishes between schizophrenia spectrum patients and normal control subjects. It 
is reliable and valid and may be used in research.
The Auditory Verbal Hallucinations – Basic Assumptions Scale (AVH-BAS; van 
den Berg et al., publication in preparation) assesses the mediator/moderator variable of 
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participants’ basic assumptions about voice hearing on treatment outcome. The AVH-
BAS is especially developed for this RCT. In another study outside of T.TIP responses 
of 176 voice-hearing patients were assessed on several items that reflect cognitive 
and emotional appraisal of voices. After item- and factor-analysis, 14 AVH-BAS-items 
remained that assess cognitive assumptions about voices. Four factors have shown to be 
relevant: (1) negative self-esteem, (2) guilt, (3) powerlessness and (4) danger/threat. 
Initial analyses suggest that the AVH-BAS may be a reliable and valid instrument.
The Memory Characteristics Questionnaire – Revised Form (MCQ-RF) 
(Hagenaars, van Minnen, Hoogduin, & Verbraak, 2009), which was adapted for the 
present study, assesses aspects of the traumatic memory as a mediator/moderator 
variable and its influence on treatment outcome. The MCQ-RF is administered within 
treatment sessions. The MCQ-RF assesses self-reported characteristics of trauma 
memories. The original MCQ has a test-retest reliability total scale of r =. 86. In T.TIP 
we used a shortened version (three items) of the re-experiencing subscale (test-retest 
reliability r = .86): sense of reliving, sense of here and now, and perceptual elements. 
We added one item about memory-related emotions (for example, dissociation, anxiety, 
anger, guilt and depression) and one item about memory-related image characteristics 
(for example, color, light and movement). Participants were asked to rate their trauma 
memories for each of the items on a 0 to 100 scale.
The Medical Outcome Studies - Social Support Survey (MOS-SSS) (Sherbourne 
& Stewart, 1991) assesses experienced social support as a possible predictor variable 
of treatment outcome. The survey consists of four separate social support subscales 
and an overall functional social support index. A higher score for an individual scale or 
for the overall support index indicates more support. Overall index internal-consistency 
reliability: α=0.97, one-year test-retest stability= 0.78. For our purposes only the 
subscales ‘emotional support’ (ES) and ‘instrumental support’ (IS) are administered to 
the participants. On a Likert type scale from 1 (‘none of the time’) to 5 (‘All of the time’) 
participants respond to four ES-items: (1) Someone you can count on to listen to you 
when you need to talk, (2) Someone to give you information to help you understand a 
situation, (3) Someone to give you good advice about a crisis, (4) Someone to confide 
in or talk to about yourself or your problems, and to four IS-items (5) Someone whose 
advice you really want, (6) Someone to share your most private worries and fears with, 
(7) Someone to turn to for suggestions about how to deal with a personal problem and 
(8) Someone who understands your problems.
The internal-consistency reliability and one-year stability for subscales ES and IS: 
α=0.96, stability =0.72 (Sherbourne & Stewart, 1991).
Fidelity checks
The interrater reliability of interview assessments with the CAPS, PSP and SCI-SR remission 
tool is accounted for ingroup wise sessions for interrater reliability enhancement and 
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interrater reliability measurements. Interrater reliability measurements will be carried 
out monthly, by presenting cases to the research assistants for scoring. All assessments 
that research assistants will perform at T0, T2, T6 and T12 are presented in a written 
report, to be reviewed by the researchers.
Therapists receive four days of training in each treatment protocol, that is, PE and 
EMDR. All treatment sessions will be videotaped. A selection will be rated for treatment 
fidelity. All therapists will be supervised by highly skilled professionals (AvM, AdJ and 
CdR, respectively) to evaluate, guide and approve the case conceptualizations and 
treatment interventions. Monthly, four-hour group supervision supports the therapist 
for the whole duration of the experimental intervention. 
Every session the therapist will fill out a self-report questionnaire about the 
elements and the steps in the treatment protocol. Deviations from the protocol will be 
reported to the supervisor.
Therapist ratings
During the whole process of training and treatment, assessments will be carried out of 
therapists’ opinions and expectations regarding the credibility and burden of treatment. 
As indicated in the Instruments section the T-TAQ is administered, comprising the 
ITTEQ-TF, the CS-TF and the BS-TF. The ITTEQ-TF is integrated into the training and 
supervision on PE and EMDR and is rated at different levels: before treatment training 
(‘prior’), halfway through training (‘theory’), after training (‘first practice’), in therapist 
group supervision session number four (‘novice’), at the end of the supervision series 
(‘competent’) and at the half year follow up (‘expert’). The session versions of both 
the CS-TF and BS-TF (CS-TSF and BS-TSF) will be used additionally within treatment 
sessions one and eight.
The TPE-TS is administered to therapists before and after treatment of each 
participant.
Analyses
The primary outcome on the PTSD measures will be analyzed using Linear Mixed Models 
(LMM) with the baseline value as a covariate. LMM will also be used with the secondary 
outcome measures. Sensitivity and specificity of the screener will be calculated with 
Receiver Operating Characteristic curves. The predictors will be assessed with (logistic) 
regression analysis. The moderator and mediator analyses will be calculated with 5,000 
bootstraps (Preacher & Hayes, 2004). The association between working memory and 
the outcome of therapy is performed by analysis of covariance (ANCOVA’s) and multiple 
regression analysis. The ESM data will be analyzed by multilevel linear regression 
modeling using STATA. In case of an effective treatment a cost-effectiveness analysis will 
be performed. The incremental cost-effectiveness ratios (ICERs) are considered to be 
a single-point estimate of an underlying continuum. Acceptability curves are produced 
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with bootstrap simulations and confidence intervals. The outcome will be costs in Euro’s 
per QALY and the costs in Euro’s per day without PTSD gained. If no intervention is 
effective, which is not expected, a cost-minimization calculation will be done.
Discussion
This present so called ‘T.TIP trial’ has several strengths that have the potential of making 
the T.TIP trial a forerunning experiment.
First, it is hypothesized that the T.TIP trial will make it possible to calibrate an 
efficacious and efficient short screening tool for assessing PTSD in the group of patients 
with psychosis. Given the fact that PTSD is underdiagnosed in this patient population 
(Lommen & Restifo, 2009;  Mueser et al., 1998), an instrument that quickly, safely and 
accurately assesses the risk of PTSD may be a significant aid to clinical practice.
The main goal of the study is to treat PTSD in patients with psychosis. The 
comparison of two trauma-focused treatments to a waiting list condition will provide 
answers about the effectiveness of these trauma-focused treatments on PTSD symptoms. 
This is the first controlled study that directly assesses the effectiveness of two guideline 
recommended trauma-focused treatments in this severely mentally ill population that 
is generally excluded from clinical trials (van Minnen et al., 2012). Further, it is a large 
study, including enough patients to make powerful conclusions. This would be an 
important contribution to treatment options for people suffering from psychosis and 
PTSD, as PTSD symptoms negatively influence the level of functioning and quality of 
life in patients with psychosis (Lysaker et al., 2007; Morrison et al., 2003). Conceivably, 
reducing these symptoms will be of great personal value to patients with psychosis who 
suffer from the consequences of exposure to traumatic events.
What is more, the study is aimed at establishing whether these treatments can 
be applied safely in this patient population. This is important for the implementation 
of the treatments, given the fact that clinicians are often hesitant to address issues of 
exposure to traumatic events in this population because they fear deterioration and 
crisis (Becker et al., 2004; Christopher Frueh et al., 2006). Interestingly, in this aspect, 
we applied short-term (eight sessions) ‘basic’ manualized treatment to this population, 
without any pre-treatment interventions, such as emotion-regulation, skills training, or 
stress management. Should these standard trauma-focused treatments prove to be safe, 
this will strengthen their implementation in clinical practice. A strength of the study is 
also that it is a multicenter trial, which will enhance the internal and external validity of 
the interventions.
In addition to PTSD-symptoms and safety, we also studied effects of treatments 
on psychopathology severity, especially psychotic symptoms. By studying several 
variables during treatment, we will be able to disentangle the complex interactions 
between traumatic events, PTSD and psychosis (Hardy et al., 2005; Lysaker et al., 
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2007; McGorry et al., 1991; Morrison et al., 2003;  Mueser et al., 2010) and identifying 
mediators, moderators and predictors of treatment outcome. This is important from 
a theoretical point of view, but also from a clinical perspective. It will provide practical 
guidelines for diagnosis and treatment of PTSD in the population of patients with 
psychosis. One limitation is that only patients are included in the intervention part of 
the present studywho suffer from psychosis and at the same time meet all PTSD criteria 
according to the DSM-IV-TR. Should the results on tertiary objectives indicate that there 
are links between the trauma characteristics and the characteristics of psychosis in this 
particular group, then these results cannot be generalized automatically to the general 
population of patients with psychosis (with individuals who have no PTSD symptoms or 
subthreshold PTSD).
Another important part of the study is the measurement of cost-effectiveness. 
When PTSD and other symptoms of psychopathology decrease as a result of treatment, 
it can be expected that patients consume less care, and thereby diminish health costs.
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Background Post-traumatic stress disorder (PTSD) is highly prevalent in patients with a 
psychotic disorder. Because a PTSD diagnosis is often missed in patients with psychosis 
in routine care, a valid screening instrument could be helpful.
Aims To determine the validity of the Trauma Screening Questionnaire (TSQ) as a 
screening tool for PTSD among individuals with psychotic disorders.
Method Among 2608 patients with a psychotic disorder, the rate of trauma exposure 
was determined and the TSQ was administered to screen for PTSD. PTSD status was 
verified in 455 patients using the Clinician-Administered PTSD Scale (trial registration: 
ISRCTN 79584912).
Results Trauma exposure was reported by 78.2% of the 2608 patients. PTSD prevalence 
was estimated at 16% (95% CI 14.6–17.4%) compared with 0.5% reported in the 
patients’ clinical charts. A TSQ cut-off score of six predicted PTSD with 78.8% sensitivity, 
75.6% specificity, 44.5% correct positives and 93.6% correct negatives.
Conclusions The TSQ seems to be a valid screening tool for PTSD in patients with a 
psychotic disorder.
Declaration of interest None.
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Although the prevalence of trauma exposure and PTSD is high in patients diagnosed with 
psychotic disorders (12.4%, 95% CI 4.0–20.8%) (Achim et al., 2011), there is evidence 
that in routine care both trauma exposure and the diagnosis of PTSD are often under-
reported (Lommen & Restifo, 2009). Moreover, in both clinical practice and research, 
patients with a psychotic disorder are often denied PTSD treatment (Becker, Zayfert, & 
Anderson, 2004; Ronconi, Shiner, & Watts, 2014). The main goal of the present study was 
to determine whether the Trauma Screening Questionnaire (TSQ) (Brewin et al., 2002) 
is a valid screening tool for individuals diagnosed with psychotic disorders to preselect 
those that might have comorbid PTSD. This was explored in a large sample of this patient 
population by first screening the patients for DSM-IV PTSD criterion-A trauma exposure 
(APA, 2000). Then, patients reporting positively on trauma exposure were screened for 
TSQ scores. The PTSD prevalence in the sample screened was then estimated using the 
gold standard, the Clinician-Administered PTSD Scale (CAPS) (Blake et al., 1995), to 
assess patients’ status on PTSD; for comparative purposes, the PTSD diagnosis recorded 
in the clinical charts of the participants was checked. The final step was to determine 
the psychometric properties of the TSQ to predict PTSD in a sample of patients with 
psychotic disorders.
Method
The present study was part of the randomised clinical trial Treating Trauma in Psychosis 
(T.TIP); details of the T.TIP design are published elsewhere (de Bont et al., 2013) (trial 
registration: ISRCTN 79584912). In 13 long-term mental healthcare services in the 
Netherlands, patients with a chart diagnosis of a psychotic disorder or a mood disorder 
with psychotic features were screened with the TSQ. Patients with elevated scores of 
PTSD symptoms (TSQ ≥6) and a randomly selected group of low scorers (TSQ <6) were 
subsequently assessed for a diagnosis of PTSD and psychotic disorder. The prevalence of 
PTSD in the target population was estimated using logistic regression. The validity of the 
TSQ to predict PTSD was assessed with receiver operating characteristic (ROC) analysis.
Inclusion criteria for screening were: adult patients (aged 18–65 years) in 
secondary or tertiary mental healthcare with a chart diagnosis of a psychotic disorder or 
a mood disorder with psychotic features, based on the DSM-IV-TR (APA, 2000). Patients 
were excluded from the screening if they had insufficient competence in the Dutch 
language, if their estimated IQ was 470 (intellectual disability), if they were unable 
Published as:
de Bont, P. A. J. M., van den Berg, D. P. G., van der Vleugel, B. M., de Roos, C., de Jongh, 
A., van der Gaag, M., & van Minnen, A. (2015). Predictive validity of the Trauma 
Screening Questionnaire in detecting post-traumatic stress disorder in patients with 
psychotic disorders. British Journal of Psychiatry, 206(5), 408-416. doi:http://dx.doi.
org/10.1192/bjp.bp.114.148486
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to travel to and from the assessment location and/or if they were in a closed ward or 
in seclusion. At the end of the screening participants were asked for their consent to 
contact them again for further interviewing. All inclusion and exclusion criteria applied 
for the screening procedure remained effective for the interviews.
Measures
TSQ
We used the TSQ, a 10-item symptom screening tool (Brewin et al., 2002) derived from 
the 17-item PTSD Symptom Scale, Self-Report version (PSS-SR) (Foa, Riggs, Dancu, & 
Rothbaum, 1993). The TSQ items are answered by ticking ‘yes’ (symptom is present 
two times a week or more) or ‘no’ (symptom is not present or present less than twice 
a week); the minimum score is zero and the maximum score is 10. The TSQ has been 
proven to have good to excellent sensitivity and specificity in assessing potential PTSD 
in British samples of crime victims and rail crash victims (Brewin et al., 2002), victims 
of the 2005 London bombings (Brewin, Fuchkan, Huntley, & Scragg, 2010) and assault 
victims in Wales (Walters, Blsson, & Shepherd, 2007). In these latter studies, a cut-off 
score of 6 on the TSQ was found to be optimal. The TSQ was translated into Dutch and 
tested against the CAPS in a Dutch sample of crime and accident victims (Dekkers, Olff, 
& Naring, 2010). The reliability was good (alpha (α) = 0.85). The optimum TSQ cut-off 
score was found to be 7, which demonstrated a sensitivity of 87%, a specificity of 69%, 
a positive predictive value (PPV) of 66%, a negative predictive value (NPV) of 89% and 
an overall accuracy of 76%. These data suggest that the Dutch version of the TSQ is an 
effective instrument to screen for PTSD. The TSQ has not yet been tested in individuals 
with a psychotic disorder.
MINI
We used the sections for psychotic disorders and mood disorders of the Mini-International 
Neuropsychiatric Interview-Plus (MINI-Plus) (Lecrubier et al., 1997; Sheehan et al., 
1998; Van Vliet & De Beurs, 2007) to assess lifetime psychotic disorder. Compared with 
the Composite International Diagnostic Interview (CIDI) (Lecrubier et al., 1997), the 
MINI shows satisfactory diagnostic properties: (a) a reliability of 0.68, sensitivity of 
0.90 and a specificity of 0.91 in generating a diagnosis of current psychotic syndromes; 
(b) 0.73, 0.94 and 0.79, respectively, for the diagnosis of major depressive disorder; 
and (c) 0.65, 0.86 and 0.96, respectively, for the diagnosis of a current manic episode. 
The test–retest reliability for psychosis was 0.90 and it was 0.80 for major depressive 
episode. The interrater reliability for the MINI sections was high: 0.88–1.00. A validation 
study (Sheehan et al., 1998) against the Structured Clinical Interview for DSM-IV (SCID-
Patient version) supported these results. Thus, the psychometric characteristics of the 
MINI-Plus make it an appropriate choice for research purposes. Preliminary studies in 
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the Netherlands have demonstrated its suitability for diagnosing psychiatric patients in 
routine clinical practice (Van Vliet & De Beurs, 2007).
CAPS
In the present study, the CAPS categorical diagnosis functions as the test of the accuracy 
of the TSQ. The 2013 guidelines of the International Society for Traumatic Stress Studies 
(ISTSS, 2013) consider the CAPS to be the gold standard for diagnosing PTSD based on 
the DSM-IV-TR. A review of the literature on the psychometric properties of the CAPS 
(Weathers, Keane, & Davidson, 2001) indicates that it has excellent reliability (>0.90) 
and consistency across items, raters and testing occasions. The CAPS also has excellent 
(>0.90) convergent and discriminant validity, diagnostic utility and sensitivity to clinical 
change.
Procedures
Participants were recruited in 2011 and 2012 by teams working in mental health 
organisations in the Netherlands. The local medical ethics committee approved the 
study (NL36649.029.12). It was explicitly agreed that not only individuals suspected of 
having PTSD would be screened with the TSQ but all patients with psychotic disorders. 
Unlike in previous TSQ studies (Brewin et al., 2010; Brewin et al., 2002; Walters et al., 
2007), in the present study the occurrence and/or nature of the participants’ traumas 
was unknown beforehand. That is why for the purpose of the present study we had 
to administer introductory questions about trauma exposure before administering the 
TSQ; only patients who reported that they had been exposed to trauma were allowed to 
fill out the TSQ.
Following our study protocol (de Bont et al., 2013), participants first answered 
the question whether they had ‘experienced or witnessed’ any PTSD A-criterion event, 
i.e. ‘. . . events that were really frightening, life-threatening, overwhelming or shocking’ 
(see Appendix, Question 1). If they indicated ‘no’, the screening ended there for that 
participant. If the answer was ‘yes’ then they could move on to the next questions. First, 
they could indicate which (one or more) of six categorised descriptions of possible 
events fitted their traumatic experiences (Appendix, Question 2): ‘sexual activities 
against your will’, ‘physical abuse’, ‘emotional or psychological abuse’, ‘severe neglect’, 
‘accident/disaster/war’ and/or the supplementary category of experiencing ‘an episode 
of psychosis’. Together, these six categories constitute a broad conceptualisation of 
events that might be considered traumatic according to the DSM-IV PTSD criterion A. 
The categories of sexual abuse, physical abuse and accident/disaster/war represent this 
conceptualisation beyond any doubt. However, which other events might be considered 
to meet the DSM-IV criterion A is still under debate (Weathers & Keane, 2007). The 
screening tool used in the present study also includes the possibility that severe 
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psychological/emotional abuse (for example self or loved ones being threatened with 
death) or severe neglect (such as insufficient shelter, clothes, food, drink or medical 
care) and traumatic psychosis and their aftermaths (Shaw, McFarlane, Bookless, & Air, 
2002) might be compatible with the PTSD criterion A. The category traumatic psychosis 
is typical for this patient population, because patients may experience traumatic events 
because of the content of their psychosis (such as the delusion of being threatened with 
poisoning) and/or as a result of factors associated with (forced) interventions, such as 
being held at a police station with violence. In Question 2 patients also indicated, per 
trauma category, how often they had experienced that particular trauma category: no 
trauma, a single trauma or multiple traumas.
After the introductory Question 1 and Question 2, the screening moves on to the 
10-item TSQ for associated PTSD symptoms (Appendix, Question 3). Note that in the 
TSQ (Appendix, Question 3) patients are not instructed to indicate for which traumatic 
experience(s) reported in Question 2 they are filling out the TSQ. The reason for this is 
that, in this particular patient population, many individuals have experienced multiple 
traumas and it seems difficult for them to relate their PTSD symptoms to one specific 
traumatic event (Lommen & Restifo, 2009). Therefore, the scores on the TSQ represent 
PTSD symptom severity associated with the whole range of trauma types and trauma 
frequencies found in our sample of multi-traumatised, chronically ill out-patients with 
psychotic disorders.
Patients filled out the questionnaire in the presence of their mental health worker. 
To complete the process the caregiver filled out a short list of demographic questions, 
asking about the consenting participant’s gender, age, legal status and housing type. 
Also, mental health services provided a copy of the complete DSM-IV-TR (Axis I to 
V with all diagnostic classifications) recorded in the patient’s chart. Subsequently, 
informed and consenting participants with a TSQ cut-off score ≥6 and a random selection 
(SPSS command ‘select random sample’) of participants with a TSQ score <6 entered 
diagnostic interviewing. These participants were interviewed for verification of the 
chartregistered lifetime history of a psychotic disorder or mood disorder with psychotic 
features (MINI-Plus) and of the presence or absence of PTSD (CAPS), both according 
to the DSM-IV-TR criteria. The CAPS interview was not based on the trauma categories 
that the patient had reported in screening Question 2 (Appendix). Instead, the CAPS 
interview was carried out following the CAPS instruction manual. The patient received 
the CAPS Traumatic Event screening. They selected a maximum of three adverse events 
that were most closely related to their PTSD symptoms. Then, they described the 
events in more detail to the interviewer to test whether the event(s) matched PTSD 
criterion A (CAPS Questions A1 and A2). Only if at least one event fulfilled the PTSD 
criterion A were the CAPS questions about symptoms (CAPS sections B, C and D), duration 
(section E) and impairment (section F) administered with respect to the A-criterion 
trauma(s). The advice of the International Society for Traumatic Stress Studies (ISTSS, 
Predictive validity of the trauma screening questionnaire in detecting posttraumatic stress disorder in patients with psychotic disorders.
99
Ch
ap
te
r 4
Regular screening for PTSD with TSQ (n = 2620)a
Excluded (n = 1279)
– not meeting inclusion criteria, i.e. no report of trauma n = 569
– did not want to participate (‘[...] informed consent to further
contact you in relation to an interview?’ = ‘no’ in a screened individual):
within-group TSQ<6 n = 563 and within-group TSQ≥6 n = 147
Eligible (n = 1341)
Consent to contact
Trauma+TSQ <6 n = 745
Consent to contact
Trauma+TSQ ≥n = 596
Excluded (n = 264)
– did not want to participate
(were contacted, yet changed mind
about consent for interviewing) n = 113
– not meeting inclusion criteria (problems
travelling to interview location; is in closed ward
or secluded; not enough mastery of Dutch for
in depth interviewing)n = 36
– other reason (e.g. no contact, no show, died,
moved away, unknown) n = 115
Excluded (n = 226)
– did not want to participate
(were contacted, yet changed mind
about consent for interviewing) n = 68
– not meeting inclusion criteria (problems
travelling to interview location; is in closed ward
or secluded; not enough mastery of Dutch for
in depth interviewing)n = 16
– other reason (e.g. no contact, no show,
unknown) n = 142
Excluded (n = 384)b
– Other reason, i.e. excluded by
random selection n = 384
Eligible (n = 361)b
– Included by random selection
Eligible and included for interviews
(n = 135)
– Initial n = 2620 individuals screened minus n = 12 exclusions from MINI-Plus (no psychosis)
yields n = 2608 individuals screened and included in analysis
– n = 455 completed interviews (n = 322 TSQ ≥6 + n = 133 TSQ <6) yielding confirmation of
psychosis using the MINI-Plus and yielding a binary outcome (yes/no) on PTSD diagnosis
using the CAPS, to compare with the TSQ
Eligible and included for interviews
(n = 332)
Excluded (n = 10)
– not meeting inclusion criteria
(no psychosis
on MINI-Plus) (n = 10)
Excluded (n = 2)
– not meeting inclusion criteria
(no psychosis
on MINI-Plus) (n = 2)
A
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s
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2013) was followed concerning symptom score rules and assessing PTSD diagnostic status 
(Weathers, Ruscio, & Keane, 1999): i.e. symptom items with a current frequency score 
of one or more, and an intensity score of two or more, counted as PTSD symptoms. To 
fulfil the diagnosis of a current PTSD on the CAPS, a participant had to score one or more 
symptoms of reliving (B-criterion symptoms), three or more symptoms of avoidance 
Figure 1. Flow diagram of the inclusion of participants (screened and interviewed) to examine the predictive validity of 
the Trauma Screening Questionnaire (TSQ) to detect post-traumatic stress disorder (PTSD) in patients with psychotic 
disorders.
CAPS, Clinician-Administered PTSD Scale; MINI-Plus, MINI-International Neuropsychiatric Interview–Plus.
a. n = 2620 screened participants were recruited on the basis of their clinical diagnosis of psychosis, being the ’regular’ 
screening arm in the T.TIP flow chart for the randomised controlled treatment study, not the ’incidental referrals’ arm that 
was designed for potential participants who were suspected to have PTSD (Blake et al., 1995). 
b. As designed (Blake et al., 1995), only a random selection of participants with a TSQ score below six were interviewed.
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(C-criterion symptoms) and two or more symptoms of hyperarousal (D-criterion 
symptoms) for a minimum duration of 1 month (E) with significant disturbance of 
functioning as a consequence (F). Figure 1 shows the flow of participants for screening 
and interviews used to examine the predictive validity of the TSQ in patients with a 
psychotic disorder. 
Data analysis
To construct ROC curves and estimate the prevalence of PTSD we imputed the CAPS 
diagnostic outcome (PTSD diagnoses ‘yes’ or ‘no’) in the total screened sample 
(n = 2608), using a predictor model. Backward stepwise logistic regression was conducted 
on the CAPS interviewed sample data (n = 455) to select strong and independent 
predictors of PTSD. Then, we predicted PTSD status per individual in the total screened 
sample based on the predictor model, using a multiple imputations procedure (by 
default, five imputations). The estimated PTSD status and the TSQ total scores of all 
individuals in the sample (n = 2608) were then used in ROC analysis to determine the 
predictive validity of the TSQ. For this, sensitivity, specificity, positive/negative predictive 
values and optimal cut-off score were calculated. Analyses were conducted using SPSS 
version 20.
Results
 
Demographic characteristics
Table 1 presents the characteristics of the participants who were screened (n = 2608) and 
of the subsample who were interviewed with the MINI-Plus and CAPS (n = 455) (Fig. 1). 
Table 1 shows that our samples are representative of the target population regarding age, 
gender distribution, diagnosis and duration of illness.
Trauma exposure in patients with psychotic disorders
Table 2 presents the results on trauma exposure, i.e. the prevalence of exposure to any 
trauma and exposure per trauma category, in the total sample and in women and men 
separately. The prevalence of trauma exposure was 78.2%, and 55.9% of the patients 
reported exposure to three or more traumatic incidents. The mean number of trauma 
categories (such as ‘physical abuse’) that patients selected was 2.2. These results indicate 
that this population is a multiple traumatised population. The logistic regression analysis 
enter method, with gender as a predictor, demonstrated significant gender differences. In 
this sample, women were more likely than men to report any kind of trauma exposure (odds 
ratio (OR) = 1.76), sexual abuse (OR = 3.58), physical abuse (OR = 1.47) and emotional 
abuse OR= 1.58). Incidents of accident/disaster/war were reported less frequently by 
women (OR = 0.83) than by men.
Predictive validity of the trauma screening questionnaire in detecting posttraumatic stress disorder in patients with psychotic disorders.
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Predictive validity of the TSQ 
Predictor variables by logistic regression
The logistic regression model included seven possible predictors. The first predictor was 
‘gender’ because, in the Netherlands, the odds ratio for women compared with men to 
develop PTSD after trauma was found to be 2.00 (de Vries & Olff, 2009). The predictors 
were ‘sexual abuse’, ‘physical abuse’, ‘emotional or psychological abuse’, ‘severe neglect’ 
and ‘accident/disaster/war’ because these five trauma categories were highly prevalent 
in our sample. Most of these variables are known for their prevalence in people with 
psychotic disorders (Read, van Os, Morrison, & Ross, 2005; Sautter et al., 1999; Varese 
et al., 2012). Finally, the seventh predictor to be entered was the TSQ total score. The 
trauma category ‘traumatic psychosis’ was excluded from the elimination procedure; the 
predictive quality of this variable was per definition limited because all participants had 
experienced psychosis by inclusion. Table 3 shows that four of the predictor variables 
Table 1: Characteristics of the screened sample and the randomised post-traumatic stress disorder (PTSD) assessment subsample 
(Mini-International Neuropsychiatric Interview-Plus (MINI-Plus) and Clinician-Administered PTSD Scale (CAPS)).
Screened group 
(n = 2608)
Interviewed group  
(MINI-Plus and CAPS)  
(n = 455)
Age, years
Median
Mean
43.0
41.9
41.0
40.9
Gender, %
Men
Women
61.8
38.2
60.0
40.0
Duration of illness (psychosis), years
Median
Mean
13.0
15.0
13.0
14.8
Primary chart diagnosis, %
Schizophrenia
Schizoaffective disorder
Delusional disorder, psychotic disorder NOS, brief psychotic disorder
Bipolar disorder with psychotic features
Depressive disorder with psychotic features
Other a,b
54.3
10.9
21.3
6.9
3.8
2.8
49.1
11.8
26.7
4.6
5.8
2.0
Legal status, involuntary treatment: % 6.4 3.7
Housing, %
Independent
Sheltered
Hospital
Parents
Others
79.5
12.9
4.2
3.1
0.3
83.1
10.0
3.9
2.1
0.9
NOS, not otherwise specified.
a. For Primary chart diagnosis in the screened sample the 2.8% ‘Other’ category includes 0.1% PTSD. In 0.4% of the 
screened sample, PTSD was classified in the charts as the secondary diagnosis (data not shown) and in 0.0% as the tertiary 
diagnosis (data not shown). Added together, a classification of PTSD in the chart diagnosis was present in 0.5% (13 people) 
of the total screened sample.
b. If a psychotic disorder was not the Primary chart diagnosis, then a psychotic disorder was recorded as the second or third 
diagnosis (data not shown).
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made a unique significant contribution to the goodness of fit of the model: sexual abuse, 
physical abuse, severe neglect (negative association) and TSQ total score.
The goodness of fit of the predictor model as a whole (Omnibus test of model 
coefficients) was significant, X2(7, n= 455) = 137.25, P<50.001. The model correctly 
classified 73.3% of the cases as opposed to 64.4% predicted correctly from the null 
model. The pseudo R2 statistics of Cox and Snell R2 (0.26) and the Nagelkerke R2 (0.35) 
suggest that 26.0–35.8% of the variance in PTSD is explained by the variables in the 
model. The Hosmer–Lemeshow goodness-of-fit test yielded significant support for the 
model, X2(8, n=455)=7.92, P=0.441 (note that, in this test, high probability values of 
P>0.05 indicate support for the model). 
The selected predictor variables (sexual abuse, physical abuse, severe neglect 
and TSQ total score) estimated the odds of having a PTSD, or not, for each individual 
in the screened sample. Probabilities >0.5 were imputed as ‘PTSD’; probabilities <0.5 
were imputed as ‘no PTSD’. We considered the pooled results of this multiple imputation 
procedure to be an estimate of the prevalence of PTSD in this sample of patients with 
psychotic disorders. 
Estimated PTSD prevalence
The procedure described above yielded an estimated PTSD prevalence in the total 
screened sample (n = 2608) of 16.0% (i.e. 416 individuals, 95% CI 14.6–17.4%). 
Significantly more women (49.3%) than men (50.7%) have estimated PTSD in 
comparison with the characteristics of the screening sample (Table 1, women 38.2%, 
men 61.8%, (X2(1, n= 2608) = 14.446, P<0.001). The significant gender difference 
in estimated PTSD prevalence closely resembles the gender difference in actual PTSD 
prevalence found in the CAPS interviewed group (n=455): more women (50%) and 
less men (50%) than expected (Table 1, men 60.0%, women 40.0%) reached a positive 
diagnostic PTSD status (X2(1, n= 455)= 6.578, P=0.010).
Clinically recorded PTSD prevalence
The mental health organisations recorded DSM-IV-PTSD classifications in 0.5% 
(13 patients) of the clinical charts of all 2608 participants, either as the primary, 
secondary or tertiary Axis 1 diagnosis. In 12 of these 13 patients (92%), the PTSD 
diagnosis in the clinical charts corresponded with the diagnosis as assessed with the 
CAPS in the present study.
Psychometric quality of the TSQ as predictor of PTSD
Comparing TSQ total scores with PTSD status yields the ROC curve presented in 
Fig. 2. The area under the curve (AUC= 0.85, 95% CI 0.83–0.87, P≤0.001) was significant 
for the TSQ total score. Table 4 presents the psychometric properties, i.e. the PTSD 
classification accuracy, for each of the 10 possible TSQ cut-off scores. A cut-off score of 
Predictive validity of the trauma screening questionnaire in detecting posttraumatic stress disorder in patients with psychotic disorders.
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Discussion
 
Trauma exposure in patients with psychotic disorders
The reported prevalence of trauma exposure in our study population (78.2%) proved to 
be similar to the estimated prevalence within the general population in the Netherlands 
(i.e. an 80.7% lifetime prevalence of any potential trauma) (de Vries & Olff, 2009). In the 
general population, women do not show a higher overall rate of trauma exposure than 
men (Olff, Langeland, Draijer, & Gersons, 2007). This is in contrast to the population 
of patients with psychotic disorders. Women reported a higher general rate of trauma 
exposure than men (Table 2) and more often reported (multiple) traumas that are 
known (Olff et al., 2007) for their high risk of developing PTSD, particularly sexual and 
physical abuse.
The experience of a traumatic psychosis
In the Method section, we explained the relevance of adding ‘an episode of psychosis’ 
to the screening questions. Of the 78.2% participants who indicated having experienced 
‘any trauma’, 78.8% reported that one (23.2%) or more than one (55.6%) episode of 
psychosis had been experienced as really frightening, life-threatening, overwhelming or 
shocking. From the available data we cannot infer the unique contribution of traumatic 
psychotic experiences to the PTSD symptoms reported in the TSQ screening. However, 
experiencing psychosis and its consequences is clearly very unsettling and, consequently, 
may contribute to the development of PTSD. For this specific patient population, 
extremely distressing experiences during their psychotic episodes, especially when they 
are experienced as lifethreatening, may be included as a traumatic event as indicated by 
the DSM-IV-PTSD-criterion A.
Estimated PTSD prevalence in the population of patients with psychotic disorders
In the present study, the estimated prevalence of comorbid PTSD in patients with 
psychotic disorders (16%) is at the higher end, but well within the prevalence range of 
12.4% (95% CI 4.0–20.8%) that was found in a meta-analysis (Achim et al., 2011). These 
results corroborate previous findings indicating that PTSD is more common in individuals 
with a psychotic disorder than in the general population, for example a 3.3% PTSD 
prevalence in the Dutch general population (de Vries & Olff, 2009). One explanation for 
this could be that patients with psychotic disorders are more vulnerable to developing 
PTSD because of deficits in information processing (Steel, Fowler, & Holmes, 2005). 
Another hypothesis is that patients with psychotic disorders more often encounter 
6 achieves the best mean of the sum of sensitivity (78.8%) and specificity (75.6%) and 
yields 44.5% correct positive and 93.6% correct negative predictions.
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multiple childhood traumas (Galletly, Van Hooff, & McFarlane, 2011; Read et al., 2005; 
Varese et al., 2012), which may form particular psychological and neurodevelopmental 
(Read, Fosse, Moskowitz, & Perry, 2014) pathways that lead from childhood adversity 
to psychosis.
As in the general population (Shaw et al., 2002), female patients with psychotic 
disorders experience PTSD significantly more often than men. Note, however, that our 
logistic regression analysis (Table 3) indicates that it is not the gender of the person 
subjected to trauma exposure that best predicts PTSD. Rather, PTSD is best predicted 
by the type and frequency of the specific events that a person has been exposed to, 
particularly (repeated) sexual or physical abuse, and by the TSQ total score reflecting 
the severity of screened PTSD symptoms. Future research should provide more insight 
into gender differences and effects in pathways from trauma-exposure characteristics to 
PTSD in patients with psychotic disorders.
Clinical documentation of PTSD in patients with psychotic disorders
Surprisingly, the estimated prevalence of 16% PTSD (417 individuals) in our total sample 
of patients with psychotic disorders is 32 times higher than the 0.5% DSM-IV-TR PTSD 
classifications (13 individuals) recorded by the mental health organisations (footnote 
to Table 1). Missing 15.5% of 16% of people with PTSD indicates an estimated under-
Table 3: Logistic regression predicting the likelihood of fulfilling the DSM-IV-TR criteria of post-traumatic stress disorder (PTSD) on the 
Clinician-Administered PTSD Scale (CAPS) (n = 455).
Predictors B S.E. Wald d.f. P Exp(B), OR (95% CI)
Predictor model a
Sexual abuse
Once
More than once
0.688
0.910
0.349
0.270
12.228
3.889
11.335
2
1
1
0.002
0.049
0.001
1.990 (1.004–3.942)
2.485 (1.463–4.220)
Physical abuse
Once
More than once
0.678
1.076
0.386
0.279
14.998
3.090
14.903
2
1
1
0.001
0.079
<0.001
1.971 (0.925–4.198)
2.933 (1.698–5.064)
Severe neglect
Once
More than once
-0.185
-0.710
0.443
0.274
6.745
0.174
6.742
2
1
1
0.034
0.676
0.009
0.831 (0.349–1.981)
0.491 (0.288–0.840)
TSQ – total score 0.431 0.060 51.539 1 <0.001 1.538 (1.367–1.730)
Not in the predictor model
Emotional or psychological abuse
Once
More than once
0.369
0.153
0.506
0.384
2.617
0.531
0.157
2
1
1
0.454
0.466
0.692
1.446 (0.536–3.897)
1.165 (0.548–2.475)
Accident/disaster/war
Once
More than once
-0.307
-0.174
0.291
0.308
1.188
1.113
0.321
2
1
1
0.756
0.291
0.571
0.736 (0.416–1.301)
0.840 (0.459–1.536)
Gender 0.260 0.247 1.106 1 0.293 1.297 (0.799–2.103)
a. Predictor model: predicts 67.9% ‘no PTSD’ and 32.1% ‘PTSD’; the prediction is 73.3% correct. Null model: predicts 100% 
‘no PTSD’ ; the prediction is 64.4% correct
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report in clinical practice of no less than 96.9% of all those with PTSD. This finding is in 
line with a previous study (Lommen & Restifo, 2009) and should raise serious concerns. 
Despite the extensive reports on the various causal pathways, and negatively mutually 
reinforcing interactions between trauma, (re)victimisation, PTSD and psychosis (Classen, 
Palesh, & Aggarwal, 2005; Morrison, Frame, & Larkin, 2003; Read et al., 2005; Varese et 
al., 2012), this literature seems to be neglected by clinicians in the field of psychosis. An 
important reason for the under-reporting of PTSD might be the hierarchical system of 
diagnosis. Once a psychotic disorder (for example schizophrenia) has been diagnosed, 
other diagnoses are often not considered (Cusack, Wells, Grubaugh, Hiers, & Frueh, 
2007). Another explanation for the underdiagnosis in clinical practice might be that, 
unlike patients (Lothian & Read, 2002) and some groundbreaking professionals (see for 
example Cusack et al., 2007; Read, Hammersley, & Rudegeair, 2007), most mental health 
professionals are hesitant to discuss traumatic events with patients with psychosis. Many 
professionals fear that they may do harm (Becker et al., 2004; van Minnen, Hendriks, 
& Olff, 2010), even though there is no evidence that adverse events might occur as a 
consequence of discussing trauma (Brown et al., 2014; Grubaugh, Tuerk, Egede, & Frueh, 
2012; van Minnen, Harned, Zoellner, & Mills, 2012). Such an attitude is likely to prevent 
adequate diagnosis and treatment of comorbid PTSD, thereby needlessly prolonging the 
adverse consequences of untreated PTSD.
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Figure 2. Receiver operating characteristic (ROC) curve for cut-off scores and for area under the curve (AUC) of the Trauma 
Screening Questionnaire (TSQ) total score to predict post-traumatic stress disorder (PTSD) or no PTSD in patients with 
psychosis.
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The TSQ as a valid predictor of PTSD in patients with psychotic disorders
In this group of patients, the TSQ demonstrated reasonably good psychometric 
properties. This instrument performs as well in the multi-trauma population in the 
present study as it does in population samples selected on the basis of sharing the same 
(single) trauma (Brewin et al., 2010; Brewin et al., 2002; Dekkers et al., 2010; Walters 
et al., 2007). Accordingly, incorporating the TSQ into a PTSD detection procedure will 
probably save time and expenditure. Interviewing every patient with a psychotic disorder 
for PTSD is not a viable option for most mental health services; however, screening for 
PTSD using the validated TSQ takes only a few minutes and is therefore an efficient 
option. More specifically, only 35% of the 2608 patients scored on or above the TSQ 
cut-off score for possible PTSD, reducing the need for CAPS interviewing by 65%. The 
TSQ’s high negative predictive value (93.6%) indicates that very few patients with 
PTSD were missed because of false-negative exclusion. Subsequently, nearly half of the 
35% of patients with a high TSQ score were diagnosed with PTSD based on the CAPS, 
indicating that on average just over two CAPS interviews were needed to detect PTSD 
in one patient. Although the cut-off score we found is in line with most previous studies 
(Brewin et al., 2010; Brewin et al., 2002; Walters et al., 2007), further research into the 
performance of the TSQ in these patients is warranted.
From a clinical point of view, it is important to note that the caregivers of the 
participating patients did not report any ‘serious adverse events’ (i.e. suicide, suicide 
attempt, self-mutilation with need for medical care, admissions to hospital, aggression 
with restraint) as a consequence of filling in the screening questionnaire. In fact, many 
patients reported the opposite and expressed gratitude that their traumas and related 
symptoms had been validated in this study’s assessment procedure.
Table 4: Classification accuracy of the Trauma Screening Questionnaire (TSQ) in predicting post-traumatic stress disorder (PTSD) v. no 
PTSD in adult with psychotic disorders.
TSQ
cut-off 
score
Sensitivity,
%
Specificity,
%
Positive 
predictive
value, %
Negative 
predictive
value, %
Positive 
likelihood
ratio, %
Accuracy,
%
Area under
the curve P
>0
>1
>2
>3
>4
>5
>6 a
>7 
>8
>9
10
100
98.0
96.5
94.9
91.3
85.3
78.8
64.6
48.8
31.3
15.3
0
23.9
35.4
46.8
55.8
66.4
75.6
83.0
90.1
94.4
97.9
20.0
24.3
27.1
30.8
34.0
38.7
44.5
48.6
55.5
58.3
64.0
-
97.9
97.6
97.4
96.2
94.8
93.6
90.4
87.8
84.6
82.2
1.0
1.3
1.5
1.8
2.1
2.5
3.2
3.8
5.0
5.6
7.1
20.0
38.7
47.6
56.4
62.8
70.2
76.3
79.3
82.0
81.8
81.4
0.85
0.85
0.85
0.85
0.85
0.85
0.85
0.85
0.85
0.85
0.85
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
a. Predictor model: predicts 67.9% ‘no PTSD’ and 32.1% ‘PTSD’; the prediction is 73.3% correct. Null model: predicts 100% 
‘no PTSD’ ; the prediction is 64.4% correct.
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Strengths and limitations
To the best of our knowledge, this is the first study to examine screening for PTSD 
in patients using mental health services who are severely mentally ill with a diagnosis 
of psychotic disorders. The study included a large sample from a long-term care 
population with chronic psychotic disorders. The fact that the TSQ was tested against 
PTSD diagnostic status using the CAPS as the gold standard contributed considerably 
to the credibility of the TSQ’s validity. Nevertheless, it could be argued that the 16% 
prevalence of PTSD reported in this study is only an estimate. Indeed, it was not a feasible 
option to interview all screened participants with the CAPS. However, considering the 
large sample sizes of both the screened group (n = 2608) and the interviewed group 
(n = 455), the narrow confidence interval of 14.6–17.4% and the fact that the prevalence 
rate is comparable with that reported in a meta-analysis (Achim et al., 2011), the PTSD 
estimate of 16% seems relatively robust and credible.
Implications
The TSQ is a valid PTSD screening tool for use in patients with psychotic disorders. 
Further, it is very short, rarely misses PTSD and can be used in multiple traumatised, 
complex patient groups with a wide variety of trauma types and frequencies that 
patients may or may not have experienced. The use of a screening tool such as the 
TSQ may be an important aid in reducing the high rate of underdiagnosis of PTSD in 
large cohorts of patients. Hopefully, the detection of PTSD will boost the application of 
PTSD treatments, such as prolonged exposure and eye movement desensitisation and 
reprocessing (De Bont, Van Minnen, & De Jongh, 2013; Frueh et al., 2009; Mueser et al., 
2008; van den Berg & van der Gaag, 2012; van den Berg et al., 2015), which has been 
proven safe in patients with psychotic disorder.
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Appendix
Introductory questions about trauma exposure and the Trauma Screening Questionnaire
Question 1
Have you ever experienced events in your life, or have you ever witnessed events that were really frightening, life-threatening, over-
whelming or shocking?
(Tick the appropriate answer)
No (Thank you for your participation, you may hand in your questionnaire)
Yes (Please continue to question 2)
Question 2
What kind of shocking experience(s) have you experienced?
(Tick what is applicable to you; you may tick more than one answer)
Question 3
Trauma Screening Questionnaire
Your own reactions now to the traumatic event
Please consider the following reactions which sometimes occur after a traumatic event. This questionnaire is concerned with your personal reactions to
the traumatic event which happened to you. Please indicate (Yes/No) whether or not you have experienced any of the following at least twice in the past
week.
B2002 The Royal College of Psychiatrists. Brewin CR, Rose S, Andrews B, Green J, Tata P, McEvedy C, et al. Brief screening instrument for
post-traumatic stress disorder. British Journal of Psychiatry 2002; 181: 158–62. Written permission must be obtained from the Royal College
of Psychiatrists for copying and distribution to others or for republication (in print, online or by any other medium).
Yes, one
traumatic
experience
Yes, more than
one traumatic
experience
No, no
traumatic
experiences
Sexual activities against your will
Physical abuse
Emotional or psychological abuse
Severe neglect
Accident/disaster/war
An episode of psychosis
At least twice in the past week?
YES NO
1 Upsetting thoughts or memories about the event that have come into your mind against your will
2 Upsetting dreams about the event
3 Acting or feeling as though the event were happening again
4 Feeling upset by reminders of the event
5 Bodily reactions (such as fast heartbeat, stomach churning, sweatiness, dizziness) when reminded of the
event
6 Difficulty falling or staying asleep
7 Irritability or outbursts of anger
8 Difficulty concentrating
9 Heightened awareness of potential dangers to yourself and others
10 Being jumpy or being startled at something unexpected
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Importance  The efficacy of posttraumatic stress disorder (PTSD) treatments in psychosis 
has not been examined in a randomized clinical trial to our knowledge. Psychosis is an 
exclusion criterion in most PTSD trials. 
Objective  To examine the efficacy and safety of prolonged exposure (PE) therapy and eye 
movement desensitization and reprocessing (EMDR) therapy in patients with psychotic 
disorders and comorbid PTSD.
Design, setting, and participants  a single-blind randomized clinical trial with 3 arms 
(N = 155), including PE therapy, EMDR therapy, and waiting list (WL) of 13 outpatient 
mental health services among patients with a lifetime psychotic disorder and current 
chronic PTSD. Baseline, posttreatment, and 6-month follow-up assessments were made.
Interventions  Participants were randomized to receive 8 weekly 90-minute sessions of PE 
(n = 53), EMDR (n = 55), or WL (n = 47). Standard protocols were used, and treatment was 
not preceded by stabilizing psychotherapeutic interventions.
Main outcomes and measures  Clinician-rated severity of PTSD symptoms, PTSD diagnosis, 
and full remission (on the Clinician-Administered PTSD Scale) were primary outcomes. Self-
reported PTSD symptoms and posttraumatic cognitions were secondary outcomes. 
Results Data were analyzed as intent to treat with linear mixed models and generalized 
estimating equations. Participants in the PE and EMDR conditions showed a greater reduction 
of PTSD symptoms than those in the WL condition. Between-group effect sizes were 0.78 
(P < .001) in PE and 0.65 (P = .001) in EMDR. Participants in the PE condition (56.6%; 
odds ratio [OR], 3.41; P = .006) or the EMDR condition (60.0%; OR, 3.92; P < .001) were 
significantly more likely to achieve loss of diagnosis during treatment than those in the WL 
condition (27.7%). Participants in the PE condition (28.3%; OR, 5.79; P = .01), but not those 
in the EMDR condition (16.4%; OR, 2.87; P = .10), were more likely to gain full remission than 
those in the WL condition (6.4%). Treatment effects were maintained at the 6-month follow-
up in PE and EMDR. Similar results were obtained regarding secondary outcomes. There were 
no differences in severe adverse events between conditions (2 in PE, 1 in EMDR, and 4 in 
WL). The PE therapy and EMDR therapy showed no difference in any of the outcomes and no 
difference in participant dropout (24.5%in PE and 20.0%in EMDR, P = .57).
Conclusions and relevance  Standard PE and EMDR protocols are effective, safe, and 
feasible in patients with PTSD and severe psychotic disorders, including current symptoms. 
A priori exclusion of individuals with psychosis from evidence-based PTSD treatments may 
not be justifiable.
Trial registration  Isrctn.com Identifier: ISRCTN79584912
Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for 
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In a meta-analysis (Achim et al., 2011) with 20 studies, the prevalence of posttraumatic 
stress disorder (PTSD) in psychosis was estimated to be 12.4% (95% CI, 4.0%-20.8%). 
The presence of comorbid PTSD is associated with poorer social functioning and more 
severe psychiatric symptoms (Lysaker & LaRocco, 2008; Mueser, Lu, Rosenberg, & 
Wolfe, 2010; Sautter et al., 1999). There is  strong empirical support for the efficacy of 
prolonged exposure (PE) therapy and eye movement desensitization and reprocessing 
(EMDR) therapy in treating PTSD (Bisson, Roberts, Andrew, Cooper, & Lewis, 2013; 
Bradley, Greene, Russ, Dutra, & Westen, 2005). These treatments are recommended as 
first-choice therapy in PTSD guidelines worldwide (Forbes et al., 2010; WHO, 2013). 
However, clinicians seem reluctant to treat PTSD in individuals with psychosis (Becker, 
Zayfert, & Anderson, 2004; Meyer, Farrell, Kemp, Blakey, & Deacon, 2014). Patients 
with psychotic disorders have been excluded from randomized clinical trials, (Olatunji, 
Cisler, & Tolin, 2010; Spinazzola, Blaustein, & van der Kolk, 2005; van Minnen, Harned, 
Zoellner, & Mills, 2012) and psychosis is the most frequently applied exclusion criterion 
(Ronconi, Shiner, & Watts, 2014). Nevertheless, evidence suggests that trauma-focused 
treatments can be effective in this patient population. A randomized clinical trial tested 
an evidencebased intervention for PTSD (cognitive restructuring) (Watts et al., 2013) 
in patients with severe mental illness and found modest results (Mueser et al., 2008). 
However, only 16% of the participants had schizophrenia or schizoaffective disorder. 
Two small open pilot studies, one using PE (Frueh et al., 2009) and one using EMDR (van 
den Berg et al., 2012) and a controlled case series study examining both PE and EMDR 
(de Bont, van Minnen, & de Jongh, 2013) found large effects on PTSD and no adverse 
events. Overall, robust evidence for the efficacy and safety of PE and EMDR in patients 
with psychosis is lacking.
This study aimed to examine the efficacy and safety of PE and EMDR in reducing 
PTSD compared with a waiting list (WL) condition in individuals with psychotic disorders 
receiving treatment as usual for psychosis. To enhance clinical relevance, the trial was 
designed with features that mimic clinical practice. (Tunis, Stryer, & Clancy, 2003) A 
representative sample was acquired by applying a minimum of exclusion criteria. The 
study was conducted in 13 outpatient mental health services and used basic treatment 
protocols delivered by therapists with different levels of expertise in the target treatments. 
During the trial, non–trauma-focused cotherapies were allowed. We hypothesized that 
PE and EMDR compared with WL would both be effective and safe. In comparing PE and 
EMDR head-to-head, we expected no statistical differences due to insufficient statistical 
power to detect small effect sizes.
Published as:
van den Berg, D. P., de Bont, P. A., van der Vleugel, B. M., de Roos, C., de Jongh, 
A., Van Minnen, A., & van der Gaag, M. (2015). Prolonged exposure vs eye movement 
desensitization and reprocessing vs waiting list for posttraumatic stress disorder in 
patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry, 72(3), 
259-267. doi:10.1001/jamapsychiatry.2014.2637
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Methods
 
Design
The trial design was approved by the medical ethics committee of the VU University 
Medical Center and was registered at isrctn.com (ISRCTN79584912). Participants gave 
written informed consent before enrollment. Full details of the study methods and 
selection of participants are published elsewhere (de Bont et al., 2013). This study is a 
single-blind randomized clinical trial with 3 arms, including PE therapy, EMDR therapy, 
and WL. With a medium effect size between conditions, a power of 0.80, and an α level 
of .05, we needed 159 participants.
Participants
The participants were recruited in 13 Dutch comparable outpatient services for patients 
with severe mental illnesses. Inclusion criteria were (1) age 18 to 65 years, (2) a lifetime 
diagnosis of a psychotic disorder or mood disorder with psychotic features according to 
the Mini-International Neuropsychiatric Interview–Plus, (Sheehan et al., 1997; Sheehan 
et al., 1998) and (3) satisfaction of the full DSM-IV-TR (APA, 2000) diagnostic criteria 
for chronic PTSD on the Clinician-Administered PTSD Scale (CAPS) (Blake et al., 1995; 
Weathers, Keane, & Davidson, 2001). The PTSD severity was rated over the last week, 
and symptoms were considered present when they occurred at least once a week 
(frequency ≥2).
Exclusion criteria were (1) an extremely high acute suicide risk, operationalized 
as meeting all 3 of the following criteria (current high suicidality score on the Mini-
International Neuropsychiatric Interview–Plus, a serious suicide attempt within the past 
6 months, and a depression score of ≥35 on the Beck Depression Inventory–II (Beck, 
Steer, Ball, & Ranieri, 1996; Beck, Steer, & Brown, 1996); (2) changes in antipsychotic or 
antidepressant medication regimen within 2 months before the assessment (to control 
for medication effects on PTSD symptoms); (3) insufficient competence in the Dutch 
language; (4) severe intellectual impairment, defined as an estimated IQ of 70 or less 
(mental retardation); (5) not being able to travel (or be accompanied) to the outpatient 
service; and (6) current involuntary admission in a closed ward. The presence of current 
psychotic symptoms was not an exclusion criterion.
Measures
Assessors were blinded to treatment allocation. The 2-way mixed single-measures 
(consistency) intraclass correlation coefficient for CAPS severity among all assessors 
over 20 randomly selected cases was 0.81.
Assessors and therapists emphasized the importance of blinding to the 
participants and repeatedly remindedthemnot to reveal the randomized treatment 
condition. Assessors avoided contact with the the rapists and other caregivers. With 
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these procedures, 27 incidents of unblinding occurred (11 in PE, 11 in EMDR, and 5 in 
WL). In case of unblinding, another assessor repeated the entire measurement.
The primary outcome measure was the CAPS (Blake et al., 1995), which provides 
a symptom severity score and assesses the presence of a PTSD diagnosis. Full remission 
(CAPS total score, <20) (Weathers et al., 2001) was also evaluated. The CAPS was 
administered once over a maximum of 3 index traumas that were most strongly related 
to PTSD symptom severity. Traumatic psychotic experiences (eg, being physically 
secluded or restrained in a psychiatric hospital) were accepted as criterion A traumas 
when these events met DSM-IV-TR A1 and A2 criteria.
Secondary outcome measures were the Posttraumatic Stress Symptom Scale Self-
Report (PSS-SR) (Foa, Riggs, Dancu, & Rothbaum, 1993), which assesses self-reported 
frequency of PTSD symptoms, and the Posttraumatic Cognitions Inventory (PTCI) 
(Foa, Ehlers, Clark, Tolin, & Orsillo, 1999), which measures trauma-related cognitive 
distortions. All outcome measures were assessed at baseline, posttreatment, and the 
6-month follow-up. Demographic characteristics were recorded at baseline.
Procedure
Recruitment took place from September 2011 through April 2013 and involved a 3-stage 
process (Figure 1). First, patients were screened for PTSD with the Trauma Screening 
Questionnaire. (Brewin et al., 2002; de Bont et al., 2015) Patients demonstrating a 
high risk of PTSD (Trauma Screening Questionnaire score ≥6) were invited for an 
inclusion interview. Second, patients were assessed using the CAPS, Mini-International 
Neuropsychiatric Interview–Plus, and Beck Depression Inventory–II to determine 
inclusion criteria. Third, eligible patients signed informed consent and completed the 
baseline assessment.
Patients could also be referred for an inclusion interview (stage 2). An 
independent randomization bureau randomized the treatment condition using stratified 
randomization blocks per therapist with equal strata sizes. Therapists confirmed the 
treatment assignment inwriting. Data were stored at the study coordination center.
Early completion was allowed when the PSS-SR scores were 10 or less on 2 
consecutive occasions and the Subjective Units of Distress Scale score of all memories 
in the treatment plan was zero. To this end, the PSS-SR was administered before every 
session in the PE and EMDR conditions. After the 6-month follow-up assessment, 
participants in the WL condition were offered their treatment of choice. All participants 
received a financial compensation of €25 (US $31) for each assessment.
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Figure 1. Flowof Participants Through the Trial.
CAPS indicates Clinician-Administered PTSD Scale; EMDR, eye movement desensitization and reprocessing; 
MINI-Plus, Mini-International Neuropsychiatric Interview–Plus; PE, prolonged exposure; PTSD, posttraumatic 
stress disorder; TSQ, Trauma Screening Questionnaire; and WL,waiting list.
Screened patients at high 
risk for PTSD (TSQ ≥6)
332 120 Referred patients
452 Assessed for eligibility
297 Excluded
233
12
29
23
Did not meet full PTSD criteria 
on CAPS
Did not meet full psychosis 
criteria on MINI-Plus
Met one of the exclusion 
criteria
Declined participation
155 Randomized
53 Allocated to PE therapy
40 Completed treatment
47
45
Completed posttreatment
Completed 6-mo follow-up
55 Allocated to EMDR therapy
44 Completed treatment
44
43
Completed posttreatment
Completed 6-mo follow-up
55 Included in analysis53 Included in analysis
47 Allocated to WL condition
39
40
Completed posttreatment
Completed 6-mo follow-up
47 Included in analysis
Treatment
All participants in the trial received comparable treatment as usual for psychosis 
delivered by multidisciplinary assertive outreach teams, with care usually consisting of 
antipsychotic medication and treatment and/or supportive counseling by psychologists, 
caseworkers, nurses, or psychiatrists. In the WL condition, participants were seen once 
by a study therapist and informed about the PTSD diagnosis and further course of the 
study. Also, an appointment was made for the start of their treatment of choice after the 
6-month follow-up period.
Both the PE and EMDR therapy were delivered in 8 weekly 90-minute sessions 
within a 10-week time frame. We did not aim to provide full therapy but rather to test 
an effective dosage of therapy that falls within the ranges in which PE and EMDR have 
been found to be effective (Nijdam, Gersons, Reitsma, de Jongh, & Olff, 2012; Powers, 
Halpern, Ferenschak, Gillihan, & Foa, 2010), also in this population (Van Den Berg & 
Van Der Gaag, 2012). In both conditions, the therapist and participant developed a 
standardized case conceptualization in the first session, which consisted of a hierarchy 
of relevant traumatic experiences. The PE therapy was conducted based on the protocol 
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by Foa et al (Foa, Hembree, & Rothbaum, 2007), and imaginal exposure was used in 
sessions 2 through 8. Each session was audio recorded. Participants listened to these 
recordings 5 times per week. In sessions 3 through 8, in vivo exposure (based on a list 
of avoided trauma-related stimuli) was added. The EMDR was conducted according to 
the standard 8-phase protocol by Shapiro (Shapiro, 2001) using the Dutch translation 
of the EMDR protocol (de Jongh & Broeke, 2003). Eye movements were applied as the 
dualattention stimulus. In sessions 2 through 8, memories were processed Shapiro, 2001.
The therapists were 19 clinical psychologists and 1 psychiatrist. Of these, 2were 
already trained (a minimum of 4 days) in PE and 4 in EMDR. All other therapists received 
4-day training in both PE and EMDR and treated at least 2 supervised cases per treatment 
during training. All therapists delivered both treatments.
Non–trauma-focused therapies were allowed. However, participants and 
caregivers were instructed not to start any other form of trauma-focused treatment (eg, 
PE, EMDR, cognitive therapy, or imagery rescripting), to keep medications unchanged, 
and to report any adverse events or deviations from standard care. After treatment 
and at the 6-month follow-up, patient fileswere reviewed to check whether trauma-
focused treatments had taken place and if there had been any changes in the prescribed 
medications, aswell as for anydeviations from standard care.
Supervision and Fidelity Monitoring
Four hours of group supervision (group size, 6-8) were provided each month by experts 
in the target treatments (2 hours by A. van M. in PE and 2 hours by C. de R. or A. de J. 
in EMDR). Additional supervision by telephone or e-mail was provided on request. All 
treatment sessions were videotaped; of these sessions, 10% were randomly selectedand 
ratedby trained raters who were blinded to treatment outcome. Raters determined 
therapist competence and adherence to the treatment protocols. Adherence to protocols 
was rated as good or excellent in 91.2% of PE sessions and 97.1% of EMDR sessions. In 
PE, no essential elements of EMDR were detected and vice versa. Almost all (96.9%) 
of the performances of the therapists were rated as competent. Treatment alliance 
of therapists to PE and EMDR did not differ (t
18
 = 0.000, P > .99). In PE, participants 
completed 84.4%of the imaginal exposureand 85.6% of the in vivo exposure homework 
assignments.
Statistical Analysis
Analyses were conducted with statistical software (SPSS 20; IBM SPSS). The 2 treatment 
conditions were compared with WL (PE vs WL and EMDR vs WL) and head-to-head (PE 
vs EMDR) on all outcomes. Continuous variables were analyzed on an intent-to-treat 
basiswith linear mixed models (LMMs). Baseline scoreswere included as covariates, time 
as a categorical variable, and treatment condition as a fixed effect. The intercept was 
treated as a random effect.
Chapter 5
122
Dichotomous outcomes were analyzed with logistic generalized estimating 
equation analyseswith exchangeable correlation structure. A generalized estimating 
equation analysis is reported to be a significantly better estimator of effects in 
dichotomous outcomes than a LMM (Twisk, 2013). Effects were computed for 
posttreatment and 6-month follow-up using interaction effects. Analyses of completers 
and intent-to-treat analyseswith last observation carried forward (with missing data on 
loss of diagnosis conservatively replaced with a negative value [ie, no loss of diagnosis]) 
were performed to test the robustness of the findings. Between-group effect sizes (PE 
vs WL and EMDR vs WL) were computed according to Cohen d (Cohen, 1992) using 
estimated data from the LMM procedure. Baseline differences in demographic and 
clinical characteristics were analyzed using X2 test, t test, and analysis of variance.The 
number needed to treat was calculated to determine the number of participants who 
needed to be treated to make one more patient lose diagnosis or achieve full remission 
compared with the control condition (Laupacis, Sackett, & Roberts, 1988).
Results
Figure 1 shows the participant flow through the study. In total, 440 inclusion interviews 
were conducted, and 155 participants were randomized. Table 1 lists the baseline 
demographic and clinical characteristics. The participants are characterized by severe 
posttraumatic, psychotic, and depressive symptoms and represent a group with chronic 
severemental illness. Most participants experienced multiple childhoodtraumas: 38.1% 
had multiple incidents of childhood sexual abuse (at age, ≤12 years). Only 5.2% 
experienced a single trauma type in adulthood. At baseline, there were no significant 
differences between the groups in any of the demographic or clinical characteristics.
Intent-to-Treat Analyses
Observed mean CAPS total scores are shown in Figure 2. Table 2 lists estimated marginal 
means produced by the LMM procedure, pre-post effect sizes, and LMM outcomes. There 
were significant effects on the mean CAPS total scores for both treatments compared 
with WL at posttreatment and 6-month follow-up. There were no significant differences 
between PE and EMDR.
Outcomes on loss of PTSD diagnosis and full remission of PTSD are listed in 
Table 3. According to the logistic generalized estimating equation analyses, participants 
in both the PE and EMDR conditions were more likely to achieve and maintain loss of 
PTSD diagnosis than participants in the WL condition. Participants in the PE condition, 
but not those in the EMDRcondition,were more likely to achieve full remission of PTSD 
than participants in the WL condition. The PE and EMDR did not significantly differ in 
loss of PTSD diagnosis and full remission.
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Self-reported PTSD symptoms (on the PSS-SR) and posttraumatic cognitions (on 
the PTCI) yielded results that were similar to the CAPS findings (Figure 2 and Table 2). 
The PSS-SR and PTCI scoreswere lower for both treatment conditions compared with 
the WL condition at posttreatment and 6-month follow-up. There were no significant 
differences between the PE and EMDR.
There was no difference in dropout between the PE (13 participants [24.5%]) 
and EMDR (11 participants [20.0%]) (P = .57). There were 8 early completers in 
PE (15.1%) and 2 in EMDR (3.6%); this difference was not statistically significant 
(P = .09). The mean number of treatment sessions attended by treatment completers 
was 7.1 in PE and 7.8 in EMDR (P = .007). All severe adverse events were reported to the 
medical ethicscommittee. There were 2 severe adverse events in PE, 1 in EMDR, and 4 
in WL. However, none of the severe adverse events were judged to have been induced 
by the study.
There were no differences between groups in additional support provided by 
caregivers. Groups did not differ in the percentage of participants receiving additional 
non–traumafocused psychotherapy during treatment (17.0% in PE, 20.8% in EMDR, 
and 21.3% in WL) and follow-up (24.5% in PE, 18.9% in EMDR, and 25.5% in WL).
No participants received other or additional trauma-focused treatments during the 
study period. There were no significant group differences in changes in prescribed 
antipsychotics, sedatives or anxiolytics, antidepressants, or mood stabilizers during 
treatment or the follow-up period. Most changes concerned antipsychotics. The dosage 
of prescribed antipsychotic medication was decreased in 7 participants and increased in 
12 participants during treatment and was decreased in 10 participants and increased in 
15 participants during follow-up.
Sensitivity Analyses
Completer analyses were performed (n = 113), among which no baseline differences 
were observed between groups in any of the demographic or clinical characteristics. In 
addition, intent-to-treat analyses with last observation carried forward were performed 
(n = 155). All results for the CAPS, PSS-SR, and PTCI were similar to the results from the 
intent-to-treat analyses, thereby underlining the robustness of the findings (Table 3).
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Table 1: Baseline Demographic and Clinical Characteristics.
Characteristic
PE
(n = 53)
EMDR
(n = 55)
WL
(n = 47)
Total Sample
(N = 155)
Age, mean (SD), y 42.6 (10.3) 40.4 (11.3) 40.3 (9.7) 41.2 (10.5)
Sex, No.
Male
Female
23
30
25
30
23
24
71
84
Cultural background, No. (%)
Dutch
Non-Western
Western, non-Dutch
36 (67.9)
12 (22.6)
5 (9.4)
34 (61.8)
17 (30.9)
4 (7.3)
27 (57.4)
19 (40.4)
1 (2.1)
97 (62.6)
48 (31.0)
10 (6.5)
Post–high school education, No. (%)a
High
Middle
Low
7 (13.2)
23 (43.4)
23 (43.4)
4 (7.3)
21 (38.2)
30 (54.5)
3 (6.4)
18 (38.3)
26 (55.3)
14 (9.0)
62 (40.0)
79 (51.0)
Employed, No. (%) 8 (15.1) 4 (7.3) 6 (12.8) 18 (11.6)
Living condition, No. (%)
Married or cohabitating
With parents, other relatives, or friends
Alone
Sheltered housing
11 (20.8)
8 (15.1)
26 (49.1)
8 (15.1)
12 (21.8)
7 (12.7)
24 (43.6)
12 (21.8)
10 (21.3)
7 (14.9)
27 (57.4)
3 (6.4)
33 (21.3)
22 (14.2) 
77 (49.7)
23 (14.8)
DSM-IV-TR A1 and A2 trauma categories,
single or multiple, No. (%)
Sexual abuse
Multiple childhood sexual abuse at age ≤12 y
Physical abuse
Traumatic psychosis
Emotional abuse in childhood
Other traumatic event such as accident, disaster, war
38 (71.7)
26 (49.1)
29 (54.7)
9 (17.0)
4 (7.5)
27 (50.9)
28 (50.9)
20 (36.4)
30 (54.5)
6 (10.9)
3 (5.5)
33 (60.0)
28 (59.6)
13 (27.7)
23 (48.9)
13 (27.7)
3 (6.4)
24 (51.1)
94 (60.6)
59 (38.1)
82 (52.9)
28 (18.1)
10 (6.5)
84 (54.2)
Lifetime MINI-Plus diagnosis, No. (%)
Schizophrenia
Schizoaffective disorder
Brief psychotic disorder
Psychotic disorder not otherwise specified
Bipolar disorder with psychotic features
Depression with psychotic features
31 (58.5)
17 (32.1)
0
1 (1.9)
2 (3.8)
2 (3.8)
34 (61.8)
15 (27.3)
0
3 (5.5)
2 (3.6)
1 (1.8)
30 (63.8)
13 (27.7
1 (2.1)
0
3 (6.4)
0
95 (61.3)
45 (29.0)
1 (0.6)
4 (2.6)
7 (4.5)
3 (1.9)
Suicide attempt ever, No. (%) 33 (62.3) 33 (60.0) 28 (59.6) 94 (60.6)
Current medium or high suicide risk on MINI-Plus, No. (%) 27 (50.9) 23 (41.8) 20 (42.6) 70 (45.2)
Current delusions on DRS, No. (%)b 34 (64.2) 32 (58.2) 30 (63.8) 96 (61.9)
Current auditory verbal hallucinations on AHRS, No. (%) 21 (39.6) 24 (43.6) 17 (36.2) 62 (40.0)
CAPS total score, mean (SD) 69.6 (14.9) 72.1 (17.6) 68.1 (15.9) 69.9 (16.2)
PSS-SR score, mean (SD) 28.5 (8.0) 30.3 (7.8) 27.7 (8.9) 28.9 (8.2)
PTCI score, mean (SD) 153.1 (35.8) 147.6 (32.6) 144.9 (28.7) 148.6 (32.6)
BDI-II score, mean (SD) 30.9 (11.4) 28.2 (11.6) 29.7 (12.4) 29.6 (11.7)
Chlorpromazine hydrochloride dose equivalent, 
mean (SD)c
227.3 (187.9) 253.2 (250.5) 250.7 (232.8) 243.6 (224.2)
Duration of psychosis, mean (SD), y 18.9 (12.8) 18.2 (11.7) 15.7 (10.5) 17.7 (11.8)
Duration of PTSD, mean (SD), y 22.8 (13.6) 21.1 (13.9) 18.95 (12.9) 21.0 (13.5)
Abbreviations: AHRS, Auditory Hallucination Rating Scale (Haddock, McCarron, Tarrier, & Faragher, 1999); BDI-II, Beck 
Depression Inventory–II; CAPS, Clinician-Administered PTSD Scale; DRS, Delusion Rating Scale (Haddock et al., 1999); 
EMDR, eye movement desensitization and reprocessing; MINI-Plus, Mini-International Neuropsychiatric Interview–Plus; PE, 
prolonged exposure; PSS-SR, Posttraumatic Stress Symptom Scale Self-Report; PTCI, Posttraumatic Cognitions Inventory; 
PTSD, posttraumatic stress disorder; WL,waiting list.
a Lower indicates primary education or lower general secondary education; middle, intermediate vocational education or 
 higher high school level; and high, higher vocational education or university.
b See de Bont et al (de Bont et al., 2013) for details on the DRS and AHRS.
c One hundred milligrams of chlorpromazine hydrochloride is equivalent to 2mg of haloperidol.
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Discussion
Both PE therapy and EMDR therapy were more effective than the WL condition in 
reducing trauma symptoms and achieving loss of PTSD diagnosis among participants 
with severe PTSD and psychotic disorders. Prolonged exposure therapy was more 
effective than WL in achieving full remission, while EMDR therapy was not. We found 
no differences in head-to-head comparisons of the 2 active treatments in any of the 
outcomes.
Similar to most trauma treatment trials, treatment effects were observed directly 
after treatment and persisted over time (Schnurr et al., 2007). Moreover, in the present 
sample with comorbid psychotic disorder, change rates in the diagnostic status were 
comparable to those reported in a meta-analysis6 of general samples. The dropout rate 
was low and comparable to that of other trials (Hembree et al., 2003). Most important, 
both treatments were found to be safe and did not result in severe adverse events.
Some of the patients in the control condition achieved remission. This might be 
the result of anticipation of a positive outcome of treatment and setting a date for the 
first session. Also, exposure to an extensive trauma interview and repeated assessments 
in the study protocol (de Bont et al., 2013) may have functioned as covert exposure 
(Krakow, Hollifield, & Warner, 2000). Last, trauma symptoms appear to fluctuate over 
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Figure 2. Observed Trajectories of the CAPS, 
PSS-SR, and PTCI Scores as a Function of Treatment 
Group in the Intent-to-Treat Sample.
The intent-to-treat sample comprised 155 
participants at baseline, 130 participants 
at posttreatment, and 128 participants at the 
6-month follow-up. CAPS indicates Clinician-
Administered PTSD Scale; EMDR, eye movement 
desensitization and reprocessing; PE, prolonged 
exposure; PSS-SR, Posttraumatic Stress Symptom 
Scale Self-Report; PTCI, Posttraumatic Cognitions 
Inventory; and WL, waiting list.
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time (McFarlane, 2000), and long-term remission rates without specific treatment are 
high in PTSD (Morina, Wicherts, Lobbrecht, & Priebe, 2014). Therefore, future studies 
should include an active non–trauma-focused (eg, befriending) control group to control 
for factors such as therapy time and attention.
The present results can be generalized to routine clinical practice. We used 
standard protocols of guideline trauma treatments in a sample of patients with psychotic 
disorders and severe psychopathology (including current paranoia, auditory verbal 
hallucinations, depression, and high suicide risk). Psychotherapeutic stabilization was 
not applied and appears unnecessary; it may even needlessly delay treatment (van 
Minnen et al., 2012). The dropout rate was comparable to that in the trial by Mueser 
and colleagues (Mueser et al., 2008) and was lower than that in an open study (Frueh et 
al., 2009) using stabilizing interventions.
Table 2: Estimated Outcomes as a Function of Treatment Group in the Intent-to-treat Sample a
Posttreatment 6-mo Follow-up
Outcome
PE
(n = 53)
EMDR
(n = 55)
WL
(n = 47)
PE
(n = 53)
EMDR
(n = 55)
WL
(n = 47)
CAPS total score, mean 
(95% CI)
37.8
(31.2-44.3)
40.3
(33.6-47.1)
56.5
(49.5-63.6)
36.7
(30.1-43.4)
38.8
(31.9-45.6)
51.9
(44.9-58.9)
Baseline score 69.6 72.1 68.1 NA NA NA
Effect size 0.78 0.65 NA 0.63 0.53 NA
LMM t
193
 = −3.84,
P < .001
t
193
 = −3.26,
P < .001
NA t
194
 = −3.10,
P = .002
t
193
 = −2.66,
P = .009
NA
PSS-SR score, mean 
(95% CI)
16.1
(13.1-19.1)
16.1
(12.9-19.2)
25.8
(22.5-28.9)
16.4
(13.4-19.4)
16.2
(13.0-19.3)
24.1
(20.9-27.4)
Baseline score 28.5 30.3 27.7 NA NA NA
Effect size 0.88 0.85 NA 0.70 0.70 NA
LMM t
188
 = −4.33,
P < .001
t
187
 = −4.26,
P < .001
NA t
189
 = −3.46,
P = .001
t
187
 = −3.51,
P = .001
NA
PTCI score, mean 
(95% CI)
113.9
(104.4-123.5)
120.4
(110.6-
130.3)
146.5
(136.2-
156.9)
120.4
(110.7-
130.1)
119.8
(109.9-
129.7)
140.5
(130.3-
150.8)
Baseline score 153.1 147.6 144.9 NA NA NA
Effect size 0.93 0.72 NA 0.57 0.57 NA
LMM t
195
 = −4.56,
P < .001
t
196
 = −3.61,
P < .001
NA t
196
 = −2.82,
P = .005
t
195
 = −2.87,
P = .005
NA
Abbreviations: CAPS, Clinician-Administered PTSD Scale; EMDR, eye movement desensitization and reprocessing; LMM, 
linear mixed model; NA, not applicable; PE, prolonged exposure; PSS-SR, Posttraumatic Stress Symptom Scale Self-Report; 
PTCI, Posttraumatic Cognitions Inventory; WL, waiting list. 
a The CAPS, PSS-SR, and PTCI scores reflect the estimated marginal mean (95% CI) from the LMM analyses. 
Between-group effect sizes are Cohen d based on estimated data from the LMM procedure. The reported effect sizes concern 
the differences between the 2 treatment conditions and theWL condition (PE vsWL and EMDR vs WL) at the different 
time points. Results from the LMM analyses concern the differences at the different time points for PE vs WL and for 
EMDR vs WL.
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Dissemination of effective trauma treatments to clinical practice appears to be 
problematic (Becker et al., 2004; Cahill, Foa, Hembree, Marshall, & Nacash, 2006; Frueh, 
Cusack, Grubaugh, Sauvageot, & Wells, 2006; Karlin et al., 2010), and PTSD is missed 
in most patients with a psychotic disorder (Lommen & Restifo, 2009; Mueser et al., 
1998). These factors decrease the chance that patients with psychosis and PTSD will 
receive evidence-based trauma treatment. There are multiple reasons for this, but the 
most important factors seem to be fear of symptom exacerbation, safety issues, and 
questions about tolerability (Cahill et al., 2006; van Minnen et al., 2012). The fact that 
professionals are particularly reluctant to treat trauma in psychosis (Becker et al., 2004; 
Meyer et al., 2014) is not based on empirical evidence (Frueh et al., 2006; Salyers, Evans, 
Bond, & Meyer, 2004). Exclusion of patients with psychotic disorders fromeffective 
trauma treatments has been the norm in both clinical practice and research (Ronconi et 
al., 2014). Even researchers stressing the importance of broadening inclusion criteria for 
trauma treatment studies indicate that schizophrenia is a reasonable exclusion criterion. 
(Bradley et al., 2005) The present results are at odds with these prejudices.
The strengths of this study are the sample size, the generalizability to clinical 
practice owing to the use of standard protocols with patients in routine long-term care, 
the correction for unblinding, and the limited loss to follow-up. We believe that this study 
demonstrates the efficacy and safety of trauma treatment in psychosis.
There are several limitations. The first limitation is that treatment consisted of only 
8 sessions. Most participants had experienced multiple childhood traumas, and for some 
participants 8 sessions were probably too few to significantly affect trauma symptoms. 
The second limitation is the fact that this study was powered to find medium to large 
effects. Therefore, small effects between conditions may not have been detected. The 
third limitation is that experts supervised the therapies, whereas similar supervision may 
not always be available in clinical practice. The fourth limitation is that treatment as usual 
for psychosis may vary between countries. Most participants in the present trial were 
treated in assertive outreach teams.
Conclusions
This study demonstrates that standard PE and EMDR protocols are effective, safe, 
and feasible in patients with psychosis and comorbid PTSD without using stabilizing 
psychotherapeutic interventions. One in 8 patients with a psychotic disorder has PTSD 
(Achim et al., 2011). There is no need to exclude these patients from effective trauma 
treatments.
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Abstract
Background In patients with psychotic disorders, the effects of psychological post-
traumatic stress disorder (PTSD) treatment on symptoms of psychosis, depression and 
social functioning are largely unknown
Method In a single-blind randomized controlled trial (RCT) 155 outpatients in 
treatment for psychosis (61.3% schizophrenic disorder, 29% schizoaffective disorder) 
were randomized to eight sessions prolonged exposure (PE, n = 53) or eye movement 
desensitization and reprocessing (EMDR, n = 55), or a waiting-list condition (WL, 
n = 47) for treatment of their co-morbid PTSD. Measures were performed on (1) 
psychosis: severity of delusions (PSYRATS-DRS), paranoid thoughts (GPTS), auditory 
verbal hallucinations (PSYRATS-AHRS), and remission from psychotic disorder (SCI-
SRPANSS); (2) depression (BDI-II); (3) social functioning (PSP). Outcomes were 
compared at baseline, post-treatment, 6-month follow-up and over all data points.
Results Both PE and EMDR were significantly associated with less severe paranoid 
thoughts post-treatment and at 6-month follow-up, and with more patients remitting 
from schizophrenia, at post-treatment (PE and EMDR) and over time (PE). Moreover, 
PE was significantly associated with a greater reduction of depression at post-treatment 
and at 6-month follow-up. Auditory verbal hallucinations and social functioning remained 
unchanged.
Conclusions In patients with chronic psychotic disorders PE and EMDR not only reduced 
PTSD symptoms, but also paranoid thoughts. Importantly, in PE and EMDR more patients 
accomplished the status of their psychotic disorder in remission. Clinically, these effects 
are highly relevant and provide empirical support to the notion that delivering PTSD 
treatment to patients with psychotic disorders and PTSD deserves increasing recognition 
and acceptance among clinicians.
Key words Depression, paranoia, psychosis, PTSD, social functioning.
Prolonged exposure and EMDR for PTSD v. a PTSD waiting-list condition: 
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Introduction
Prolonged Exposure (PE) and Eye Movement Desensitization and Reprocessing (EMDR) 
therapy show good results in the treatment of post-traumatic stress disorder (PTSD; 
Watts et al., 2013). Also, in various PTSD patient populations, PE and EMDR have shown 
positive secondary effects on several co-morbid conditions (Bisson, Roberts, Andrew, 
Cooper, & Lewis, 2013) albeit the secondary effects are more extensively investigated 
for PE (for a review see Van Minnen et al., 2015) than for EMDR. Among the positive 
secondary PTSD treatment effects are clinically relevant reductions of symptoms of 
depression (Ronconi, Shiner, & Watts, 2015; van Minnen, Zoellner, Harned, & Mills, 
2015) and, for PE, an increase in social functioning (Ronconi et al., 2015). 
In patients with psychotic disorders, PTSD is a prevalent condition (12.4%; Achim 
et al., 2011) and in patients with PTSD the likelihood of endorsing symptoms of psychosis 
is increased (odds ratio 3.55, 95% confidence interval 2.74–4.55; Sareen, Cox, Goodwin, 
& Asmundson, 2005). However, in both clinical practice and studies, patients with the 
combination of PTSD and psychosis have been largely excluded from trauma-focused 
treatments (Becker, Zayfert, & Anderson, 2004; Ronconi, Shiner, & Watts, 2014). This 
exclusion is mainly due to the widespread belief that treatment of PTSD in patients with 
psychotic disorders is harmful and will result in an exacerbation of symptoms associated 
with the disorder (Becker et al., 2004; van Minnen, Hendriks, & Olff, 2010). Recently this 
belief has been examined in three feasibility studies with psychotic individuals (Frueh et 
al., 2009; van den Berg & van der Gaag, 2012; de Bont, Van Minnen, & De Jongh, 2013a). 
These studies reported promising neutral to positive results of PTSD treatment on 
symptoms associated with psychosis, depression and social function. Four other studies 
examined mixed severe mental illness (SMI) samples analysing outcomes in psychotic 
and non-psychotic individuals as one group (Rosenberg, Mueser, Jankowski, Salyers, & 
Acker, 2004; Mueser et al., 2008, 2015; Grubaugh et al., 2016). Therefore these studies 
can only provide tentative evidence about the effects of PTSD treatment in psychotic 
individuals. Particularly, the SMI studies’ results showed that PTSD treatment had no 
negative effects on psychosis, depression or functioning; indeed some positive effects 
were found for depression and social functioning. Therefore, on the basis of all these 
studies we now assume that the effects of PTSD treatment in patients with psychotic 
disorders are similar to those found in non-psychotic patient groups, i.e. PTSD treatment 
reduces co-morbid symptoms instead of aggravates them, including symptoms of 
Published as:
de Bont, P.A.J.M., van den Berg, D. P., van der Vleugel, B. M., de Roos, C., de Jongh, 
A., van der Gaag, M., & van Minnen, A. (2016). Prolonged exposure and EMDR for PTSD 
v. a PTSD waiting-list condition: effects on symptoms of psychosis, depression and social 
functioning in patients with chronic psychotic disorders. Psychological Medicine, 46, 
2411-2421. doi:10.1017/S0033291716001094
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psychosis (van den Berg & van der Gaag, 2012; De Bont et al., 2013a), depression 
(Rosenberg et al., 2004; Mueser et al., 2008; van den Berg & van der Gaag, 2012) and 
social functioning (Mueser et al., 2008).
This study presents outcome data of a large randomized controlled trial (RCT) 
in a population of PTSD patients with psychosis (De Bont et al., 2013b). The primary 
outcome study demonstrated that PE and EMDR were effective in reducing PTSD 
symptom severity and that they were safe (Van den Berg et al., 2015a). The present 
study examines secondary effects of psychological trauma-focused treatments of PTSD 
in patients with chronic psychotic disorders. Based on the extensive evidence from various 
PTSD population studies without co-morbid psychotic disorders our hypothesis is that 
PE and EMDR will similarly reduce co-morbid depression and increase social functioning 
in patients with psychotic disorders. Based on indications from a few pilot studies in 
PTSD patients with psychosis, we specifically hypothesize that both psychological PTSD 
treatments will reduce symptoms of psychosis.
Method
This study is part of the RCT ‘Treating Trauma in Psychosis’ (TTIP). Our design paper 
described the trial’s primary to quaternary objectives, inclusion and exclusion criteria, 
recruitment, CONSORT chart, measurement procedures, instruments, intervention 
conditions and statistical procedures (De Bont et al., 2013b).
The primary outcome paper of the RCT describes the safety and efficacy of 
PTSD treatment for patients with psychotic disorders and provides details on patient 
flow, sample characteristics, safety, control procedures, blinding, treatment protocols, 
temporary restrictions imposed on treatment as usual (TAU; including medication), 
integrity checks, early completion, completers, drop-outs, serious adverse events, and 
medical ethical reports (Van den Berg et al., 2015a). Therefore, only a brief description 
of the trial is presented below.
Design
This study is a single-blind RCT with three arms [PE, EMDR, and waiting list (WL)] and is 
registered at Current Controlled Trials (ISRCTN 79584912). The design was approved by 
the Medical Ethics Committee of the VU University Medical Center (NL: 36649.029.12).
Participants
Participants were recruited in 13 Dutch outpatient services. Recruitment involved 
two enrolment arms (De Bont et al., 2013b). In the first arm eligible individuals were 
recruited as part of a validation study (De Bont et al., 2015) of the Trauma Screening 
Questionnaire (TSQ; Brewin et al., 2002), in which 2608 adult patients in care for 
psychosis were screened to detect trauma exposure and possible PTSD. In the second 
Prolonged exposure and EMDR for PTSD v. a PTSD waiting-list condition: 
effects on symptoms of psychosis, depression and social functioning in patients with chronic psychotic disorders.
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arm caregivers referred individuals for possible participation. Subsequently, consenting 
patients fulfilling the Mini-International Neuropsychiatric Interview Plus (MINI Plus; 
Sheehan et al., 1998) criteria for psychotic disorders and the Clinician-Administered 
PTSD Scale (CAPS; Blake et al., 1995) criteria for PTSD were eligible for inclusion in our 
intervention study. Exclusion criteria (De Bont et al., 2013b) in terms of co-morbidity 
were restricted to mental retardation and severe suicidality (operationalized as MINI Plus 
‘currently high suicide risk’ + BDI-II-score >35 + a serious attempt at suicide <6 months). 
Five patients were excluded because of severe suicidality. In addition, eight patients were
excluded on the basis of our criterion that within 2 months prior to the study no changes 
in medication (mood regulators, antipsychotics) were allowed. Recruitment led to the 
inclusion and randomization of 155 participants with various and severe co-morbid 
conditions, thereby strengthening the study’s generalizability (Bradley, Greene, Russ, 
Dutra, & Westen, 2005) and clinical relevance (Tunis, Stryer, & Clancy, 2003). None of 
the 155 participants received trauma-focused treatment in regular care, i.e. TAU.
Measures
Psychosis was extensively measured with three different tools:
1. The Psychotic Symptom Rating Scale interview (PSYRATS; Haddock, McCarron, Tarrier, & 
Faragher, 1999) assessed the severity of delusions (Delusion Rating Scale; DRS) and auditory 
hallucinations (Auditory Hallucinations Rating Scale; AHRS).
2. The Green Paranoid Thoughts Scale (GPTS; Green et al., 2008) is a self-report scale and 
assessed the severity of paranoid thoughts.
3. The Structured Clinical Interview for Symptoms of Remission (Andreasen et al., 2005; Opler, 
Yang, Caleo, & Alberti, 2007) for the Positive and Negative Syndrome Scale (SCI-SR-PANSS; 
Kay, Fiszbein, & Opler, 1987) assessed remission of psychotic symptoms, based on eight 
symptoms of the PANSS. Each participant was interviewed for functional status on delusions, 
unusual content of thought, hallucinations and apathy. Scores on conceptual disorganization, 
lack of spontaneity, blunted affect and posturing were based on clinical observation. Note 
that we assessed all 155 psychotic participants and not just those with a diagnosis of 
schizophrenia for whom the SCI-SR-PANSS was originally designed. Individuals with no 
functional interference of any SCI-PANSS symptom are rated ‘in remission’. Individuals with 
at least one of the eight symptoms functionally interfering are rated ‘not in remission’. We 
omitted the 6-month-span remission criterion (Andreasen et al., 2005) and, as in the majority 
of remission studies (AlAqeel & Margolese, 2012), only used the symptom severity criterion.
Depression severity was measured with the Beck Depression Inventory – II (BDI-II 
self-report; Beck, Steer, & Brown, 1996).
The Personal and Social Performance Scale (PSP; Morosini, Magliano, Brambilla, 
Ugolini, & Pioli, 2000) globally assessed routine social functioning based on assessments 
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in four main areas (socially useful activities, personal and social relationships, self-care, 
and disturbing and aggressive behaviours). Changes in the medication regimen were 
checked with the patient weekly during treatment, and again at post-treatment and at 
the 6-month follow-up. Patients were reviewed at post-treatment and at the 6-month 
follow-up for (unauthorized) additional trauma-focused treatment.
Patients were reviewed for additional support from TAU.
Procedure
Demographic characteristics of the participants were recorded at baseline. All secondary 
outcome measures were assessed at baseline, post-treatment and at the 6-month follow-
up. Blinded assessors performed the measurements throughout the study. 
After screening and inclusion, participants completed a baseline assessment 
designed to meet all needs related to the objectives of the TTIP trial (De Bont et 
al., 2013b) including assessments on secondary outcomes. Then, 155 consenting 
individuals were randomly assigned to either eight weekly 90-min sessions of PE 
(n = 53) or EMDR (n = 55) for their PTSD, or to the WL condition (n = 47). At the 
6-month follow-up assessment individuals in the WL condition were offered treatment 
of choice. All participants received a financial compensation of €25 for each assessment.
Treatment
The therapists provided patients in the WL condition with information about PTSD and 
an appointment after the follow-up period to discuss the patient’s choices for PTSD 
treatment.
Patients in the treatment conditions received eight weekly scheduled treatment 
sessions, following official PTSD treatment manuals. Details of the protocols for PE (Foa, 
Hembree, & Rothbaum, 2007) and EMDR (Shapiro, 2001) are already published (van 
den Berg et al., 2015a). Multidisciplinary Assertive Community Treatment is TAU for 
patients with psychosis in The Netherlands. Teams in the 13 participating mental health 
services delivered comparable TAU in all three conditions to the 155 participants for 
their psychotic disorders. In this study TAU consisted of medication, and treatment and/
or support by therapists, caseworkers, nurses and/or coaches; all this with the exclusion 
of trauma-focused interventions.
Training, supervision and treatment adherence 
The training and supervision of therapists was aimed at strictly and solely applying the 
experimental procedures (PE and EMDR therapy protocols, and WL) in order to prevent 
secondary outcomes being dependent on unsanctioned interventions and deviations 
(Waller & Turner, 2016). ‘Secondary’ symptoms that might possibly emerge during the 
sessions, such as auditory verbal hallucinations (AVHs) or delusions, which may or may 
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not be trauma related in origin (Bentall, Wickham, Shevlin, & Varese, 2012; Van Nierop 
et al., 2014), were not to be targeted directly.
All treatment sessions were videotaped and 10% was randomly selected and 
rated by trained and blinded raters. Adherence was rated good or excellent in 91.2% 
of the PE and 97.1% of the EMDR sessions, indicating that the therapists had optimal 
fidelity concerning the treatment protocols.
Statistical analysis
Analyses were conducted with SPSS v. 20 (IBM Corp., USA). Baseline differences on 
demographic and clinical variables were analysed using analysis of variance, χ² test and t 
test. Treatment outcome was compared across the three conditions at post-treatment, 
at 6-month follow-up and over time (i.e. over all data points), using interaction effects.
Linear mixed model (LMM) intention-to-treat (ITT) analyses were conducted 
on the continuous variables paranoid thoughts (GPTS), depression (BDI-II) and social 
functioning (PSP). Baseline scores were included as covariate, time as categorical 
variable, and treatment condition as a fixed effect. The intercept was treated as a 
random effect. Between-group effect sizes (PE v. WL and EMDR v. WL) were computed 
according to Cohen’s d (Cohen, 1992) using estimated data from the LMM procedure.
Logistic generalized estimating equations (GEE; Twisk, 2013) with exchangeable 
correlation structure ITT analysis was used to examine effects on the dichotomous 
variable remission from psychosis (SCI-SRPANSS).
Unfortunately, not all data from the AHRS and DRS were optimally suited for LMM 
analyses. Both interviews start with a dichotomous question on the presence or absence 
of symptoms (AVHs and delusion, respectively), forcing us to delete all observations 
from non-symptomatic individuals from the LMM analyses. Because GPTS continuous 
data of all 155 participants were available, the LMM of the DRS data was omitted. 
However, because an alternative instrument measuring hallucinations was lacking, we 
used the hallucinations AHRS continuous scores in the LMM analysis (from individuals 
who were symptomatic at any time point).
Sensitivity analysis was performed with completers (n = 113) and ITT analyses with 
the last observation carried forward (LOCF) (n = 155), with missing data conservatively 
replaced with a negative value, i.e. no loss of symptom.
Ethical standards
The authors assert that all procedures contributing to this work comply with the 
ethical standards of the relevant national and institutional committees on human 
experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
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Results 
ITT analyses
Details on the flow and baseline characteristics of the participants are published 
elsewhere (Van den Berg et al., 2015a) and are available online (Supplementary Fig. S1 
and Supplementary Table S1). Table 1 shows the baseline characteristics of the secondary 
symptoms per condition and in total. The 61.9% individuals with active delusions and the 
40.0% individuals with active hallucinations exhibited medium severe symptom intensity. 
The mean level of paranoid thoughts was relatively high (Freeman, Pugh, Vorontsova, 
Antley, & Slater, 2010) considering our sample’s heterogeneous mix of psychotic 
disorders. Of all individuals, 55.5% presented current core symptoms of schizophrenia, 
signalling impaired wellbeing and functioning. The baseline average depression score of 
the entire group scaled moderate to severe (Beck et al., 1996); prominent were suicide 
attempts in the past (60.6%) and current medium to high suicidal risks (45.2%). The 
baseline mean score on personal and social performance indicated moderate to serious 
impairment of social, occupational or school functioning (Morosini et al., 2000). There 
were no differences between the conditions on any variables at baseline.
Table 1: Baseline demographic, clinical and secondary symptom characteristics
Characteristics
PE 
(n = 53)
EMDR 
(n = 55)
WL 
(n = 47)
Total sample
(n = 155)
Age (years), mean (S.D.) 42.6 (10.3) 40.4 (11.3) 40.3 (9.7) 41.2 (10.5)
Gender, n
Male
Female
23
30
25
30
23
24
71
84
Psychosis
Chlorpromazine drug dose equivalents, mean (S.D.)a
Duration psychosis in years, mean (S.D.)
227.3 (187.9)
18.9 (12.8)
253.2 (250.5)
18.2 (11.7)
250.7 (232.8)
15.7 (10.5)
243.6 (224.2)
17.7 (11.8)
MINI Plus classifications, n (%)
Schizophrenia
Schizoaffective disorder
Remaining psychotic disorders
Mood disorders with psychotic features
31 (58.5)
17 (32.1)
1 (1.9)
4 (7.6)
34 (61.8)
15 (27.3)
3 (5.5)
3 (5.4)
30 (63.8)
13 (27.7)
1 (2.1)
3 (6.4)
95 (61.3)
45 (29.0)
5 (3.2)
10 (6.4)
PTSD
CAPS, mean (S.D.)
Duration PTSD in years, mean (S.D.)
69.6 (14.9)
22.8 (13.6)
72.1 (17.6)
21.1 (13.9)
68.1 (15.9)
18.95 (12.9)
69.9 (16.2)
21.0 (13.5)
Suicidality, n (%)
Suicide attempt (ever)
MINI-Plus current medium or high suicide risk
33 (62.3)
27 (50.9)
33 (60.0)
23 (41.8)
28 (59.6)
20 (41.6)
94 (60.6)
70 (45.2)
Secondary outcome
DRS delusions, mean (S.D.)
GPTS paranoid/referential thoughts, mean (S.D.)
AHRS auditory verbal hallucinations, mean (S.D.)
SCI-SR-PANSS no remission from psychotic disorder, n (%)
BDI-II depression, mean (S.D.)
PSP functioning, mean (S.D.)
9.1 (7.7)
88.8 (37.6)
10.64 (14.1)
38 (52.8)
30.9 (11.4)
50.9 (12.7)
8.7 (8.0)
82.7 (29.2)
12.04 (14.8)
30 (54.5)
28.2 (11.6)
51.0 (12.6)
10.7 (8.4)
83.8 (31.4)
10.26 (14.2)
28 (59.6)
29.7 (12.4)
51.5 (9.6)
9.5 (8.0)
85.1 (32.8)
11.02 (14.3)
86 (55.5)
29.6 (11.7)
51.1 (11.7)
AHRS, Auditory Hallucination Rating Scale; BDI-II, Beck Depression Inventory – II; CAPS, Clinician-Administered PTSD Scale; 
DRS, Delusion Rating Scale; EMDR, eye movement desensitization and reprocessing; GPTS, Green Paranoid Thought Scale; 
MINI Plus, MINI International Neuropsychiatric Interview-Plus; PSP, Personal and Social Performance scale; PTSD, post-
traumatic stress disorder; SCI-SR-PANSS, Structured Clinical Interview for Symptoms of Remission for the Positive and 
Negative Syndrome Scale; S.D., standard deviation.
ª 100 mg CPZ = 2 mg Haldol.
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Fig. 1 summarizes the major findings of the study by presenting the observed 
trajectories of outcomes for each of the variables in the study.
Table 2 presents estimated marginal means produced by the LMM procedure, pre-
post effect sizes and LMM outcomes, based on ITT between-group analyses comparing 
PE and EMDR to WL. Compared to WL, PE and EMDR showed a significantly greater 
decrease of paranoid thoughts at post-treatment and over time; this was maintained at 
6-month follow-up only for PE.
EMDR and WL yielded similar results in reducing depression, whereas PE 
was superior to WL at posttreatment, follow-up and over time, and also superior to 
EMDR (not presented in Table 2; at 6-month follow-up the between-group effect size 
PE v. EMDR = 0.48, p = 0.026, and over time p = 0.036). PE, EMDR and WL did not differ 
on AVHs and social functioning. 
LMM sensitivity analyses of completers (n = 113) and of ITT-LOCF yielded 
similar results.
Table 3 presents GEE ITT between-group analyses of remission status, comparing 
PE and EMDR to WL. The treatments were associated with a significantly greater number 
of remissions from psychotic disorders than WL at post-treatment and over time (PE); 
ITT LOCF sensitivity analysis showed significantly more remission for PE only at post-
treatment.
As was previously published (for details see Van den Berg et al., 2015a) there 
were no differences between conditions in additional support or nontrauma-focused 
psychotherapy (e.g. cognitive behaviour therapy) or changes in the use of medication. 
Moreover, and importantly, no participants received additional trauma-focused 
treatments.
Chapter 6
144
Ta
bl
e 
2:
 E
st
im
at
ed
 s
ec
on
da
ry
 s
ev
er
it
y 
ou
tc
om
es
 a
s 
a 
fu
nc
ti
on
 o
f t
re
at
m
en
t g
ro
up
 (n
=1
55
) i
nt
en
ti
on
 to
 tr
ea
t
Po
st
-t
re
at
m
en
t
6-
m
on
th
 fo
llo
w
-u
p
O
ve
r 
ti
m
e
Si
gn
ifi
ca
nt
 d
iff
er
en
ce
s 
PE
v.
 E
M
D
R
 v
. W
L 
(p
<0
.0
5)
PE
EM
D
R
W
L
Si
gn
ifi
ca
nt
di
ff
er
en
ce
s 
PE
 v
.
EM
D
R
 v
. W
L 
(p
<0
.0
5)
PE
EM
D
R
W
L
Si
gn
ifi
ca
nt
di
ff
er
en
ce
s 
PE
 v
.
EM
D
R
 v
. W
L 
(p
<0
.0
5)
PE
EM
D
R
G
PT
Sa
, m
ea
n 
[n
] 
(9
5%
 C
I)
67
.3
 [
47
]
(6
0.
1–
74
.5
)
68
.0
 [
44
]
(6
0.
6–
75
.5
)
82
.7
 [
39
]
(7
4.
9–
90
.6
)
PE
>W
L,
 M
D
R
>W
L
65
.0
 [
45
]
(5
7.
7–
72
.3
)
70
.2
 [
43
]
(6
2.
7–
77
.7
)
78
.3
 [
39
]
(7
0.
5–
86
.2
)
PE
>W
L
PE
 >
W
L,
 E
M
D
R
>W
L
B
as
el
in
e 
sc
or
e 
[n
]
88
.8
 [
53
]
82
.7
 [
55
]
83
.8
 [
47
]
88
.8
 [
53
]
82
.7
 [
55
]
83
.8
 [
47
]
B
et
w
ee
n-
gr
ou
p 
ef
fe
ct
 s
iz
eb
0.
62
0.
59
0.
54
0.
33
LM
M
c
t 2
00
 =
−2
.8
6
(0
.0
05
)
t 2
00
 =
 −
2.
68
(0
.0
08
)
t 2
02
 =
−2
.4
6.
(0
.0
15
)
t 2
01
 =
−1
.4
8
(0
.1
40
)
t 1
29
 =
 −
3.
03
(0
.0
03
)
t 1
29
 =
−2
.3
8
(0
.0
19
)
A
H
R
Sd
, m
ea
n 
[n
] 
(9
5%
 C
I)
18
.8
 [
22
]
(1
3.
2–
24
.4
)
16
.8
 [
23
]
(1
1.
2–
22
.3
)
24
.2
 [
17
]
(1
7.
8–
30
.6
)
n.
s.
22
.5
 [
20
]
(1
6.
6–
28
.4
16
.1
 [
22
]
(1
0.
4–
21
.7
)
16
.8
 [
18
]
(1
0.
6–
23
.1
)
n.
s.
n.
s.
B
as
el
in
e 
sc
or
e 
[n
]
21
.7
 [
26
]
24
.5
 [
27
]
23
.0
 [
21
]
21
.7
 [
26
]
24
.5
 [
27
]
23
.0
 [
21
]
B
et
w
ee
n-
gr
ou
p 
ef
fe
ct
 s
iz
e
0.
56
0.
40
−0
.4
2
0.
06
LM
M
t 1
01
 =
−1
.2
6
(0
.2
12
)
t 1
02
 =
 −
1.
74
(0
.0
85
)
t 1
02
 =
 1
.3
1
(0
.1
95
)
t 1
01
 =
−0
.1
8
(0
.8
57
)
t 6
6 =
−1
.1
03
(0
.2
74
)
t 6
6 =
 0
.0
23
(0
.9
81
)
B
D
I-
II,
 m
ea
n 
[n
] 
(9
5%
 C
I)
18
.3
 [
47
]
(1
5.
2–
21
.4
)
22
.2
 [
44
]
(1
9.
0–
25
.4
)
26
.7
 [
39
]
(2
3.
3–
30
.0
)
PE
>W
L
17
.8
 [
45
]
(1
4.
6–
20
.9
)
22
.9
 [
43
]
(1
9.
7–
26
.2
)
24
.5
 [
39
]
(2
1.
2–
27
.9
)
PE
>W
L,
 P
E>
EM
D
R
PE
> 
W
L,
 P
E>
EM
D
R
B
as
el
in
e 
sc
or
e 
[n
]
30
.9
 [
53
]
28
.2
 [
55
]
29
.7
 [
47
]
30
.9
 [
53
]
28
.2
 [
55
]
29
.7
 [
47
]
B
et
w
ee
n-
gr
ou
p 
ef
fe
ct
 s
iz
e
0.
78
0.
42
0.
64
0.
15
LM
M
t 1
75
 =
−3
.6
1
(<
0.
00
1)
t 1
74
 =
 −
1.
91
(0
.0
58
)
t 1
77
 =
−2
.9
2
(0
.0
04
)
t 1
76
 =
−0
.6
9
(0
.4
93
)
t 1
33
 =
 −
3.
52
(0
.0
01
)
t 1
33
 =
−1
.4
1
(0
.1
61
)
PS
P,
 m
ea
n 
[n
] 
(9
5%
 C
I)
52
.4
 [
47
]
(4
9.
1–
55
.7
)
53
.5
 [
44
]
(5
0.
1–
56
.9
)
50
.4
 [
39
]
(4
6.
8–
54
.0
)
n.
s.
52
.6
 [
45
]
(4
9.
3–
56
.0
)
51
.9
 [
43
]
(4
8.
5–
55
.4
)
49
.1
 [
39
]
(4
5.
5–
52
.7
)
n.
s.
n.
s.
B
as
el
in
e 
sc
or
e
50
.9
 [
53
]
51
.0
 [
55
]
51
.5
 [
47
]
50
.9
 [
53
]
51
.0
 [
55
]
51
.5
 [
47
]
B
et
w
ee
n-
gr
ou
p 
ef
fe
ct
 s
iz
e
−0
.1
7e
−0
.2
7
−0
.3
1
−0
.2
5
LM
M
t 2
23
 =
 0
.8
1
(0
.4
21
)
t 2
23
 =
 1
.2
5
(0
.2
14
)
t 2
25
 =
 1
.4
2
(0
.1
56
)
t 2
24
 =
 1
.1
3
(0
.2
60
)
t 1
33
 =
 1
.3
4
(0
.1
83
)
t 1
32
 =
 1
.4
3
(0
.1
55
)
A
H
RS
, A
ud
ito
ry
 H
al
lu
ci
na
tio
n 
Ra
tin
g 
Sc
al
e;
 B
D
I-I
I, 
Be
ck
 D
ep
re
ss
io
n 
In
ve
nt
or
y-
II;
 C
A
PS
, C
lin
ic
ia
n-
Ad
m
in
ist
er
ed
 P
TS
D
 S
ca
le
; C
I, 
co
nf
id
en
ce
 in
te
rv
al
; E
M
D
R,
 e
ye
 m
ov
em
en
t d
es
en
sit
iz
at
io
n 
an
d 
re
pr
oc
es
sin
g;
 G
PT
S,
 G
re
en
 
Pa
ra
no
id
 T
ho
ug
ht
 S
ca
le
; L
M
M
, L
in
ea
r M
ix
ed
 M
od
el
 a
na
ly
se
s;
 n
.s
., 
no
t s
ig
ni
fic
an
t; 
PE
, p
ro
lo
ng
ed
 e
xp
os
ur
e;
 P
SP
, P
er
so
na
l a
nd
 S
oc
ia
l P
er
fo
rm
an
ce
 sc
al
e;
 S
.D
., 
st
an
da
rd
 d
ev
ia
tio
n;
 W
L,
 w
ai
tin
g 
lis
t.
a  D
at
a 
re
fle
ct
 e
st
im
at
ed
 m
ar
gi
na
l m
ea
ns
 (
95
%
 C
I)
 fr
om
 th
e 
LM
M
 a
na
ly
se
s.
b  B
et
w
ee
n-
gr
ou
p 
ef
fe
ct
 si
ze
s c
on
ce
rn
 th
e 
di
ffe
re
nc
es
 b
et
w
ee
n 
th
e 
tr
ea
tm
en
t c
on
di
tio
ns
 P
E 
an
d 
EM
D
R 
v.
 W
L 
co
nd
iti
on
 a
t t
he
 d
iff
er
en
t t
im
e 
po
in
ts
. E
ffe
ct
 si
ze
, C
oh
en
’s 
d 
is 
ca
lc
ul
at
ed
 u
sin
g 
th
e 
di
ffe
re
nc
e 
of
 e
st
im
at
ed
 
m
ar
gi
na
l m
ea
ns
 (
LM
M
) 
di
vi
de
d 
by
 th
e 
av
er
ag
e 
S.
D
..
c 
LM
M
 o
ut
co
m
e 
re
su
lts
 (
t v
al
ue
s a
nd
 p
 v
al
ue
s)
 c
on
ce
rn
 th
e 
co
m
pa
ris
on
 o
f P
E 
an
d 
EM
D
R 
v.
 W
L.
 R
es
ul
ts
 o
f c
om
pa
ris
on
s o
f P
E 
v.
 E
M
D
R 
ar
e 
no
t i
nc
lu
de
d 
in
 th
is 
Ta
bl
e 
(a
va
ila
bl
e 
fr
om
 fi
rs
t a
ut
ho
r)
.
d  N
ot
e 
he
re
 th
at
 L
M
M
 w
as
 p
er
fo
rm
ed
 o
n 
a 
su
bs
am
pl
e 
of
 a
ct
iv
el
y 
(i
.e
. p
re
, p
os
t a
nd
/o
r f
ol
lo
w
-u
p)
 h
al
lu
ci
na
tin
g 
in
di
vi
du
al
s.
e  A
s o
pp
os
ed
 to
 th
e 
ot
he
r i
ns
tr
um
en
ts
 h
ig
he
r P
SP
 m
ea
n 
sc
or
es
 re
pr
es
en
t i
m
pr
ov
em
en
t i
ns
te
ad
 o
f w
or
se
ni
ng
; a
 n
eg
at
iv
e 
ef
fe
ct
 si
ze
 h
er
e 
m
ea
ns
 th
at
 th
e 
be
tw
ee
n-
gr
ou
p 
ef
fe
ct
 is
 p
os
iti
ve
 fo
r t
he
 e
xp
er
im
en
ta
l c
on
di
tio
n.
Prolonged exposure and EMDR for PTSD v. a PTSD waiting-list condition: 
effects on symptoms of psychosis, depression and social functioning in patients with chronic psychotic disorders.
145
Ch
ap
te
r 6
Discussion
In our group of patients with psychotic disorders, PE and EMDR therapy were superior 
to the WL condition in reducing psychotic symptoms. Even though symptoms of 
psychosis were not directly addressed in these treatments, the severity of paranoid 
thoughts decreased significantly and rates of remission from psychotic disorders 
increased. Because co-morbid PTSD worsens the course and severity of psychotic 
disorders (Lysaker & Larocco, 2008), it is expected that reducing PTSD will attenuate 
psychosis. This empirical finding is in agreement with the assumed interactions between 
PTSD and SMI.
Figure 1. Observed outcomes trajectories as a function of treatment group. AHRS, Auditory Hallucination 
Rating Scale; BDI-II, Beck Depression Inventory – II; CAPS, Clinician-Administered PTSD Scale; GPTS, Green 
Paranoid Thoughts Scale; SCI-SRPANSS, Structured Clinical Interview for Symptoms of Remission for the 
Positive and Negative Syndrome Scale. a Mean scores are based on individuals who were actively hallucinating 
at baseline and/or post-treatment and/or follow-up.
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The strong and lasting decrease in the severity of paranoid thoughts following 
PTSD treatment was expected and is in line with results from pilot effect studies (Van 
den Berg & van der Gaag, 2012; De Bont et al. 2013a), studies on paranoia (Freeman, 
2007; Freeman & Fowler, 2009), a comparison of paranoia and PTSD (Gracie et al. 2007; 
Alsawy, Wood, Taylor, & Morrison, 2015) and (meta-analytical) studies linking trauma 
to psychosis (Bentall et al. 2012; Reiff, Castille, Muenzenmaier, & Link, 2012; Varese et 
al. 2012; Van Nierop et al. 2014). Also, the integrated socio-developmental-cognitive 
model of schizophrenia reduction of anxiety and dysfunctional cognitions resulting from 
PTSD treatment abates the paranoid interpretations of aberrant information processing 
and helps prevent or diminish psychosis. However, the result that paranoid thoughts 
diminished may also partly be explained by the reduction of PTSD symptoms. PTSD was 
found to be associated with an increased likelihood of endorsing one or more psychotic 
symptoms (Butler, Mueser, Sprock, & Braff, 1996; Sareen et al. 2005) so reducing 
PTSD might reduce paranoia. Furthermore, notwithstanding the fact that paranoia and 
PTSD clearly differ from each other (Freeman et al. 2013), they also share a number 
of features including increased arousal (e.g. hyper vigilance, poor sleep, anger) and 
negative cognitions (e.g. distrust in others).
Contrary to our expectation and in seeming contradiction to aetiological (Reiff 
et al. 2012; Varese et al. 2012; Van Nierop et al. 2014) and phenomenological (Hardy 
et al. 2005; Gracie et al. 2007; Alsawy et al. 2016) findings, the severity of AVHs did 
not diminish to a greater extent in the treatment conditions compared to the WL 
condition. Unfortunately, our weakened analysis of data on AVHs yielded qualitatively 
unsatisfactory results. More research, preferably with continuous measures to assess 
AVHs, is needed to examine whether our unanticipated lack of PTSD treatment effect 
on verbal hallucinations can be replicated.
The reduction of symptoms of depression was significantly greater in PE than in 
EMDR therapy. The finding that depressive symptoms decreased together with PTSD 
during PE was expected. Both the comorbidity rate of PTSD and depression (Kessler, 
Chiu, Demler, & Walters, 2005) and the depression outcomes associated with treatments 
for PTSD (Ronconi et al. 2015) including studies examining SMI patients (Rosenberg et 
al. 2004; Mueser et al. 2008) indicate that depression attenuates alongside the reduction 
of PTSD. However, although similar to PE the expectation applies to EMDR (Kessler et al. 
2005; van den Berg & van der Gaag, 2012; Ronconi et al. 2015) the severity of depression 
did not decline with EMDR therapy. This could be a deviant result or there might be an 
alternative explanation. For example, both treatments demanded considerable effort and 
a certain amount of courage from the patients, but the disclosure of traumatic events 
is much more detailed in PE. Further, PE involves a considerable amount of homework 
whereas EMDR does not. Perhaps the higher degree of activation in PE and a heightened 
sense of personal accomplishment helped to reduce depression in PE.
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No changes occurred in social 
functioning, possibly and partly due to the 
fact that not all traumas of our multi-trauma 
sample (Van den Berg et al. 2015a; De Bont 
et al. 2015) could be addressed in treatment, 
which may have limited social change. But 
an even more important factor might have 
been that the PSP is not very reactive to 
subtle changes in social function. A PSP score 
change reflects significant changes in one or 
more domains (work, friendship, etc.). Now 
the duration of the treatment (eight sessions) 
and assessment period (6-month follow-up) 
was very brief relative to the chronicity of 
patients’ behavioural and social dysfunction 
(mean duration of psychosis was 17.7 years). 
Subtle changes in social functioning might 
have occurred, but major changes were not 
to be expected in the short amount of time. 
So for future studies instruments suited for 
assessing subtle, shortterm changes in social 
functioning or extended treatment and follow 
up periods using the PSP are recommended.
Generally speaking, our successful 
treatment of the PTSD symptoms of patients 
with psychosis helped reduce some of the 
burden of co-morbid symptoms as well. Our 
observations fit the network view on psychiatric 
disorders (e.g. Goekoop & Goekoop, 2014) 
that postulates that symptoms (e.g. anxiety, 
voice hearing, depressed mood) fire up each 
other and that treatment of one symptom 
also benefits associated symptoms. For a 
long time, psychosis has been the highest 
ranking exclusion criterion for psychological 
PTSD treatment, out of fear of doing patients 
harm. Yet, our PTSD treatment outcome 
data demonstrate that together with 
the PTSD symptoms (Van den Berg et al. 
2015a) significant additional symptom relief 
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of psychosis can be achieved by trauma-focused treatment. This also holds true for 
symptoms of depression (for PE).
It could be regarded as a limitation that we used the SCI-SR-PANSS for assessing 
remission status in individuals with and without the diagnosis of schizophrenic disorder. 
After all the SCI-SR-PANSS was specifically designed for people with schizophrenic 
disorders. However, we believe that this is acceptable given the DSM-IV diagnostic 
features of our sample (61% schizophrenia, 29% schizoaffective, 6% mood with psychotic 
features) and given the fact that clinical manifestations of DSM-IV schizophrenic 
disorders are extraordinarily varied with very unclear syndrome boundaries (Tandon 
et al. 2013). A limitation of the current study is the relatively impaired examination of 
AVHs and the absence of examination of other than verbal hallucinatory experiences, 
especially visual hallucinations. Another limitation is that in this study we did not monitor 
changes in our outcome variables during and between sessions. Insight in changes 
occurring during treatment is important, because a possible increase of symptomatology 
during treatment may also be a concern of clinicians, especially after the start of the 
trauma-focused sessions. This concern is addressed in a recent publication by Van den 
Berg et al. (2015b). The study demonstrates that in our study sample, compared to 
WL, the trauma-focused treatment groups were significantly associated with less 
symptom exacerbation and less adverse events during the treatment, including the first 
traumafocused treatment sessions. Clearly all of these findings combined do not support 
the conventional idea that it is best clinical practice to withhold this patient group from 
trauma-focused therapy; on the contrary, all of these findings build a strong case that 
delivering PTSD treatment to patients with psychosis and PTSD deserves recognition 
and acceptance among clinicians and researchers.
The strengths of this study include its highly controlled design, the recruitment 
of patients in care for psychosis from routine clinical settings, the inclusion of patients 
with severe levels of co-morbidity, and the application of widely used PTSD treatment 
protocols. These strengths enhance the generalizability of the observed effects to 
patients in routine clinical practice, and add credibility to the idea that offering trauma-
focused treatment to this patient group is clinically feasible.
Conclusions
To our knowledge this is the first RCT to treat psychotic patients with PTSD and 
examine clinically relevant secondary effects, in particular effects on psychosis. The 
PTSD symptoms were successfully treated by both PE and EMDR therapy, with strong 
secondary reductions of paranoid thoughts and with more patients achieving the status 
of remission from their psychotic disorder; in PE, depression was also reduced. The 
results indicate that patients with psychotic disorders benefit from PTSD treatment in 
more than one symptom domain. This finding agrees with that of other PTSD efficacy 
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studies in non-psychotic populations; in addition our results fit the network model of 
interconnected psychiatric symptom domains and are congruent with the integrated 
sociodevelopmental-cognitive model of schizophrenia.
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Supplementary Fig. S1 Flow of participants through the trial.
Abbreviations: CAPS, Clinician-Administered PTSD Scale; EMDR, Eye Movement Desensitization and 
Reprocessing; 6-mo, 6 month; MINI-Plus, Mini-International Neuropsychiatric Interview-Plus; PE, Prolonged 
exposure; PTSD, posttraumatic stress disorder; TSQ, Trauma Screening Questionnaire; and WL, Waiting list.
 
  
 
332 Screened patients at high risk for  PTSD  
 (TSQ ≥ 6)  
 
120 Referred patients 
 
297 Excluded  
 233  Did not meet full PTSD criteria on CAPS 
 12 Did not meet full psychosis criteria on 
MINI-Plus    
 29  Met one of the exclusion criteria  
 23 Declined participation 
452 Assessed for eligibility 
155 Randomized 
53 Allocated to PE therapy 55 Allocated to EMDR therapy 
40 Completed treatment 44 Completed treatment  
 
47 Allocated to WL condition 
 
 
53 Included in analysis 55 Included in analysis 47 Included in analysis 
39 Completed post-treatment 
 
40 Completed 6-mo follow-up 
 
47 Completed post-treatment 
 
45 Completed 6-mo follow-up 
44 Completed post-treatment 
 
43 Completed 6-mo follow-up 
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Supplementary Table S1: Baseline demographic and clinical characteristics
Characteristics
PE
(n=53)
EMDR
(n=55)
WL
(n=47)
Total 
sample
(n=155)
Age (years), mean (SD) 42.6 (10.3) 40.4 (11.3) 40.3 (9.7) 41.2 (10.5)
Gender, No.
Male
Female
23
30
25
30
23
24
71
84
Cultural background, No. (%)
Dutch
Non-western
Western (non Dutch)
36 (67.9)
12 (22.6)
5 (9.4)
34 (61.8)
17 (30.9)
4 (7.3)
27 (57.4)
19 (40.4)
1 (2.1)
97 (62.6)
48 (31.0)
10 (6.5)
Post-high school educationa, No. (%)
High
Middle
Low
7 (13.2)
22 (43.4)
23 (43.4)
4 (7.3)
21 (38.2)
30 (54.5)
3 (6.4)
18 (38.3)
26 (55.3)
14 (9.0)
62 (40.0)
79 (51.0)
Employed, No. (%) 8 (15.1) 4 (7.3) 6 (12.8) 18 (11.6)
Living conditions, No. (%)
Married/cohabitating
With parents, other relatives or friends
Alone
Sheltered housing
11 (20.8)
8 (15.1)
26 (49.1)
8 (15.1)
12 (21.8)
7 (12.7)
24 (43.6)
12 (21.8)
10 (21.3)
7 (14.9)
27 (57.4)
3 (6.4)
33 (21.3)
22 (14.2)
77 (49.7)
23 (14.8)
A1/A2 index traumas (single or multiple), No .(%)
Sexual abuse
Multiple CSA age ≤ 12 years
Physical abuse
Traumatic psychosis
Emotional abuse in childhood
Other traumatic events (e.g. accident, disaster,war)
38 (71.7)
26 (49.1)
29 (54.7)
9 (16.9)
4 (7.6)
27 (50.9)
28 (50.9)
20 (36.4)
30 (54.6)
6 (10.9)
3 (5.5)
33 (60.0)
28 (59.6)
13 (27.7)
23 (48.9)
13 (27.7)
3 (6.4)
24 (51.1)
94 (60.7)
59 (38.1)
82 (52.9)
28 (18.1)
10 (6.5)
84 (54.2)
Lifetime diagnosis M.I.N.I.-Plus, No. (%)
Schizophrenia
Schizoaffective disorder
Brief psychotic disorder
Psychotic disorder not otherwise specified
Bipolar disorder with psychotic features
Depression with psychotic features
Suicide attempt (ever), No. (%)
Current medium or high suicide risk M.I.N.I.-Plus,No.(%)
31 (58.5)
17 (32.1)
0 (0.0)
1 (1.9)
2 (3.8)
2 (3.8)
33 (62.3)
27 (50.9)
34 (61.8)
15 (27.3)
0 (0.0)
3 (5.5)
2 (3.6)
1 (1.8)
33 (60.0)
23 (41.8)
30 (63.8)
13 (27.7)
1 (2.1)
0 (0.0)
3 (6.4)
0 (0.0)
28 (59.6)
20 (41.6)
95 (61.3)
45 (29.0)
1 (0.6)
4 (2.6)
7 (4.5)
3 (1.9)
94 (60.6)
70 (45.2)
Current delusions on DRS, No. (%)
Current verbal hallucinations on AHRS, No. (%)
CAPS, mean (SD)
PSS-SR, mean (SD)
PTCI, mean (SD)
BDI-II, mean (SD)
Chlorpromazine drug dose equivalents, mean (SD)b
Duration psychosis in years, mean (SD)
Duration PTSD in years, mean (SD)
34 (64.2)
21 (39.6)
69.6 (14.9)
28.5 (8.0)
153.1 (35.8)
30.9 (11.4)
227.3 (187.9)
18.9 (12.8)
22.8 (13.6)
32 (58.2)
24 (43.6)
72.1 (17.6)
30.3 (7.8)
147.6 (32.6)
28.2 (11.6)
253.2 (250.5)
18.2 (11.7)
21.1 (13.9)
30 (63.8)
17 (36.2)
68.1 (15.9)
27.7 (8.9)
144.9 (28.7)
29.7 (12.4)
250.7 (232.8)
15.7 (10.5)
18.95 (12.9)
96 (61.9)
62 (40.0)
69.9 (16.2)
28.9 (8.2)
148.6 (32.6)
29.6 (11.7)
243.6 (224.2)
17.7 (11.8)
21.0 (13.5)
Abbreviations: EMDR, eye movement desensitization and reprocessing; AHRS, Auditory hallucination rating scale{Haddock 1999}; 
BDI-II, Beck Depression Inventory-II; CAPS, Clinician-Administered PTSD Scale; CSA, Childhood Sexual Abuse; DRS, Delusion Rating 
Scale{Haddock 1999}; M.I.N.I.-Plus, MINIInternational Neuropsychiatric Interview-Plus; PSS-SR, Posttraumatic Stress Symptom Scale Self-
Report; PTCI, Posttraumatic Cognitions Inventory; PTSD, posttraumatic stress disorder; SD, standard deviation.
1 lower = primary education or lower general secondary education; middle = intermediate vocational education or higher high school levels; 
high = higher vocational education or university.
1 100 mg CPZ = 2 mg Haldol
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Abstract 
Background Co-occurrence of PTSD in psychosis (estimated as 12%) raises personal 
suffering and societal costs. Health-economic studies on PTSD treatments in patients 
with a diagnosis of a psychotic disorder have not yet been conducted, but are needed 
for guideline development and implementation. This study aims to analyze cost-
effectiveness of guideline PTSD therapies in patients with a psychotic disorder.
Methods This health-economic evaluation alongside a randomized controlled trial 
included 155 patients with a psychotic disorder in care as usual (CAU), with comorbid 
PTSD. Participants received eye movement desensitization and reprocessing (EMDR, 
n=55), prolonged exposure (PE, n=53) or waiting list (WL, n=47) with masked 
assessments at baseline (T0), and at the 2-month (post treatment, T2) and 6-month 
follow-up (T6). Costs were calculated using the TiC-P interview for assessing healthcare 
consumption and productivity losses. Incremental cost-effectiveness ratios and 
economic acceptability were calculated for quality-adjusted life years (EQ-5D-3L-based 
QALYs) and PTSD ‘Loss of diagnosis’ (CAPS).
Results Compared to WL, costs were lower in EMDR (-€ 1,410) and PE (-€ 501) per 
patient per six months. In addition, EMDR (robust SE 0.024, t=2.14, p=0.035) and 
PE (robust SE 0.024, t=2.14, p=0.035) yielded a 0.052 and 0.051 incremental QALY 
gain respectively, as well as 26% greater probability for LoD following EMDR (robust 
SE=0.096, z=2.66, p=0.008) and 22% following PE (robust SE 0.098, z=2.28, p=0.023). 
Acceptability curves indicate high probabilities of PTSD treatments being the better 
economic choice. Sensitivity analyses corroborated these outcomes.
Conclusion Adding PTSD treatment to CAU for individuals with psychosis and PTSD seem 
to yield better health and less PTSD at lower costs, which argues for implementation.
Key words cost-effectiveness, psychotic disorder, quality-adjusted life years, PTSD, 
EMDR, prolonged exposure.
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Health-economic benefits of treating trauma in psychosis 
Until now, no study has assessed the cost-effectiveness of trauma-focused treatment 
(TFT) in patients with a psychotic disorder. This is probably related to existing 
controversies as to whether or not to offer TFT to this target group, e.g. for a comorbid 
PTSD. On the one hand manuals (Foa, Hembree, & Rothbaum, 2007), guidelines (Cloitre 
et al.,2012), clinicians (Becker, Zayfert, & Anderson, 2004; Frueh, Cusack, Grubaugh, 
Sauvageot, & Wells, 2006; Meyer, Farrell, Kemp, Blakey, & Deacon, 2014; Salyers, Evans, 
Bond, & Meyer, 2004; van Minnen, Hendriks, & Olff, 2010) and researchers (Ronconi, 
Shiner, & Watts, 2014) generally apply exclusion or a stabilization program instead of 
offering TFT for psychotic individuals. On the other hand, there is no evidence to suggest 
that TFT would be unsafe and detrimental for individuals with comorbid problems 
such as psychosis (Brand, McEnery, Rossell, Bendall, & Thomas, 2017; van Minnen 
et al., 2010). On the contrary, evidence suggests that firstline TFT, more specifically 
prolonged exposure (PE) and eye movement desensitization and reprocessing (EMDR) 
therapy, might be as effective in psychotic patients as in other patient groups (Brand et 
al., 2017; De Jongh et al., 2016). This controversy affects many people. It is estimated 
that in Europe about 600 thousand and in the USA a quarter of a million adults need 
treatment for both a psychotic disorder and a comorbid PTSD (Achim et al., 2011). Yet, 
given the practice of exclusion very few individuals will have received TFT. Resolving the 
PTSD treatment controversy is not only important for patients, but also for their families 
and the larger community, because, worldwide, psychosis (Murray et al., 2012; Neil, 
Carr, Mihalopoulos, Mackinnon, & Morgan, 2014b; Reininghaus et al., 2015) and PTSD 
(Beard, Weisberg, & Keller, 2010; Issakidis, Sanderson, Corry, Andrews, & Lapsley, 2004) 
are among the most personally disabling and economically costly disorders. The joint 
impact of both disorders worsens the course of the disease and further increases costs 
(Lysaker & LaRocco, 2008; Seow et al., 2016). The need to address costs and effects 
of PTSD treatment in psychosis is reported as one of the NICE 2014 key priorities for 
implementation in recent clinical guidelines, sparking the awareness and assessment of 
trauma and PTSD in psychosis (NICE, 2014). The 2017 APA PTSD guideline (APA, 2017) 
and the 2013 WHO Guidelines for the Management of Conditions Specifically Related 
to Stress (WHO, 2013) state the importance of cost-effectiveness studies to expand 
the evidence base for future guideline recommendations. Guideline panels and financiers 
need cost-effectiveness examinations in order to be able to decide on the application, 
Published as:
de Bont, P. A. J. M., van der Vleugel, B. M., van den Berg, D. P. G., de Roos, C., Lokkerbol, 
J., Smit, F., . . . van Minnen, A. (2019). Health-economic benefits of treating trauma in 
psychosis. European Journal of Psychotraumatology, 10(1), 1565032-1565032. doi:10.1
080/20008198.2018.1565032
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dissemination and implementation of TFT for individuals with psychotic disorders. 
Importantly, no economic data are currently available on this topic. 
Cognitive behavioral therapy (CBT) has favorable economic evaluations for anxiety 
disorders (Issakidis et al., 2004; Mihalopoulos, Baxter, Whiteford, & Vos, 2014) and PTSD 
(Mihalopoulos et al., 2015), but was not examined in psychotic PTSD populations. A 
study among US veterans (N=60) showed that PE for PTSD led to a significant and strong 
reduction in symptomatology and PE reduced health service utilization by (on average) 
$194 per person (Tuerk et al., 2013). A randomized controlled trial in a nonpsychotic 
traumatized population (N=103) showed PE to be cost-effective relative to sertraline, 
saving $262 per individual and yielding a 0.056 incremental gain in qualityadjusted 
life years (QALY) (Le, Doctor, Zoellner, & Feeny, 2014). PE was considered to be the 
preferable treatment option. Although EMDR is a recommended treatment for the 
effects of exposure to traumatic events, it has not yet produced a cost-effectiveness 
study in any patient group. 
The present study conducts a cost-effectiveness analysis alongside a randomized 
clinical trial. In that trial we challenged the no-TFT paradigm in psychosis by demonstrating 
that TFT for PTSD primarily reduced PTSD (van den Berg et al., 2015b) and secondarily 
also paranoid thinking (de Bont et al., 2016), depression (in PE) (de Bont et al., 2016) 
and re-victimization risk (van den Berg et al., 2015a). Additionally, TFT fostered 
remission from schizophrenia and had no detrimental effect on voice hearing and social 
functioning (de Bont et al., 2016). The present health-economic analysis addresses 
the question as to whether PTSD treatment in patients with a psychotic disorder is 
economically affordable and perhaps even cost-saving. The study assesses costs and 
effects in 155 patients in care as usual (CAU) for psychosis, comparing a PTSD waiting 
list (WL) to add-on first-line PTSD treatments, i.e. eye movement desensitization and 
reprocessing (EMDR) therapy and prolonged exposure therapy (PE).
Methods
 
Participants and procedures
Full details of the study are reported elsewhere (van den Berg et al., 2015b; de Bont 
et al., 2013). In brief, the study was designed as a randomized controlled trial in three 
parallel groups (EMDR, PE, WL) measuring costs and effects at baseline (T0), and at 
the 2-month (post treatment, T2) and 6-month follow-up (T6). Only the experimental 
conditions (EMDR and PE) had a longer-term follow-up, conducted at 12 months post-
baseline, including measurements of both effects and costs, in order to assess the 
development (the robustness) of both outcomes over time.
Participants were recruited from 13 mental health services in the Netherlands. 
Eligible were adults (18-65 years) in care for psychotic disorders or mood disorders 
with psychotic features as confirmed by the Mini-International Neuropsychiatric 
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Interview Plus (MINI Plus) (Sheehan et al., 1998) and suffering from co-morbid PTSD 
as established with the Clinician Administered PTSD Scale (CAPS) (Blake et al., 1995). 
Exclusion criteria were i) language or attendance problems, ii) seclusion, iii) staying in 
a closed ward, iv) high suicidality (MINI-Plus ‘high’ suicidality + last suicide attempt < 
6 months + BDI-II-score ≥ 35), v) mood and/or antipsychotic medication changes 2 
months prior to study start, and vi) IQ <70. All eligible participants received a study 
description and 155 individuals gave written consent to participate. The CONSORT flow 
chart is available online (supplemental Figure 1). The independent randomization bureau 
of the Parnassia Psychiatric Institute randomized participants using www.randomizer.
org, yielding N=47 participants in WL, N=55 in EMDR and N=53 in PE. Assessors masked 
for the participants’ randomization status carried out the measurements. The trial (de 
Bont et al., 2013) was designed in accordance with CONSORT guidelines, registered at 
isrctn.com (ISRCTN79584912) and approved by the Medical Ethics committee of the 
VU University Medical Center.
Interventions
All 155 participants received standard care from Multidisciplinary Assertive Community 
Treatment teams, consisting of pharmaceutical intervention, psychological treatment, 
casework, nursing and/or coaching (e.g. individual placement and support). Trauma-
focused interventions were not allowed in CAU.
As fully described elsewhere (van den Berg et al., 2015b; de Bont et al., 2013) the 
waiting list patients obtained information on PTSD from their therapists. After 6 months 
they could choose the PTSD treatment they desired. Patients in the experimental 
conditions received eight weekly sessions of EMDR or PE therapy, yielding good to 
excellent adherence and therapist competence. EMDR was provided in 90-min sessions 
conducted according to the standard 8-phase EMDR protocol using the Dutch translation. 
Eye movements were applied to tax patients’ working memory. EMDR therapy did not 
contain homework assignments. PE consisted of 90-min imaginal exposure sessions 
in which the patient recounted the most disturbing traumatic memories. Between 
the sessions, patients listened daily to the audiorecording of the weekly sessions and 
completed exposure in vivo assignments, during which fearful trauma-related situations 
were approached.
Measures
The health outcome was Quality Adjusted Life Years (QALY) based on the EuroQol (EQ-
5D-3L) self-report (König, Roick, & Angermeyer, 2007) which measured health-related 
quality of life in five dimensions: mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression. The five dimensions have three scoring levels (no problem, some 
problem, severe problem) describing 243 health states. The preference for each health 
state is expressed in utilities. A utility is anchored at 1 (perfect health) and 0 (death). We 
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based utilities on a survey in the Netherlands (Lamers, Stalmeier, McDonnell, Krabbe, 
& van Busschbach, 2005) and used the so-called ‘Dutch tariff’. Utilities were obtained 
at baseline (T0), post-treatment (T2), and at 6 months (T6). Changes in utilities over 
time were converted to QALYs with the area under the curve method (Matthews, 
Altman, Campbell, & Royston, 1990). The EQ-5D has good reliability and validity 
(König et al., 2007).
The clinical outcome was’ loss of PTSD diagnosis’ (LoD), measured with 
the Clinician-Administered PTSD Scale (CAPS-IV). The CAPS (Blake et al., 1995) 
demonstrates excellent reliability, validity and sensitivity (Weathers, Keane, & Davidson, 
2001). The CAPS is considered to be the gold standard for diagnosing DSM-IV-TR (APA, 
2000) PTSD presence (y/n) and symptom severity (0-136). Following PTSD benchmark 
guidelines (Schnurr and Lunney, 2016) we defined loss of diagnosis as no longer fulfilling 
the criteria of a CAPS-PTSD diagnosis and a CAPS severity score < 45. LoD was measured 
at 6-months follow-up in all conditions, and at 12-months follow-up only in the PE and 
EMDR conditions.
Costs
Costs were assessed using the Trimbos/iMTA questionnaire for Costs associated 
with Psychiatric Illness, TiC-P (Hakkaart-van Roijen, 2002) developed by Trimbos 
institute and the Institute for Medical Technology Assessment (MTA). The TiC-P 
interview asks individuals for ‘health care units’ (see Table 1), i.e. the number of contacts 
with healthcare providers (e.g. ‘family doctor/GP’) and for productivity losses stemming 
from absenteeism and/or presenteeism, i.e. being less productive while at work 
or at home.
Healthcare costs (including intervention costs of the add-on experimental 
treatments) were calculated by multiplying health care units by the standard full 
economic unit cost price in 2014 Euro (supplementary Table 1). Medication costs were 
calculated by multiplying the official Dutch costs of Daily Defined Dosages (DDD) 
(http://www.medicijnkosten.nl) by the number of prescription days, plus €6.00 for the 
pharmacist’s dispensing costs.
Costs of productivity losses. Productivity losses stemming from absenteeism 
and presenteeism were calculated according to the human capital approach (Rice and 
Cooper, 1967) using standard hourly productivity costs (Hakkaart-van Rooijen, Tan, & 
Bouwmans, 2010).The cost accumulation from baseline to 6 months was assessed with 
the area under the curve method (Matthews et al., 1990).
Societal costs are the sum of healthcare costs and productivity losses: the total 
amount that is imposed upon society to pay as a consequence of the disorder.
The TiC-P is a reliable and valid alternative for collecting data on care consumption 
and productivity losses (Bouwmans et al., 2013). Costs were measured in Euro (€) for 
the reference year 2014.
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Analysis
The cost-effectiveness analyses were conducted in accordance with the CONSORT 
(http://www.consort-statement.org/) and CHEERS (Husereau et al., 2013) guidelines. 
The aim of the cost-utility study (CUA) is to obtain incremental cost-utility ratios (ICURs) 
of costs per QALY gained. The aim of the cost-effectiveness study (CEA) is to obtain 
cost-effectiveness ratios (ICERs) of costs per lost PTSD diagnosis (LoD). Missing values 
of LoD, QALYs, and costs at follow-up were imputed using the expectation maximization 
(EM) algorithm as implemented in SPSS 22.0. In a linear probability model the incremental 
effects on QALY health gains and LoD clinical improvement were examined using robust 
standard errors based on the first-order Taylor-series linearization method.
An ICER (or ICUR) summarizes cost-effectiveness of a healthcare intervention. 
ICERs are calculated as (C1 − C0)/(E1 − E0) where C1 and E1 are the cost and effect 
in an experimental condition (i.e. EMDR or PE) and C0 and E0 are the cost and effect 
in the control condition (WL). In Stata14.2 resampling procedures (bootstrapping) 
generated 2500 ICERs, with incremental costs and incremental effects under a seemingly 
unrelated regression equations (SURE) model adjusted for possibly confounding baseline 
differences between the conditions. The simulated ICERs were depicted as a scatter 
over a cost-effectiveness plane: the intersection (zero) represents WL, the vertical axis 
represents the incremental costs of the treatment condition compared to WL and the 
horizontal axis represents the incremental effects of the treatment compared to WL. 
When most ICERs fall in the top left quadrant of the plane (Q2), depicting less effect 
at higher costs of the treatment compared to WL, then the treatment is considered 
‘inferior’ to WL and is consequentially rejected from a costeffectiveness perspective. 
When most simulated ICERs fall into the lower right quadrant (Q4), i.e. more health 
effect and lower costs, the intervention (EMDR or PE) is said to show ‘dominance’ over 
the control intervention (no treatment, WL). Obviously this outcome is the best possible 
from an economic perspective: the dominant treatment is considered to be the preferred 
option over the no treatment alternative. The bottom-left quadrant (Q3) implies health 
loss but for concomitantly lower cost. For decision-making purposes we need to take 
an additional step when the ICERs fall into the upper right-hand quadrant (Q1) where 
better health is obtained at additional costs. Then we need to address the question about 
the willingness to pay (WTP) for an additional unit of effect. We used a WTP ceiling of 
€50,000 for gaining one extra QALY.
Sensitivity analysis
To assess the robustness of the main analysis we carried out three sensitivity analyses. 
In the first two we switched from EM imputation (used in the main analysis) to last 
observation carried forward (LOCF) and to regression imputation (REG) as alternatives. 
The third re-analysis excluded the costs of admissions to psychiatric hospitals from the 
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EM imputed dataset, as these were considered to be influential outlier costs (i.e. only a 
few patients generated high hospitals costs). 
Non-parametric paired samples Wilcoxon testing was used to assess longer-term 
consolidation of costs in PE and EMDR at 12-months follow-up.
Results
 
Sample
Table 1 presents the baseline characteristics of the intention-to-treat sample (N=155). 
Regarding current symptoms at baseline, 61.9% of the participants had active delusions, 
40.0%  had active hallucinations, 55.5% had current core symptoms of schizophrenia, 
60.6% reported suicide attempts in the past, and 45.2% had  a current medium to high 
suicidal risk (de Bont et al., 2016). At baseline, there were no clinically or economically 
relevant differences between the conditions. Treatment dropout (EMDR 20%, PE 24.5%, 
P = .57) and dropout from our main assessment at 6-months follow-up (EMDR 22%, PE 
15% and WL 15%, P= .56) also showed no significant differences between the conditions.
Costs
The cost and effect outcomes of the main analysis are presented in Table 2; note that 
the societal and healthcare perspectives are included, and the productivity perspective 
can be deduced from this.
Compared to costs in the WL condition, healthcare costs (i.e. costs of CAU plus 
the add-on experimental intervention) were reduced by € 1,410 per patient in the EMDR 
condition and by € 501 per patient in the PE condition. In other words, the experimental 
conditions (EMDR and PE) were associated with lower costs, even when offering EMDR 
or PE entails additional healthcare costs of their own.
Compared to costs in the WL condition, the total societal costs (i.e. healthcare 
costs plus costs stemming from productivity losses) were reduced by €1,574 in the 
EMDR condition and by €422 in the PE condition.
Effects
The main analysis showed that EMDR gained 0.052 more QALYs compared with WL: this 
is a significant difference (robust SE=0.025, t=2.09, p=0.039). Similarly, PE gained 0.051 
more QALYs compared with WL (robust SE 0.024, t=2.14, p=0.035).
In the EMDR condition 26% more patients fulfilled the criteria of LoD than in the 
WL condition (incremental LoD=0.256, robust SE=0.096, z=2.66, p=0.008). Similarly PE 
yielded an incremental effect of 22% (incremental LoD=0.223, robust SE 0.098, z=2.28, 
p=0.023).
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Table 1: Baseline characteristics of the intention-to-treat sample for the three conditions with costs 
under expectation maximization imputation (N=155)
EMDR
(n=55)
PE
(n=53)
WL
(n=47)
Total sample
(n=155)
Demographic characteristics
Age (years), mean (SD)
Female gender, No.(%)
Dutch cultural background, No.(%)
Lower educationa, No.(%)
Unemployed, No.(%)
Living alone or in sheltered housing, No.(%)
40.4 (11.3)
30 (54.5)
34 (61.8)
30 (54.5)
51 (92.7)
36 (65.4)
42.6 (10.3)
30 (56.6)
36 (67.9)
23 (43.4)
45 (84.9)
34 (64.2)
40.3 (9.7)
24 (51.1)
27 (57.4)
26 (55.3)
41 (87.2)
30 (63.8)
41.2 (10.5)
84 (54.2)
97 (62.6)
79 (51.0)
137 (88.4)
100 (64.5)
Clinical characteristics
Psychosis, lifetime diagnosis MINI-Plus, No.(%)
Schizophrenia
Schizoaffective disorder
Remaining psychotic disorders
Mood disorders with psychotic features
Chlorpromazine drug dose equivalentsb, mean (SD)
Psychosis duration in years, mean (SD)
34 (61.8)
15 (27.3)
3 (5.5)
3 (5.4)
253.2 (250.5)
18.2 (11.7)
31 (58.5)
17 (32.1)
1 (1.9)
4 (7.6)
227.3 (187.9)
18.9 (12.8)
30 (63.8)
13 (27.7)
1 (2.1)
3 (6.4)
250.7 (232.8)
15.7 (10.5)
95 (61.3)
45 (29.0)
5 (3.2)
10 (6.4)
243.6 (224.2)
17.7 (11.8)
PTSD, CAPS severity score, mean (SD)
PTSD duration in years, mean (SD)
72.1 (17.6)
21.1 (13.9)
69.6 (14.9)
22.8 (13.6)
68.1 (15.9)
18.95 (12.9)
69.9 (16.2)
21.0 (13.5)
Economic characteristics
Utility, EQ5D, Mean (SD) 0.55 (0.29) 0.46 (0.31) 0.43 (0.29) 0.48 (.30)
Costs, TiC-P, in 2014 Euro per month, Mean € (SD)
Health carec
Outpatient mental health service
Inpatient mental health service
Medical non-mental health care
Family doctor/GP
Alternative healing
Psychopharmacologya
Paramedical care
Professional home care
Informal care (family, friends)
Out-of-pocket costs (travel)
Productivity losses
Work loss
Work cut-back
Domestic loss and cut-back
689.2 (1005.5)
262.4 (516.6)
142.8 (746.2)
16.4 (41.2)
16.2 (29.7)
0 (0.0)
7.6 (8.9)
77.3 (159.8)
45.6 (116.8)
103.2 (277.3)
17.9 (22.2)
213.4 (318.5)
5.7 (42.2)
21.8 (127.8)
185.9 (292.5)
678.0 (747.2)
261.0 (427.5)
0 (0.0)
21.7 (45.5)
27.4 (36.5)
9.8 (51.1)
8.6 (12.9)
141.4 (253.6)
63.8 (145.9)
120.2 (288.6)
24.0 (22.5)
323.9 (600.9)
34.1 (165.6)
118.2 (457.9)
171.5 (206.1)
1012.6 (1699.8)
260.0 (335.6)
57.8 (249.0)
14.8 (37.7)
19.0 (30.6)
1.5 (7.4)
5.2 (5.9)
111.6 (257.0)
43.1 (77.1)
477.2 (1629.7)
22.2 (21.3)
208.5 (315.6)
42.9 (203.7)
51.4 ( 178.4)
114.3 (116.1)
783.4 (1195.4)
-
-
-
-
-
-
-
-
-
-
249.7 (436.1)
-
-
-
Total societal cost 902.6 (1060.8) 1001.9 (905.4) 1221.1 (1717.6) 1033.1 (1252.9)
Abbreviations: CAPS, Clinician-Administered PTSD Scale; EMDR, eye movement desensitization and reprocessing; EQ5D, EuroQol 5D; 
M.I.N.I.-Plus, MINI-International Neuropsychiatric Interview-Plus; PE, Prolonged Exposure; PTSD, posttraumatic stress disorder; SD, 
standard deviation; TiC-P, Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness; WL, Waiting list.
a Lower = primary education or lower general secondary education, as opposed to intermediate to high vocational education or university.
b 100 mg CPZ = 2 mg Haldol; medication prescribed for psychotic disorders and mood disorders with psychotic features.
c The cost item of ‘outpatient mental health service’ included visits to psychiatrists, psychologists, nurses and so on. ‘General hospital’ 
included costs related to somatic care visits. Visits to the ‘family doctor/GP’ were categorized separately. ‘Alternative healing’ included all 
visits to healthcare workers outside regular care, e.g. paranormal healers. ‘Psychopharmacology’ included all medication plus dispensing 
costs of non-controlled-for medication. ‘Paramedical care’ included care such as physiotherapy or dietetics. ‘Professional home care’ 
included all professional household support whereas ‘informal care’ included all support from family and peers. Healthcare-related 
transportation costs (‘out-of-pocket costs’) included all trips to healthcare services, including parking costs.
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Cost-utility analysis
Healthcare perspective. From the healthcare perspective, the ICUR of EMDR was 
associated with a cost reduction of €26,924 per QALY gained and in PE a reduction of € 
9,741, i.e. both PTSD treatment conditions are ‘dominant’ over WL (i.e. comparatively, 
they yielded reduced healthcare costs while QALYs were gained). 
Societal perspective. When adopting the societal perspective, compared to WL, 
both EMDR and PE yielded lower costs while gaining QALYs. The ICUR of EMDR is 
-€30,061 and the ICUR in PE is -€8,209. Therefore, both PTSD treatment conditions 
seem to be the better choice, i.e. ‘dominant’ over WL (i.e. better health outcomes for 
lower costs). Figure 1 shows 2500 bootstrapped ICERs in a scatterplot: for EMDR 97.4% 
and for PE 69.4% of the ICERs fall into the ‘dominant’ quadrant (Q4). This implies a high 
(PE) to very high (EMDR) probability that the treatments are dominant over WL. Figure 
1 also shows the acceptability curves that depict the probability that EMDR and PE are 
Figure 1 Cost-utility of QALY gain in main analysis (EM) after bootstrapping (n = 2500) comparing EMDR and 
PE to WL: ICUR planes and acceptability curves.
Abbreviations: CAU, care as usual; EMDR, eye movement desensitization and reprocessing; ICUR, incremental 
cost-utility ratio; PE, prolonged exposure; QALY, Quality Adjusted Life Year; Q1, Quadrant 1 (more effective, 
more expensive); Q2, Quadrant 2 (the inferior quadrant: less effective, more expensive); Q3, Quadrant 3 
(less effective, less expensive); Q4, Quadrant 4 (the dominant quadrant: more effective, less expensive); WL, 
waiting list.
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Figure 2 Cost-effectiveness of PTSD loss of diagnosisa in main analysis (EM) after bootstrapping (n = 2500) 
comparing EMDR and PE to WL: ICER planes and acceptability curves.
Abbreviations: CAU, care as usual; EMDR, eye movement desensitization and reprocessing; ICER, incremental 
cost-effectiveness ratio; PE, prolonged exposure; PTSD, post traumatic stress disorder; QALY, Quality Adjusted 
Life Year; Q1, Quadrant 1 (more effective, more expensive); Q2, Quadrant 2 (the inferior quadrant: less 
effective, more expensive); Q3, Quadrant 3 (less effective, less expensive); Q4, Quadrant 4 (the dominant 
quadrant: more effective, less expensive).
a ‘PTSD loss of diagnosis’ indicates the combination of no longer meeting CAPS IV-PTSD criteria + CAPS IV 
-severity score < 45.
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deemed cost-effective relative to WL at varying willingness-to-pay ceilings for gaining 
one QALY. The curves show that, if there is no willingness to pay money at all, EMDR still 
has a 98% probability and PE about a 70% probability of being more cost-effective than 
WL.
Cost-effectiveness analysis
Healthcare perspective. Comparison of WL and the experimental conditions shows 
that the ICER of EMDR is -€5,497 per LoD and that of PE is -€2,245, signifying that 
both experimental conditions are associated with better clinical outcomes and lower 
healthcare costs.
Societal perspective. The ICER of EMDR is -€-6,138 and for PE is -€ 1,892, 
signifying lower costs for society while gaining one additional LoD. Figure 2 presents the 
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cost-effectiveness graphs of LoD from the societal perspective. The scatter of the 2500 
simulated ICERs shows that 98.8% and 70.8% of the ICERs fall in the dominant quadrant 
for EMDR and PE, respectively. When there is no willingness to pay for a LoD, EMDR still 
has a 99% probability and PE a 72% probability of being costeffective.
Sensitivity Analyses
As shown in Table 2, all three sensitivity checks corroborated that EMDR and PE are 
dominant over WL in terms of their cost-utility and cost-effectiveness. The results of 
LOCF and REG imputed analyses are comparable to the main analysis, which was based 
on EM imputation. 
An important finding is that one of the sensitivity analyses, i.e. ‘EM analysis 
without psychiatric hospital costs’, showed smaller cost reductions than the other three 
analyses, all of which included hospital costs (main analysis, LOCF and REG analysis). 
This finding indicates that a sizeable proportion of the relatively lower costs in EMDR and 
PE originates from fewer days in psychiatric hospitals.
Longer-term follow-up in EMDR and PE
Nonparametric paired samples Wilcoxon tests showed a significant decrease between 
the follow-up at 6 months and the extended follow-up at 12 months in healthcare costs 
(z=-4.99, p<0.001) and production loss (z= -2.250, p=0.024) in EMDR, whereas in PE 
the healthcare costs (z= -5.794, p<0.001) decreased and productivity losses (z=-0.907, 
p=0.364) remained the same over time. Apparently, cost reductions in the experimental 
conditions did not decay but were sustained or even increased over time.
Implementation costs
Up to now we have examined the so-called ‘steady-state costs’ in our health economic 
evaluation, i.e. the operating cost of offering CAU plus EMDR and PE interventions. This 
was done to the exclusion of the initial investment cost of about i) €2,800 for eight days 
of EMDR and PE training, and ii) an additional €1,100 for 10 sessions of supervision plus 
€1,100 for 10 sessions of inter-vision. The sum total of these one-off costs is €5,000 
per therapist. Assuming that a trained and supervised therapist treats 10 patients in 
the first implementation year, then the per-patient costs would average at 5000/10 
= €500; in the present study, these are costs recouped within 6 months by offering 
PTSD treatment. Therefore, the implementation costs can be seen as a good return on 
investment. Obviously, the per-patient costs of the implementation decrease after the 
initial phase, although some costs for supervision and/or inter-vision might continue.
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Discussion
 
Main findings
This study evaluated the cost-effectiveness of eye movement desensitization and 
reprocessing (EMDR) and prolonged exposure (PE) therapy for treating post-traumatic 
stress disorder (PTSD) in patients with a psychotic disorder compared to care as usual 
(CAU) for these patients while waitlisted for PTSD treatment (WL). Costs and effects 
were measured at 6-months follow-op. Convincing evidence was obtained that both 
EMDR and PE are likely to reduce costs and yield better outcomes with regard to health 
gains expressed in quality adjusted life years (QALYs) and PTSD ‘Loss of diagnosis’. Three 
sensitivity analyses confirmed the robustness of the main findings. One sensitivity analysis 
provided an indication that, to some extent, lower costs in PTSD treatment originated 
from fewer days of hospital admission. A longer-term (12-month) assessment of costs in 
the treatment conditions showed that cost reductions were sustained or even increased.
Strengths and limitations
Strengths. To our knowledge, this is the first study to evaluate the costeffectiveness 
of guideline trauma-focused treatment protocols for PTSD in psychotic psychiatric 
patients. Additionally, this study is the first to examine the costeffectiveness of EMDR 
therapy in any patient group. The training and implementation of the treatments we 
studies is considered feasible in clinical practice, since EMDR and PE protocols are widely 
used and easily accessible. Dropout was low and comparable to PTSD studies in other 
patient groups (Hembree et al., 2003).
Limitations. A 6-month follow-up is too short to draw final conclusions, as 
differences in costs and effects between the conditions might change over time. However, 
we found favorable developments in the costs at the extended 12-month follow-up 
concomitant with previously reported beneficial effects at 12 months followup on PTSD, 
depression, paranoid-referential thinking and remission from schizophrenia (van den Berg 
et al., 2018) and a strongly reduced re-victimization risk (van den Berg et al., 2015a). 
This suggests that cost reductions could increase further over time. Another limitation 
is that the economic evaluation relied on participants’ self-report regarding healthcare 
usage and changes in productivity; however, a validation study found a satisfactory to 
nearly perfect agreement between patientreported data and data provided by health 
services (Bouwmans et al, 2013). Third, the imputation of missing endpoints using the 
EM algorithm might have added to outcome uncertainty; however, all of our sensitivity 
analyses replicated the results of the main analysis. Finally, the generalizability of our 
results is limited due to differences in healthcare systems across settings and countries. 
We recommend replication in different mental healthcare settings.
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Conclusions
The present results suggest that in individuals with psychotic disorders and PTSD add-on 
EMDR and PE for PTSD reduce costs and yield better quality of life (more QALY gains) 
and clinical effects (more loss of diagnosis) than standard treatment for psychosis 
alone. At every level of society’s willingness to pay for a unit health gain (one loss of 
diagnosis, one QALY gained), adding PTSD treatment is the preferred option. The 
current findings challenge the ‘no trauma-focused treatment’ paradigm for psychotic 
individuals. Adjustment of clinical treatment guidelines and implementation decisions 
seem warranted. With about one in eight patients with a psychotic disorder having 
PTSD, implementing PTSD treatment might yield considerable personal and economic 
benefits in this relatively costly sector within mental health care.
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Supplemental Figure 1 Flow of Participants Through the Trial.
Abbreviations: CAPS, Clinician-Administered PTSD Scale; EMDR, Eye Movement Desensitization and 
Reprocessing; 6-mo, 6 months; MINI-Plus, Mini-International Neuropsychiatric Interview-Plus; PE, Prolonged 
exposure; PTSD, posttraumatic stress disorder; TSQ, Trauma Screening Questionnaire; and WL, Waiting list.
 
 
 
 
332 Screened patients at high risk for 
PTSD (TSQ ≥ 6) 
 
120 Referred patients 
 
297 Excluded  
 233  Did not meet full PTSD criteria on 
CAPS 
 12 Did not meet full psychosis criteria 
on MINI-Plus    
 29  Met one of the exclusion criteria  
 23 Declined participation 
452 Assessed for eligibility 
155 Randomized 
53 Allocated to PE  therapy 55 Allocated to EMDR therapy 
40 Completed treatment 44 Completed treatment 
 
 
47 Allocated to WL condition 
 
 
53 Included in analysis  55 Included in analysis  47 Included in analysis  
39 Completed post -treatment 
 
40 Completed 6-mo follow- up 
 
47 Completed post -treatment 
 
45 Completed 6- mo follow-up 
44 Completed post -treatment 
 
43 Completed 6-mo follow- up 
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Supplementary Table 1: Standard full economic cost price per visit in the Netherlands in 2014.
Health care EUR
Outpatient mental health service
Psychiatrist
Psychiatric social nurse
Psychologist/psychotherapist
Social work, including
individual placement and support
Psychiatric home care
112.00
73.00
112.00
65.00
23.00
Inpatient mental health service
General costs (per day)
Psychiatrist
Psychologist
302.00
112.00
112.00
Self-employed
Psychiatrist, psychologist/psychotherapist 94.44
Medical non-mental health care
General practitioner/family doctor
Occupational medicine physician
Occupational social work
Medical specialist in general hospital
Medical specialist in academic hospital
Other visits to general/academic hospital
Paramedical care (e.g. physiotherapist, dietician)
33.00
33.00
65.00
47.00
86.00
33.00
33.00
General
District nurse
Alternative medicine
Professional home care
Informal care (family and peers)
Self-help group
73.00
23.00
23.00
14.00
14.00
Out-of-pocket costs (transport)
Per kilometer
Parking per visit
0.19
3.00
Productivity loss
Work absenteeism/presenteeism per hour
Domestic absenteeism/presenteeism per hour
34.75
14.00
Abbreviations: CAPS, Clinician-Administered PTSD Scale; EMDR, eye movement desensitization and reprocessing; EQ5D, EuroQol 5D; 
M.I.N.I.-Plus, MINI-International Neuropsychiatric Interview-Plus; PE, Prolonged Exposure; PTSD, posttraumatic stress disorder; SD, 
standard deviation; TiC-P, Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness; WL, Waiting list.
a Lower = primary education or lower general secondary education, as opposed to intermediate to high vocational education or university.
b 100 mg CPZ = 2 mg Haldol; medication prescribed for psychotic disorders and mood disorders with psychotic features.
c The cost item of ‘outpatient mental health service’ included visits to psychiatrists, psychologists, nurses and so on. ‘General hospital’ 
included costs related to somatic care visits. Visits to the ‘family doctor/GP’ were categorized separately. ‘Alternative healing’ included all 
visits to healthcare workers outside regular care, e.g. paranormal healers. ‘Psychopharmacology’ included all medication plus dispensing 
costs of non-controlled-for medication. ‘Paramedical care’ included care such as physiotherapy or dietetics. ‘Professional home care’ 
included all professional household support whereas ‘informal care’ included all support from family and peers. Healthcare-related 
transportation costs (‘out-of-pocket costs’) included all trips to healthcare services, including parking costs.
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General Discussion
Concise overview 
1. Although the notion that trauma-focused treatment will do harm to psychotic 
patients is empirically unsubstantiated, it remains persistently prevalent in psychiatry 
(Chapter 1).
2. A pilot study (Chapter 2) and a randomized controlled trial (RCT) (Chapters 3-7) 
allowed empirical investigation of the effects of treatment for post-traumatic stress 
disorder (PTSD) in patients with psychosis.
3. The population of patients with psychosis is a multi-trauma population with a PTSD 
point prevalence of about 16%. The Trauma Screening Questionnaire (TSQ) has 
been validated to preselect patients with PTSD using a cut-off score of 6, yielding 
44.5% correct positives and 93.6% correct negatives (Chapter 4).
4. In patients with psychotic disorders, comorbid PTSD showed a significantly greater 
decrease as a result of evidence-based first-line psychological PTSD treatments, i.e. 
prolonged exposure (PE) and eye movement desensitization and reprocessing (EMDR) 
therapy, compared to the no-treatment control conditions (Chapters 2 and 5).
5. The feared adverse reactions of psychotic individuals to PTSD treatment, such as 
worsening of psychosis, depression, social functioning or serious adverse events 
(e.g., suicide, psychiatric crisis), did not occur (Chapters 2, 5-6). In fact, findings 
from our RCT indicate the opposite, i.e. both treatments for PTSD significantly 
reduced paranoid thinking and increased remission rates of psychotic symptoms. 
Also, PE therapy significantly reduced depression (Chapter 6).
6. From a cost-effectiveness perspective, offering PTSD treatment to patients with 
psychotic disorders is preferable to denying them this treatment. Both PE and EMDR 
therapy yielded significantly more loss of PTSD diagnosis and more health gain for 
lower economic costs (Chapter 7).
7. All these findings empirically challenge the ‘no trauma-focused treatment’ paradigm 
in the presence of psychosis.
Detecting PTSD in patients with psychosis
As reported by others (Lommen & Restifo, 2009), we also observed a very high rate 
(96.9%) of missed PTSD diagnoses in patients with psychotic disorders in clinical 
practice. We validated the TSQ as an aid to detect PTSD (Brewin et al., 2002), which 
is a precondition for fostering PTSD treatment. The (adapted) TSQ is not only short 
and easy to fill out, but also preselects most of the ‘at risk’ patients (with a negative 
predictive value of 93.6%) who are indicated for further PTSD assessment. 
The design of the TSQ study enabled the subsequent intervention study to 
include a naturalistic variety of ‘real’ patients. Allowing participation of a large group 
of individuals in care for psychosis to enter the trauma and the PTSD screening study, 
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guaranteed that no pre-selection of psychotic patients had taken place before the 
intervention study started. Therefore, our sample of participants can be considered 
highly representative of the actual clinical patient group. 
To date, no validated alternative for the TSQ is available for this patient group. 
Recently, one group failed to succeed in validating the widely used Posttraumatic 
Checklist (PCL) as a screening measure to identify PTSD in individuals diagnosed with 
a psychotic disorder (Steel, Doukani, & Hardy, 2017; Weathers, Litz, Herman, Huska, & 
Keane, 1993). Therefore, at this moment, the TSQ is recommended to detect PTSD in 
this patient population. 
However, irrespective of which PTSD screening instrument performs the best, the 
most important unresolved challenge is how to ensure that mental health organizations 
and/or individual therapists actually implement and use tools such as the TSQ. Therapist-
related factors are one of the main causes of under-detection and under-utilization 
of trauma-focused interventions (Meyer, Farrell, Kemp, Blakey, & Deacon, 2014; van 
Minnen, Harned, Zoellner, & Mills, 2012). In clinical practice, the use of validated 
PTSD screening tools is lagging behind, despite their availability and accessibility (Foa, 
Gillihan, & Bryant, 2013), a fate that might also befall the validated TSQ. This would be 
unfortunate because, as shown in this study, the population of psychotic patients, who 
(generally) suffered multiple traumas, seems to be particularly vulnerable for PTSD. 
As a first step, mental health services should invest time and effort in implementing 
screening tools and, when indicated, in conducting PTSD diagnostic interviews for 
psychotic patients. It is recommended to periodically (re-)screen chronically ill psychotic 
patients for traumas and PTSD, in order not to miss trauma-related problems. It is also 
important to note that not only traumas in a patient’s past personal history, but also 
relatively recent traumas may cause PTSD symptoms. This is relevant because psychotic 
individuals are prone to re-victimization (Khalifeh et al., 2015; Maniglio, 2009). An open 
atmosphere is needed to be able to disclose any traumatic event and to freely talk about 
it. Clinicians and staff who acknowledge the possible role of trauma as a risk factor in 
psychiatric illness, and explicitly ask about it and provide patients with relevant generic 
information (e.g. websites such as www.traumaenpsychose.nl or www.psychosenet.nl), 
convey to the patient that it is normal and important to disclose traumatic experiences 
(Lothian & Read, 2002). For this purpose, it is important to train staff in mental health 
organizations to raise trauma awareness (https://www.kenniscentrumphrenos.nl/
diensten/cursussen/eendaagse-incompany-training-trauma-gesproken/). 
Effectiveness of EMDR and PE for PTSD in patients with psychotic disorders
The positive results described in the feasibility study and the RCT TTIP study are 
promising. However, replication is needed to test the robustness of the findings and 
to compare different treatments for PTSD. A meta-analysis of five PTSD studies in 
psychotic patients showed that those with PTSD as a comorbid condition may benefit 
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from trauma-focused treatment (Hardy & van den Berg, 2016; Sin & Spain, 2017); this 
conclusion appeared to rely heavily on the results of our TTIP trial. Interestingly, other 
studies included in the meta-analysis contributed little (or negatively) to the overall 
effect; however, most of these studies were cognitive restructuring (CR) investigations 
that did not apply the (direct) trauma-focused treatment techniques used in the TTIP 
trial. This raises the question as to whether, in this patient group, a trauma-focused 
approach is more effective than an indirect reprocessing therapy. Future studies could 
include CR to enable comparison of trauma-focused treatments (e.g. PE/EMDR) versus 
indirect (CR) trauma processing procedures (Hardy & van den Berg, 2016). Preparations 
for a study addressing this topic (i.e. a follow-up of the TTIP study) are in progress in 
the Netherlands. Another interesting example of a non-trauma-focused, indirect and 
effective approach to consider for future research is Interpersonal Psychotherapy for 
PTSD (for a PTSD trial in depressed patients, see (Markowitz et al., 2015). It is important 
to have evidence-based treatment alternatives for non-responders, or non-trauma-
focused treatment alternatives for patients who are not willing or unable to be directly 
confronted with their trauma. 
A limitation of our study was that the control condition, a waiting list for 
PTSD treatment, was not optimal. We intended to include a control condition that 
resembled the treatment as usual (TAU) for this patient population, consisting of TAU 
for psychosis and a waiting list for PTSD. Surprisingly, however, this control condition 
also led to improvements in PTSD symptoms. Given that, at baseline, our patients 
reported (on average) almost 20 years of untreated chronic PTSD, it is unlikely that 
these improvements were due to spontaneous recovery (Morina, Wicherts, Lobbrecht, 
& Priebe, 2014), or to favorable fluctuations in symptoms (McFarlane, 2000). A more 
likely explanation is that the anticipation of receiving PTSD treatment after the waiting 
list period may have provided some beneficial effect (Boot, Simons, Stothart, & Stutts, 
2013). Another hypothesis is that our vigorous baseline assessment of participants’ 
lifetime trauma exposure and PTSD (de Bont et al., 2013) worked as covert exposure, i.e. 
‘treatment by assessment’, or (in other words) as a placebo effect (Krakow, Hollifield, 
& Warner, 2000). For future research we recommend to include different types of 
control conditions. For instance, expectation management control groups or studies 
examining the influence of expectation on the effect of a particular treatment might 
serve to tackle the expectation variable (Boot et al., 2013). However, controlling for the 
covert exposure (placebo effects) of trauma assessments might prove more difficult. 
One approach to solving this problem could be to investigate only the effects of trauma 
and PTSD assessments,  i.e. without applying any additional interventions. 
Another point for discussion is that the choice of our study groups does not 
allow to clarify the different effects of specific and non-specific treatment factors 
on treatment outcomes. Unlike patients in the control condition, patients in the 
experimental conditions may have benefited from non-specific factors (such as the 
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therapist-patient interaction) as compared with the specific treatment techniques that 
are part of empirically supported treatments for PTSD, such as PE/EMDR (Keijsers, 
2014). In our severely ill, (relatively) socially isolated and inactive group of patients, 
non-specific factors (e.g. receiving warmth, attention, time scheduling and recognition) 
may have provided added value in bringing about a positive change. Active control 
conditions, such as befriending (Turkington, Spencer, Lebert, & Dudley, 2017), can be 
used as alternatives to control for non-specific factors. 
Two other limitations should also be noted. First, in the TTIP study, the treatment 
dose comprised only eight sessions; this implies that, for some patients, their PTSD 
symptoms were undertreated, especially given their multi-trauma background. 
Therefore, it seems important to design a study that provides patients with an extended 
or full-dose of therapy. However, this recommendation does not detract from the 
fact that, irrespective of the low treatment dose, beneficial effects were achieved and 
had persisted at the 12-month follow-up. Secondly, the context of health care in the 
Netherlands differs from that in other countries, thereby limiting the generalizability of 
our results. In the Netherlands, psychosis care is delivered by specialized outreach teams 
(e.g. Flexible Assertive Community Treatment) that offer psychiatric, psychological, and 
social care. This implies that delivering psychosis care in the Netherlands is promoted by 
several contextual circumstances, e.g. the population density is high, accessibility (short 
travelling distances) to mental health services is (relatively) good, living standards 
are (relatively) high, and health insurance is well provided. Other cultures and other 
countries probably have (very) different healthcare contexts. Therefore, we recommend 
replication of our studies in different mental healthcare systems across different settings 
and countries.
Effects of trauma-focused treatment for PTSD on symptoms of psychosis, 
depression and social functioning
Whereas our results suggest that paranoid ideation and ideas of reference 
diminished and remission of psychotic disorders was enhanced due to PTSD treatment, 
no positive effects on auditory hallucinations were observed. Although associations 
between patients’ hallucinatory voices and traumas have been empirically demonstrated 
(Bentall, Wickham, Shevlin, & Varese, 2012; Hardy et al., 2005; Romme & Escher, 1989), 
suggesting possible treatability (i.e. addressing the trauma memory may diminish 
voice hearing), we found no post-treatment between-group differences on auditory 
hallucinations. This finding is inconsistent with the significant improvements in auditory 
hallucinations found in an earlier exploratory study (Van Den Berg & Van Der Gaag, 
2012). One reason why our successful trauma-focused therapies did not affect auditory 
hallucinations might be that, in our sample, voice hearing was not (often) trauma 
related. However, considering the association between trauma and voice hearing in 
previous studies (Bentall et al., 2012; Hardy et al., 2005; Romme & Escher, 1989), this 
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explanation is not very plausible. Another explanation might be that mediators of the 
relationship between trauma and voice hearing remained unaffected by PTSD treatment. 
One mediator candidate is dissociation, which has shown substantial mediation between 
trauma memories and hallucinations (Bellido-Zanin et al., 2018; O'Driscoll, Laing, 
& Mason, 2014; Wearne et al., 2018). However, in our study, patients both with and 
without the dissociative subtype of PTSD showed a similar large reduction in PTSD 
symptoms on the CAPS (Zoet, Wagenmans, van Minnen, & de Jongh, 2018), suggesting 
that dissociation did not mediate the relationship between trauma and PTSD outcome. 
It should be noted that this does not necessarily exclude the possibility that dissociation 
mediates the relationship between trauma and hallucinations. It remains debatable 
whether pathways and mechanisms from trauma memories to specific symptom 
constellations differ between PTSD and hallucinations; thus, questions on the reasons for 
the absence of secondary effects on hallucinations remain. Replication studies addressing 
the effects of PTSD treatment on hallucinations are needed, with additional focus on the 
role of mediators of this effect. In addition, measuring hallucinations in more than the 
auditory modality alone is important; for example, visual hallucinations are known to be 
closely linked to traumas of sexual abuse (Bentall et al., 2012).
Unfortunately, we also found no effect of PTSD treatment on social functioning. 
This is an important issue, because the pursuit of societal participation and satisfactory 
role taking is essential to the recovery mission in severely mentally ill individuals. There 
are several possible reasons for the lack of effect on social functioning. First, there might 
be a delay in the social effects of the treatment, so that these are unlikely to be detected 
in the relatively short-term follow-up period of our study. It may take a considerable 
amount of time for chronically ill patients to first overcome severe symptoms and then 
to ‘translate’ this clinical gain to improving one’s social behavior and trying to catch up. 
This ‘delayed effect’ hypothesis suggests that effects may occur beyond the study’s 
time frame. Indications for this hypothesis can be deduced from two studies that used 
a long-term follow-up for psychotic individuals (Pot-Kolder, Veling, Geraets, & van der 
Gaag, 2016) and individuals at risk for psychosis (Ising et al., 2016). Thus, extending 
the follow-up period seems advisable in future studies. Another explanation for the 
lack of change in social functioning involves the topic of (self) stigma. Stigma and self-
stigma exert a negative influence on the ability of severely mentally ill patients to pursue 
behaviors related to important life goals and societal participation; this is also known 
as the ‘Why try?’ effect (Corrigan, Larson, & RÜSch, 2009). This hypothesis implies 
that individuals’ trauma histories and their years of chronic suffering from PTSD, and 
especially psychosis, have initiated stigma (Schulze & Angermeyer, 2003) and possibly 
self-stigma as well as negative self-esteem (Horsselenberg, van Busschbach, Aleman, 
& Pijnenborg, 2016). Translating this to our study, our PTSD treatments may not have 
influenced social functioning due to the unchanged influence of (self) stigmatization. 
Stigma constitutes a limiting force in itself which, again, emphasizes the importance of 
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early detection and treatment of both PTSD and psychosis. A third explanation might be 
found in the instruments used. Although the social change assessment was conducted 
using a validated instrument (Burns & Patrick, 2007), it is debatable whether a classic 
‘paper and pencil’ instrument is sensitive enough to detect subtle changes. Nowadays, 
daily-life measures delivered via mHealth (using mobile apps), such as the Experience 
Sampling Methodology, seem to be better alternatives for the classic social function 
scales (Schneider et al., 2017). Finally, engaging members of the patients’ social 
network (e.g. family, friends, colleagues) was not part of the PTSD treatment protocols 
used. However, for persons with psychotic disorders, family interventions are associated 
with improved social functioning (Mueser, Deavers, Penn, & Cassisi, 2013; NICE, 2009) 
and, for persons with PTSD, social support moderates positive outcome (Thrasher, 
Power, Morant, Marks, & Dalgleish, 2010). Therefore, it seems worthwhile to examine 
the effects of involving members of the patient’s social network in the PTSD treatment 
(for psychotic individuals). That is, the assessment and treatment of the interpersonal 
aftermaths of trauma might help improve interpersonal functioning by relieving some 
of the trauma-related interpersonal difficulties (e.g., marital discord, familial alienation, 
parental problems, work problems).
Because a meta-analysis of depressive symptom outcomes in PTSD trials showed 
a general decrease in the severity of depression (Ronconi, Shiner, & Watts, 2015), for 
our study we expected a similar outcome. Although this hypothesis was supported for 
PE therapy, this was not the case for EMDR therapy. More specifically, PE performed 
significantly better than both EMDR and WL in decreasing depressive symptom severity, 
whereas EMDR and WL showed no significant difference in this respect. A possible 
reason for the lack of effect of EMDR could be that the many hours of homework in PE 
activates and structures the patient in his/her daily life and instills a greater sense of 
self-accomplishment as compared to EMDR; both activation and self-accomplishment 
might have yielded a reduction in depression. In line with this idea, one study on patients 
with severe mental illness found that the more successful the completion of cognitive 
behavioral therapy (CBT) homework, the greater the reduction in PTSD symptoms 
(Mueser et al., 2008). This effect might also extend (secondarily) to depressive 
symptoms. Future studies could investigate whether mediators of the decrease in 
depressive symptoms are affected in different ways by PE and EMDR therapy. 
Taken together, our findings imply that the widely held assumption of clinicians 
that trauma-focused PTSD treatment causes exacerbation of comorbid symptoms of 
psychosis and depression is probably false. This is important, because it is this ‘fear’, 
particularly the fear of possible worsening of the psychotic symptoms, that withholds 
clinicians from applying trauma-focused treatment. In fact, our study demonstrates that 
the benefits of undergoing PTSD treatment outweigh the relative burden: psychotic 
patients do not show excessive dropout, and any symptom exacerbation in an individual 
(e.g., PTSD, paranoia, or depression) tended to occur more frequently in the WL 
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condition than in the PE or EMDR therapy conditions (van den Berg et al., 2015). Some 
comorbid symptoms decreased alongside the PTSD symptoms, or at least remained 
stable during treatment. Now that some of the restrictive fears have been disproven, 
the essential finding is that the PTSD symptomatology of psychotic patients (as in 
other PTSD populations) can be alleviated after standard first-line psychotherapeutic 
treatments. 
Cost-effectiveness of PTSD treatment in patients with psychotic disorders
Our cost-effectiveness study is the first investigation involving PTSD in psychotic patients 
and the first involving EMDR in any patient group. Although our results are encouraging, 
more studies are needed. Hopefully, future studies will expand the evidence base for 
the cost-effectiveness of PTSD treatment in patients with psychotic disorders, especially 
since the variation in socio-economic contexts across countries limits the generalizability 
of our study. Different healthcare systems, divergent financial positions regarding 
a society’s willingness to pay for health, variations in health insurance coverage and 
accessibility of treatments, etc., will influence cost-effect outcomes in other countries.
Conversely, within the context of the Dutch healthcare system, it seems reasonable 
to assume that adding PTSD treatment to treatment-as-usual for patients with psychosis 
will help alleviate psychological suffering and reduce economic costs.
General considerations
It should be noted that, even though the studies presented here yield new and positive 
results in some important respects, the positive results might ‘shrink’ in later (replication) 
studies, as occurred in other ‘well-accepted’ studies (Collaboration Open Science, 2015; 
Lehrer, 2010). Therefore, replication of our studies and actual replication of positive 
results are pivotal to any substantiated scientific claim. Nevertheless, our results were 
achieved after following rigorous research guidelines and principles, and all the studies 
were adequately powered. The methodology used was in accordance with the main 
principles of the CONSORT statement and the CHEERS guidelines (for the economic 
evaluation). Therefore, until proven otherwise, the position arising from this thesis is 
that PTSD treatment is beneficial in various ways for psychotic patients compared to 
those who are not treated for their PTSD; moreover, no significant negative side-effects 
were observed. In support of this position it is important to note that smaller explorative 
studies on this topic, without exception, reported neutral to positive effects of CBT 
and PE/EMDR therapy on a decrease in PTSD symptom severity in psychotic patients; 
moreover (as in our investigations), these studies also found a decrease in comorbid 
symptoms (e.g. psychosis, depression and dissociation) (Frueh et al., 2009; Mueser et al., 
2008; van den Berg & van der Gaag, 2012). Our findings are also in line with the positive 
outcomes of treatment studies in PTSD patient populations with other severe forms 
of psychopathology, e.g. substance use disorders (Hien et al., 2010; Hien, Ruglass, & 
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Back, 2017; Roberts, Roberts, Jones, & Bisson, 2015) and borderline personality disorder 
(Clarke, Rizvi, & Resick, 2008; Feeny, Zoellner, & Foa, 2002; Harned, Wilks, Schmidt, & 
Coyle, 2018).
Clinical implications
The treatments we applied (i.e. PE and EMDR therapy) are widely used and accepted 
interventions for PTSD. Importantly, because no ‘adapted’ treatment manuals were used 
for the application of PE/EMDR, clinicians will not encounter difficulty in performing 
these treatments. Also, employer organizations do not have to invest large sums of 
money for training and, moreover, the investment is economically viable. The extra time 
and money expended on therapy sessions is also limited and appears to be recouped by 
the reduction in PTSD and comorbid symptomatology.  
The most likely problem to occur in clinical practice is the dissemination of 
PTSD treatment in care-as-usual for psychosis. In order to foster dissemination and 
implementation, our research team has developed staff training courses for mental health 
teams in psychosis care, i.e. a training for all professionals involved in teams for psychosis. 
It is not a training for PTSD treatment, but aims to initiate an open, well-informed and 
professional attitude (among working teams) with regard to trauma. The aim of the staff 
training project is to enhance awareness, foster a trauma-sensitive attitude, stimulate 
the use of relevant and evidence-based measurement tools, raise awareness of the wide 
range of useful interventions/referrals that might help limit the impact of trauma (e.g. 
evidence-based PTSD treatment, individual placement and support, medical-physical 
examination), and promote proper reporting of trauma- related issues in patient charts 
(e.g., classification and descriptive diagnosis, treatment plan). The educational effects 
of this ‘Talking about trauma’ staff training are currently being examined. 
Future directions
New initiatives in treating trauma in psychosis
Only since the 1990s has psychotherapy, more specifically CBT, been recommended 
in guidelines for the treatment of patients with psychotic disorders (e.g. NICE). Before 
that time, apart from token economies and skills training, psychotherapy with psychotic 
patients was ‘not done’ (van der Gaag, 2016). However, today, impressive developments 
are taking place in the field of psychotherapy in relation to psychotic disorders. These 
new directions, applications and innovations are also reflected in this ‘treating trauma in 
psychosis’ thesis. One of the innovations is Virtual Reality (VR); recently, VR exposure 
programs for both psychotic disorders (Pot-Kolder et al., 2018) and PTSD (Botella, 
Serrano, Baños, & Garcia-Palacios, 2015) have shown promising results. These studies 
imply that, in the future, VR studies on PTSD should refrain from excluding psychotic 
patients. Another innovation is research on combinations of evidence-based PTSD 
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strategies; for example, an intensive treatment program combining PE and EMDR therapy 
for PTSD in a complex patient group yielded good results (Van Woudenberg et al., 2018). 
Especially the formats of intensive PTSD treatments show promising results in case of 
severe comorbidity in terms of reduction of attrition and comorbid psychopathology, 
including psychosis (for an overview see (Hendriks, de Kleine, Broekman, Hendriks, and 
van Minnen (2018).
Trauma, ‘at-risk mental state’ and psychotic children
Given that trauma-focused PTSD treatment in chronically ill psychotic patients is 
effective, safe and less costly than not treating the PTSD, a subsequent step could be 
to explore the same application in persons at risk for psychosis. Patients with an ‘at-
risk mental state’ (ARMS), usually adolescents and young adults, present attenuated 
psychotic symptoms or a florid psychosis that without treatment remits within seven 
days. ARMS can now be treated with CBT aimed at the psychotic(-like) symptoms (van 
der Gaag, van den Berg, & Ising, 2017). However, considering that exposure to trauma is 
prevalent in patients with ARMS with prevalence rates of over 85% (Kraan et al., 2015), 
and trauma in ARMS is associated with multi-morbidity (Kraan et al., 2015; Kraan et al., 
2017; van Dam et al., 2015), trauma-focused treatment of patients with ARMS seems 
a highly relevant research topic. Preventing psychosis by applying as many effective 
treatment options as possible, including trauma-focused treatment, is an important 
direction for future research in the field of psychosis care.
Another area to investigate is child and adolescent psychiatry. A systematic review 
of 19 population-based studies showed that psychotic symptoms (i.e., not disorders) are 
relatively common in childhood (17% in children aged 9-12 years) and in adolescence 
(7.5% in adolescents aged 13-18 years) (Kelleher et al., 2012). It was also shown that 
children who experienced adult violence, peer bullying or accidents before the age of 
12 years, more often presented psychotic symptomatology than their non-traumatized 
peers (Varese et al., 2012). Thus, just as the likelihood of psychosis in adulthood is 
associated with childhood trauma (Bentall et al., 2012; Varese et al., 2012), psychotic 
symptoms in childhood are related to childhood trauma. Therefore, research is needed 
among children with severe trauma, examining the childhood onset of (trauma-related) 
psychotic symptoms (Varese et al., 2012) and PTSD. Although practice guidelines for 
childhood PTSD mainly recommend CBT (including writing therapy) (de Roos et al., 
2017), EMDR has also received empirical support (de Roos et al., 2011; de Roos et 
al., 2017). Practice guidelines for (first-episode) psychosis in children or adolescents 
(e.g. NICE) now recommend to always assess the child’s trauma history as part of the 
evaluation and treatment program. The question remains whether researchers/clinicians 
are now in fact prepared to examine or apply trauma-focused treatment for PTSD and/
or for trauma-related psychotic symptoms in youngsters with psychotic symptoms or 
disorders. Our group experienced that our intervention trial with adult participants met 
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with considerable skepticism and resistance from professionals and (sometimes) family 
members. When children are involved, there may be even greater resistance to this kind 
of research, primarily based on the fear of doing harm. However, since this fear has now 
shown to be unsubstantiated for adults, successful trauma-focused treatment might 
also yield good results in children, on both the personal and economic level. Should this 
treatment be proven efficacious, this will represent an important additional intervention 
for the prevention of future psychiatric problems.
Trauma and PTSD: predictors of psychopathology
The introduction to this thesis (Chapter 1) described that, for many decades, ‘trauma’ 
was not taken seriously as a potentially contributory causal factor in psychopathology, 
especially in patients with psychosis. After disclosure of their history of traumas, 
psychotic patients were often faced with a response from professionals along the lines 
of implying: ‘wish-fulfilling phantasies’ or ‘delusional beliefs’. However, recent studies 
demonstrate that trauma and PTSD are transdiagnostic and causal key factors in the 
development of all kinds of severe psychopathology. A study on patients with PTSD 
found a two times higher percentage of comorbid disorders compared with patients 
without PTSD (Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995). It was also found 
that trauma, i.e. child abuse, is causally prevalent in a wide array of psychiatric disorders, 
including anxiety disorders, addiction, mood disorders, traumatic stress syndromes 
(Teicher & Samson, 2013) and psychotic disorders (Varese et al., 2012). Moreover, 
patients with an acute stress reaction or PTSD are at greatly increased risk of developing 
schizophrenia (IRR 3.80, CI 2.33-5.80), schizophrenia spectrum disorder (IRR 2.34, 
CI 1.46-3.53) and bipolar disorder (IRR 4.22, CI 2.25-7.13) in the first five years after 
diagnosis of the trauma-related stress disorder (Okkels, Trabjerg, Arendt, & Pedersen, 
2016). In addition, it was demonstrated that in individuals with an at-risk mental state 
for psychosis, a history of child maltreatment increased the odds of transitioning in 
adulthood not only to psychosis, but also to depressive disorder (OR=4.92), PTSD 
(OR=2.06), panic disorder (OR=2.00) and social phobia (OR=2.47) (Kraan et al., 2017). 
All these findings indicate that trauma and PTSD are pluripotent predictors of a range of 
psychopathological pathways. Together with the impact of other factors, e.g., genetic/
biological factors (Teicher & Samson, 2013), the substantial impact of trauma and 
trauma-related stress disorders on psychopathology has to be acknowledged. It is now 
known that, in a considerable proportion of the patients classified with ‘non-trauma’ 
diagnostic classifications, the disorder is in fact related to trauma and trauma-related 
stress disorders. Therefore, we need to systematically assess and treat those trauma-
related aspects in all psychiatric disorders. To achieve this, we have to go beyond the ‘one- 
disorder, one-treatment’ approach that is often common for psychological treatments in 
mental health care.
General discussion
193
Ch
ap
te
r 8
We end this discussion by reiterating our conclusion that the studies in this thesis 
convincingly challenge the ‘no trauma-focused treatment’ paradigm in patients with 
psychosis. Our studies add important and, in this these patients, novel methods to 
the treatment armamentarium by providing the option of PTSD treatment. We have 
indicated the importance of studying the effects of trauma-focused treatment in severely 
ill patient populations and/or in populations at risk for developing severe trauma-related 
psychopathology. It is hoped that these studies will stimulate additional clinical and 
economic effect studies and help foster investigation of the role of trauma and PTSD in 
the development of (severe) psychopathology.
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Summary 
Background
The purpose of the studies presented in this thesis was to enhance the recognition and 
detection of post-traumatic stress disorder (PTSD) in patients with psychotic disorders, 
and to examine the effects of evidence-based trauma-focused treatments for PTSD 
in this patient group in terms of change in PTSD symptoms, secondary symptoms 
(e.g., auditory hallucinations, paranoid thinking) and economic costs. 
The general introduction (Chapter 1) describes the pre-scientific but, 
nevertheless, dominant paradigm that for many years instructed clinicians to exclude 
patients with psychotic disorders from trauma-focused treatments. The assumptions 
underlying this paradigm were that i) patients’ reports of traumas did not represent 
‘real’ traumas to begin with but rather delusions and wish-fulfilling phantasies, and/or 
that ii) trauma-focused treatment would cause an unacceptable burden for, or harm to 
psychotic patients. Even though widely accepted, these assumptions have never been 
empirically examined.
Chapter 2 describes an initial investigation concerning whether or not psychotic patients 
could benefit from trauma-focused treatment, using a multiple baseline within-group 
controlled design (N=10). The participating patients suffered from both psychosis and 
PTSD. All received trauma-focused treatment, i.e. either eye movement desensitization 
and reprocessing (EMDR) or prolonged exposure (PE) therapy. This feasibility study 
yielded encouraging results. That is, the basic protocols for EMDR and PE appeared to 
be safe and effective in diminishing PTSD symptoms in a maximum of only 12 sessions. 
We observed no worsening of delusions, hallucinations or functioning, and no serious 
adverse events occurred (e.g. admissions, suicide, and crisis). Instead, as a result of the 
treatment aimed at their PTSD, we found that patients improved on psychotic prone 
thinking and general psychopathology. 
Chapter 3 presents the design of a multicenter randomized controlled trial (RCT) 
entitled ‘Treating Trauma in Psychosis’ (TTIP). The TTIP design covered research topics 
for three dissertations on trauma and trauma-focused PTSD treatment in psychotic 
patients, comprising descriptions of our methods and procedures. With regard to the 
present dissertation, the design includes detailed information on the measurements 
aimed at examining the screening and prevalence of PTSD in psychotic patients, and the 
study of the primary and secondary clinical outcomes and the health-economic effects 
of PTSD treatment.
As part of the TTIP trial, in Chapter 4 we describe the validation of the short PTSD 
screening instrument, i.e. the Trauma Screening Questionnaire (TSQ), among patients 
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with psychotic disorders (N=2608). Data from the 2608 TSQs were tested against 
the diagnostic outcomes of in-depth PTSD interviews (CAPS) with 455 of the 2608 
psychotic patients. At the most optimal cut-off score of 6 (range 0-10), the TSQ yielded 
a sensitivity of 78.8%, a specificity of 75.6%, and 44.5% correct positives and 93.6% 
correct negatives. We also found that the percentage of patients in care for psychotic 
disorders who had been exposed to at least one traumatic event in their life (78%) is 
comparable to that in the general population.  However, unlike persons in the general 
population, individuals in the psychosis group (N=2608) experienced on average more 
incidences of trauma exposure (about 56% ≥ 3 traumatic incidents) in more categories 
(>2, e.g. sexual/physical abuse and neglect). The conclusion is that the group of 
psychotic individuals in mental health care is, by and large, a multi trauma group. 
Accordingly, we found that the estimated prevalence rate of PTSD among these patients 
was significantly higher (16%) than in the general population in the Netherlands (past 
year prevalence 3.3%).
In the TTIP intervention study (Chapter 5) we conducted an RCT with medium to severely 
chronically ill psychotic patients (N=155) receiving treatment as usual (TAU) for their 
psychotic condition and suffering from an untreated comorbid PTSD. We demonstrated 
that eight sessions of EMDR or PE therapy added to TAU were more effective than a 
waiting list control condition (WL) in reducing PTSD in psychotic patients. In EMDR and 
PE, the proportion of patients that no longer fulfilled the criteria for a DSM IV-PTSD 
diagnosis after treatment was significantly larger compared to WL. Moreover, compared 
with the WL, there was a significant decrease in the severity of PTSD symptoms and of 
dysfunctional post-traumatic cognitions. There were no significant differences between 
the three conditions in the occurrence of dropout or serious adverse events (e.g. death, 
admission, psychiatric crisis). All effects were maintained at the 6-month follow-up. 
This study demonstrates that a trauma-related stress disorder, such as PTSD, can be 
successfully treated in patients with psychotic conditions using standard guideline 
trauma-focused treatment procedures. 
 In the context of the intervention study described in Chapter 5, another study on 
secondary outcomes was conducted (Chapter 6). This study addressed the main concern 
among professionals that keeps them from including psychotic patients in trauma-
focused treatment, i.e. the fear of causing more psychosis or other types of deterioration 
by exposing psychotic patients to reminders of traumas, thereby inducing high arousal 
levels that they, allegedly, cannot regulate adequately. We found that the treatment 
conditions (PE and EMDR therapy) led to significantly better results compared with WL 
in reducing the severity of paranoid thinking and depression (depression only in PE) and 
in fostering remission of psychosis. No between-group effects were found on auditory 
hallucinations and social functioning. The results were sustained at the 6-month follow-
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up. Therefore, the ‘fear of doing harm’ is not endorsed by our findings. On the contrary, 
our data show that treating comorbid PTSD in psychotic patients is not too burdensome 
for them and might in fact help to also (secondarily) alleviate some of their psychotic 
and/or mood problems. 
Chapter 7 describes our health-economic evaluation in the context of our RCT. Both 
psychosis and PTSD are among the most economically costly psychiatric disorders 
worldwide. Therefore, we examined whether the economic costs of implementing and 
applying PTSD treatment in this specific patient group are justified when considering 
them in relation to the health benefits. We found that after 6 months, and compared 
to WL, EMDR and PE were associated with lower health care costs (EMDR -€1410, PE 
-€501) per patient per six months, a 0.05 incremental health gain (quality adjusted life 
years, QALY) and 0.26 (EMDR) and 0.22 (PE) incremental clinical improvement, i.e. ‘loss 
of PTSD diagnosis’ (no longer fulfilling CAPS-IV-PTSD criteria and a CAPS severity < 
45). Converted this means that for each year of health gain (1 QALY) treatment costs 
were €8,200 (PE) or €30,000 (EMDR) lower than when not treating the PTSD; and per 
‘loss of PTSD diagnosis’ the treatment costs were about €1,890 (PE) or €6,100 (EMDR) 
lower compared to no treatment. Scatterplots and acceptability curves indicated a high 
probability of the treatments being the best economic choice at any level of willingness 
to pay. The robustness of these findings at the 6-month follow-up was confirmed by 
three sensitivity analyses and by the 12-month follow-up check in the experimental 
conditions, showing that cost reductions did not decay but were sustained or even 
increased over time. Even when costs for implementation (e.g. training and supervising 
staff to perform these treatments) were included, offering PTSD treatment to psychotic 
patients remained the better economic choice. 
Chapter 8 presents the General Discussion. To promote the detection of trauma and 
PTSD in psychotic patients it is required that organizations and professionals start using 
and implementing available resources (such as the TSQ) and foster a trauma- sensitive 
attitude; for this, staff training might be helpful. Replication of our intervention study 
is needed in the future. Other types of PTSD treatment might also be included in the 
comparisons, especially formats of intensive (combinations of) PTSD treatments and/
or variants that are not directly trauma-focused, such as cognitive restructuring or 
interpersonal therapy for PTSD. 
One limitation of our study is that the choice of the control group was not 
optimal: it was passive (waiting list) and, at baseline, participants were exposed to in-
depth trauma and PTSD interviews, probably yielding enhanced improvement due to a 
placebo effect. Future studies may need to consider other control conditions. Replication 
is also needed because the results obtained in the context of Dutch health care cannot 
necessarily be generalized to other locations/contexts; this applies even more to our 
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cost-effectiveness study than to our intervention study, due to very different healthcare 
systems and governance, economics, demography and infrastructures across countries. 
We also discuss the lack of effect of the treatment conditions on hallucinations and 
on social functioning, as well as the lack of effect of EMDR on depression. Possible 
explanations are offered and some recommendations are made for future research. 
Nevertheless, even when considering the absence of certain expected effects, we can 
conclude that trauma-focused treatment appears to alleviate some of the psychotic 
symptoms of patients rather than increasing them. 
The discussion emphasizes that studies have proven that trauma and trauma-
related stress syndromes, such as PTSD, are general pluripotent predictors of future 
severe psychopathology, including psychosis. This underlines, once again, that trauma 
and PTSD need attention in the assessment and treatment plans of patients with various 
manifestations/classifications of severe mental illness.
With regard to our initial research questions, the general discussion concludes 
that, contrary to long-standing but unproven views, it is in fact possible and beneficial to 
detect and treat PTSD in patients with psychosis. Guideline-based trauma-focused PTSD 
treatments, such as PE and EMDR therapy, have now empirically been shown to decrease 
PTSD and the symptoms of psychosis and depression (PE), as well as the overall costs 
involved.
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Samenvatting 
Achtergrond
Het doel van de studies die in dit proefschrift worden beschreven was om de detectie 
van posttraumatische stressstoornis (PTSS) bij patiënten met psychotische stoornissen 
te verbeteren en om bij deze patiënten de effecten van evidence-based traumagerichte 
behandelingen op PTSS-symptomen, op secundaire symptomen (waaronder auditieve 
hallucinaties, paranoïde denken) en op economische kosten te onderzoeken. .
De algemene inleiding (Hoofdstuk 1) beschrijft het onwetenschappelijke, maar 
desalniettemin dominante paradigma, dat decennialang behandelaren voorschreef dat 
zij hun psychotische patiënten moesten uitsluiten van traumagerichte psychologische 
behandelingen. De aannames die ten grondslag liggen aan dit paradigma waren dat i) 
trauma’s van psychotische patiënten geen 'echte' trauma's waren, maar wanen en/
of fantasieën over situaties die zij heimelijk wensten, en / of dat ii) traumagerichte 
behandeling een te grote belasting zou betekenen voor, of zelfs schade zou kunnen 
toebrengen aan psychotische patiënten. Hoewel deze veronderstellingen breed gedragen 
werden, waren ze opmerkelijk genoeg nooit empirisch getoetst.
Hoofdstuk 2 beschrijft een verkennend onderzoek met een multiple baseline design, 
naar de vraag of psychotische patiënten (N=10) baat kunnen hebben bij traumagerichte 
behandeling. De deelnemende patiënten hadden zowel een psychotische stoornis 
als PTSS. Allen ondergingen traumagerichte behandeling, namelijk eye movement 
desensitization and reprocessing (EMDR) of prolonged exposure (PE). Deze verkennende 
studie leverde bemoedigende resultaten op. De basisprotocollen voor EMDR en PE 
bleken in maximaal 12 sessies veilig en effectief te zijn om PTSS-symptomen te doen 
verminderen. Wanen, hallucinaties en dagelijks functioneren verslechterden niet, en 
er waren geen ernstige bijwerkingen (bijvoorbeeld opnames, zelfmoord, crisis etc.). 
Integendeel, we vonden dat patiënten na de PTSS-behandeling juist minder symptomen 
van psychotisch denken en algemene psychopathologie rapporteerden. 
Hoofdstuk 3 presenteert het studie-design van een multicenter gerandomiseerde 
gecontroleerde trial (RCT) met als titel 'Trauma in Psychosis' (TTIP). Het TTIP-design 
beschrijft de onderzoeksvragen met aanverwante methoden en technieken voor drie 
proefschriften rondom het thema trauma en traumagerichte PTSS-behandeling bij 
psychotische patiënten. Met betrekking tot het huidige proefschrift bevat het studie-
design gedetailleerde informatie over de PTSS screening- en prevalentiestudie, over de 
behandelstudie met de primaire uitkomst (PTSS), secundaire klinische uitkomsten (o.a. 
psychose) en de kosteneffectiviteit.
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Als onderdeel van de TTIP-studie beschrijven we in Hoofdstuk 4 de validatie van een kort 
PTSS-screeningsinstrument, de Trauma Screening Questionnaire (TSQ), bij patiënten 
met psychotische stoornissen (N = 2608). De gegevens van de 2608 TSQ's werden 
geanalyseerd en vergeleken met de diagnostische resultaten van gestructureerde PTSS-
interviews (CAPS) bij 455 van de 2608 psychotische patiënten. Bij de meest optimale 
afkap-score van 6 (range 0-10), had de TSQ een sensitiviteit van 78,8%, een specificiteit 
van 75,6%, 44,5% correct positieve voorspellingen en 93,6% correct negatieve 
voorspellingen. Daarnaast vonden we dat het percentage patiënten in de psychosezorg 
dat was blootgesteld aan ten minste één traumatische gebeurtenis in hun leven (78%) 
vergelijkbaar is met het percentage in de algemene bevolking. In tegenstelling tot 
personen in de algemene populatie, maakten individuen in de psychosegroep (N = 2608) 
echter gemiddeld meer trauma’s mee (ongeveer 56% ≥ 3 traumatische incidenten) in 
meer categorieën (> 2, bijvoorbeeld seksueel / fysiek misbruik en verwaarlozing). De 
conclusie is dat de groep psychotische personen in de geestelijke gezondheidszorg over 
het algemeen een multitraumagroep is. In overeenstemming met deze bevinding bleek 
dat de geschatte prevalentie van PTSS in deze patiëntengroep aanzienlijk hoger was 
(16%) dan in de algemene bevolking in Nederland (prevalentie 3,3% in het afgelopen 
jaar).
In de TTIP-interventiestudie (Hoofdstuk 5) voerden we een RCT uit met chronische, 
gemiddeld tot ernstig psychotische patiënten met een comorbide chronische PTSS 
(N = 155), die standaardbehandeling (‘treatment as usual’, TAU) voor hun psychose 
kregen. We toonden aan dat de toevoeging aan TAU van maximaal acht sessies 
EMDR- of PE-therapie effectiever was dan een wachtlijst-controleconditie (WL) voor 
het verminderen van PTSS-symptomen bij psychotische patiënten. In de EMDR en 
PE condities, was het aantal patiënten dat na behandeling niet langer voldeed aan de 
criteria voor een DSM IV-PTSS-diagnose significant groter in vergelijking met de WL. 
Bovendien was er, vergeleken met WL, een significante afname in de ernst van PTSS-
symptomen en van disfunctionele posttraumatische cognities. Er waren geen significante 
verschillen tussen de drie condities EMDR, PE en WL qua uitval of ernstige bijwerkingen 
(bijvoorbeeld overlijden, opname, psychiatrische crisis). Alle effecten bleken bij de 
follow-up van 6 maanden behouden. Deze studie toont aan dat een trauma gerelateerde 
stress-stoornis, zoals PTSS, bij patiënten met psychotische aandoeningen met succes 
kan worden behandeld met traumagerichte behandelmethoden die in de richtlijnen 
beschreven staan. 
In de context van de interventiestudie zoals beschreven in hoofdstuk 5, werden de 
secundaire uitkomsten bestudeerd (Hoofdstuk 6). Deze studie richtte zich op de 
belangrijkste zorg van professionals die hen ervan weerhoudt om psychotische patiënten 
traumagerichte behandeling te geven: de angst om meer psychotische symptomen of 
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andere vormen van achteruitgang of schade te veroorzaken. Deze schadelijke effecten, 
zo is de angst, zouden kunnen optreden door psychotische patiënten bloot te stellen aan 
herinneringen aan trauma’s waardoor intense spanning en emoties worden opgeroepen, 
die deze patiënten verondersteld worden niet te kunnen reguleren. We vonden echter, 
dat de behandelcondities (PE en EMDR) vergeleken met WL, tot significant meer 
vermindering van de ernst van paranoïde gedachten en depressieve klachten (depressie 
alleen bij PE) leidden, en tot betere resultaten qua remissie van psychose. Er werden 
geen verschillen tussen de groepen gevonden voor wat betreft de ernst van auditieve 
hallucinaties en het sociaal functioneren. De resultaten bleven behouden na de follow-
up van 6 maanden. We concludeerden dat de 'angst om schade te berokkenen' niet 
wordt bevestigd door onze bevindingen. Integendeel, onze gegevens tonen aan dat 
de behandeling van comorbide PTSS bij psychotische patiënten niet te belastend voor 
hen is en in feite juist kan helpen om psychotische en / of stemmingsproblemen te 
verminderen.
Hoofdstuk 7 beschrijft onze bevindingen van de kosteneffectiviteit van de PTSS-
behandelingen in de context van de beschreven RCT. Zowel psychose als PTSS 
behoren wereldwijd tot de economisch meest kostbare psychiatrische stoornissen. 
Daarom hebben we onderzocht of de economische kosten van het implementeren en 
toepassen van PTSS-behandeling in deze specifieke patiëntengroep gerechtvaardigd 
zijn, als we ze onderzoeken in relatie tot de gezondheidsvoordelen. We vonden dat na 
6 maanden EMDR en PE, in vergelijking met de WL, gepaard gingen met lagere kosten 
(EMDR -€ 1410, PE -€ 501). De zogeheten incrementele (toegenomen) gezondheidswinst 
(quality adjusted life years, QALY) was 0.05 bij beide behandelcondities. De incrementele 
klinische verbetering van het kwijtraken van PTSS diagnosen (= niet langer voldoen aan 
de CAPS-IV-PTSD-criteria en een CAPS-IV-ernst <45) was respectievelijk 0.26 (EMDR) 
en 0.22 (PE). Omgerekend betekent dit dat voor elk jaar van gezondheidswinst (1 QALY) 
de kosten € 8.200 (PE) of € 30.000 (EMDR) lager waren dan bij niet-behandelen van de 
PTSS; en voor het 'kwijtraken van 1 PTSS-diagnose' waren de kosten € 1.890 (PE) of € 
6.100 (EMDR) lager in vergelijking met niet-behandelen. Scatterplots en acceptability 
curves gaven aan dat de PTSS behandelingen met (zeer) grote waarschijnlijkheid de 
betere economische keuze zijn ten opzichte van niet-behandelen, ongeacht hoeveel geld 
de samenleving bereid is om voor verbetering te betalen (willingness to pay). De soliditeit 
van deze bevindingen werd bevestigd door drie sensitiviteitsanalysen. Uit een 12-maands 
follow-up controle van de experimentele groepen bleek dat de kostenverlagingen 
niet verloren waren gegaan, maar in de loop van de tijd gehandhaafd bleven of zelfs 
toenamen. Zelfs als de implementatiekosten van training en behandelsupervisies mee 
werden berekend, bleef het bieden van PTSS-behandeling aan psychotische patiënten 
de betere economische keuze.
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Hoofdstuk 8 bevat de algemene discussie. Om de detectie van trauma en PTSS bij 
psychotische patiënten te bevorderen, is het nodig dat organisaties en professionals 
beschikbare middelen (zoals de TSQ) gaan gebruiken en implementeren, en opmerkzaam 
zijn voor wat betreft traumatische ervaringen in de levensgeschiedenis. Hiervoor kan 
training van personeel nuttig zijn. 
Replicatie van ons interventieonderzoek in de toekomst is nodig. Andere varianten 
van PTSS-behandeling kunnen dan ook in de vergelijkingen worden opgenomen, zoals 
vormen van intensieve (combinaties van) PTSS-behandelingen en/of varianten die niet 
direct op trauma zijn gericht, zoals cognitieve herstructurering of interpersoonlijke 
therapie voor PTSS. 
Een beperking van onze studie is dat de keuze van de controlegroep niet optimaal 
was. De controlegroep was passief (wachtlijst) en werd op baseline blootgesteld aan 
uitgebreide klinische interviews naar trauma en PTSS-klachten, wat mogelijk resulteerde 
in verbetering als gevolg van een placebo-effect. Toekomstige studies kunnen andere 
controlecondities overwegen. 
Replicatie van de studies is nodig omdat de resultaten die wij verkregen hebben 
in de context van de Nederlandse gezondheidszorg niet zomaar gegeneraliseerd 
kunnen worden naar andere locaties of contexten. Dit geldt vooral voor ons 
kosteneffectiviteitsonderzoek, omdat tussen landen zeer sterke verschillen bestaan in 
gezondheidszorg- en verzekeringsstelsels, bestuursvormen, economie, demografie en 
infrastructuur. 
We bespreken ook het gebrek aan effect van de behandelingen op hallucinaties en 
op sociaal functioneren, evenals het gebrek aan effect van EMDR op depressieve klachten 
van de patiënten. Mogelijke verklaringen worden geboden en enkele aanbevelingen 
worden gedaan voor toekomstig onderzoek. Toch, zelfs als we de afwezigheid van 
bepaalde verwachte effecten beschouwen, kunnen we concluderen dat traumagerichte 
behandeling secundaire symptomen van patiënten zoals psychoseklachten lijkt te 
verlichten in plaats van verergeren. 
In de discussie worden studies besproken die hebben aangetoond dat trauma en 
trauma gerelateerde stress-stoornissen, zoals PTSS, algemene pluripotente voorspellers 
zijn - dat wil zeggen dat trauma en traumagerelateerde stress-stoornissen een waaier van 
toekomstige ernstige psychopathologie kunnen voorspellen, waaronder psychose. Dit 
onderstreept hoe belangrijk het is dat trauma en PTSS aandacht krijgen in de diagnostiek 
en behandeling van patiënten met ernstige psychische aandoeningen.
Met betrekking tot onze oorspronkelijke onderzoeksvragen trekken we in de 
algemene discussie de conclusie dat, in tegenstelling tot de gangbare opvatting, het 
mogelijk en nuttig is om PTSS op te sporen en te behandelen bij patiënten met een 
psychose. Voor de effectiviteit van de op richtlijnen gebaseerde traumagerichte PTSS-
behandelingen, zoals PE- en EMDR, is nu empirische ondersteuning. Deze behandelingen 
verminderen PTSS-klachten, symptomen van psychose en depressie en ze verminderen 
de kosten voor de samenleving.
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Dankwoord
David, Berber, 
Guys, wat een geweldig stel zijn jullie. Echt helemaal top dat ik de eer, het genoegen en 
het plezier had om met jullie te werken. Zonder elkaar was het niet gelukt, in elk geval 
niet zoals het nu is gelukt. Ik ben jullie ongelooflijk dankbaar en jullie zijn me ongelooflijk 
dierbaar geworden.
Wat hebben we gedaan: (top)publicaties gemaakt, internationale workshops gegeven, 
richtlijnen opgeschud, visies opengebroken, de GGZ-praktijk beïnvloed, een onderlegger 
gemaakt voor nieuwe onderzoeksinitiatieven, een legertje Toegepast Psychologen/
onderzoeksassistenten opgeleid, therapeuten gesuperviseerd, dóórdenksessies 
gehouden, plenaire sessies met de profs (in de hand) gehouden, hilarische of aangrijpende 
workshops gegeven, eindeloos inclusies en data gedubbelcheckt, overgenomen voor 
elkaar, een traumacursus voor teams gemaakt….het was geweldig om mee te maken. 
Ik ben er ontzettend blij van geworden en heel erg trots. Ik voel me totaal schatplichtig 
aan jullie intelligentie, visie, scherpte en kritische zin. Het was een liefdevol, gedreven 
en fantastisch project. Jullie zijn superlieve vrienden, briljante collega’s en heel, heel erg 
bedankt.
Agnes, Ad, Mark,
Jullie zijn een ultiem promotie-dreamteam geweest. Een team dat sprookjes helpt waar te 
maken en tot een goed einde weet te helpen. En om maar even in de sprookjes-metafoor 
te blijven: Agnes, je bent de Koningin van het consequent en met beleid stapsgewijs 
empirisch ontmaskeren van mythes over traumabehandeling – daarmee de deuren 
naar traumabehandeling openend voor hele groepen patiënten. Ad, de Magiër, je hebt 
onbegrijpelijke voorraden energie en goud, betoverende interventies en een tomeloze 
drift om al je geheime formules te delen met anderen. En dan Mark, de Gigant, je kijkt 
over alles en iedereen heen en schept orde in chaos, zet processen in gang, verheldert 
en stuurt bij waar anderen niet kunnen reiken op een schaal die alleen een Gigant kan 
overzien. 
Alle drie wil ik jullie bedanken voor jullie begeleiding, commentaren, ongebreidelde inzet, 
lessen, geduld en liefde voor dit project en voor ons, de drie promovendi van het TTIP 
project.
Carlijn
Omdat je de EMDR training en supervisies mee verzorgde was je er bij. Alle vergaderingen 
van het TTIP-collectief heb je bijgewoond in het kader van je eigen promotietraject 
en niemand van ons die dat in twijfel trok. Every step of the way heb je meegedacht. 
Dat zegt alles: zo hartelijk en gezellig, zo betrokken en enthousiast, zo deskundig en 
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leergierig. Iemand die iedereen wel wil leren kennen. Dankjewel! En uiteraard heel erg 
bedankt voor je supervisies aan de therapeuten.
Filip en Joran
Heel erg bedankt voor de noodzakelijke ondersteuning bij het reken- en schrijfwerk van 
de gezondheidseconomische studie. Ondanks oponthoud en hobbels van diverse aard 
is het tot een prachtig resultaat gekomen en voor mij de mooist denkbare afsluiting 
geworden van de reeks studies in mijn proefschrift.
Datamanagers, therapeuten en research-assistenten
Psychologen in 13 GGZ-instellingen en researchassistenten van vijf verschillende 
hogescholen in Nederland die in opleiding waren tot Toegepast Psycholoog, hebben zich 
meerdere jaren ik-weet-niet-hoeveel slagen in de rondte gewerkt om alle behandelingen 
te verzorgen en alle data te verzamelen. En hoe! De behandelingen zijn goed uitgevoerd 
en de kwantiteit en kwaliteit van de data die zijn vergaard en ingeklopt zijn fenomenaal. 
Een enorme prestatie, waarvoor niet alleen ik en het hele TTIP promotieteam jullie 
onnoemelijk dankbaar zijn. 
In het bijzonder verdienen in dit kader Marion Bruns en Danielle Palmboom-Tilburgs 
hartelijke dank. Jullie hebben gezorgd voor gestroomlijnde logistiek richting behandelaren 
en assistenten, voor extreem zorgvuldige archivering van de patiëntenstroom over de 
meetmomenten, voor het zorgvuldig inkloppen van data, voor het inwerken en trainen 
van assistenten, voor duizend-en-één klussen tussendoor. Ontzettend bedankt!
Participerende patiënten
Ik wil de patiënten die meededen bedanken. Immers, traumagerichte behandeling 
bij psychotische patiënten was altijd een ‘no-go’, een keiharde, breed gedragen en 
officiële contra-indicatie. Heel veel patiënten hadden dat al vaak gehoord tijdens hun 
behandelingen: over trauma’s moet je niet praten, dat gaat alleen maar problemen 
geven, we houden “het deksel maar liever op de put”. Daarom is het ook zo opmerkelijk 
dat bijna 3000 psychose-patiënten zich voor onze studie lieten screenen op PTSS, dat 
455 patiënten akkoord gingen met intensieve PTSS interviews voor de screener- en 
prevalentiestudie. Even bijzonder is het dat na deze massale deelname 155 patiënten 
aan de interventiestudie mee wilden doen en bewust het risico namen dat het niks 
werd, of erger. Wat een lef en wat een visie aan de kant van de patiënten. Hulde! De 
patiënten wisten denk ik al veel langer en beter dan wij wat ze wel en niet aankonden en 
aandurfden - en hoe belangrijk dat onderwerp ‘trauma’ voor hun problematiek was. Een 
pleidooi weer voor ervaringsdeskundigheid in de GGZ.
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Jesse, 
Alleen al omdat eigenlijk alles wat ik doe ook voor jou is krijg je een plaats in dit dankwoord. 
Maar zonder dat je het wist heb je me echt geholpen, toevallig juist in de jaren dat er 
het hardst gewerkt moest worden. Want je was jong en leuk en gezellig en blije vaders 
werken harder. En ik kon heel vaak mooi doorwerken op ‘mijn’ dagen, als ik bijvoorbeeld 
lekker zat te wachten en te kijken aan de kant van de zwemles, de keeperstraining of de 
middagdutjes. Een geweldige formule! Bedankt. 
Last but not least, Irma,
Lieverd, hoeveel promovendi scheiden er wel niet. Heel veel! Maar wij lekker niet. 
Superbedankt voor je geduld en je liefde om me een aantal jaren te delen met dit 
studieproject; soms zó veel te delen dat het echt niet leuk meer was. Maar altijd zag je 
weer hoe groot mijn drive was, dat het me blij maakte en dat er toch geen houden aan 
was. Lieverd, ik ben zo gelukkig dat je me de ruimte hebt gegeven om het af te maken en 
daarvoor bedank ik je uit de grond van mijn hart. Dat was liefde. Ik houd van je. Bedankt.
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